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Abstract
Q u in o lin a te  phosphoribosyltransferase (QPRTase, B.C. 2 .4 .2.19) is 
considered to be a unique enzyme in that it is thought to catalyse two distinct chemical 
reactions. Both the transfer of a phosphoribosyl group from 5-phosphoribosyl-l- 
pyrophosphate onto the nitrogen of quinolinic acid and the subsequent decarboxylation 
of the inteimediate to form nicotinic acid mononucleotide are thought to be catalysed by 
the QPRTase system.
Analogues of quinolinic acid were designed as potential inhibitors of QPRTase. 
These contain acidic groups at the 2- and 3- positions but are unable to decarboxylate. 
However, such compounds may be able to undergo the phosphoribosyl transfer 
reaction, potentially increasing their inhibitory potency. These compounds may be 
useful as "biological tools" allowing the neurological effects of an increase in quinolinic 
acid levels to be investigated. The compounds may show anti-fungal activity blocking 
the kynurenine pathway for NAD production.
2-Sulfonicotinic acid was synthesised by the oxidation of 2-mercaptonicotinic 
acid by either basic potassium permanganate, or iodine, with the structure was 
confirmed by X-ray crystallography. In biological testing the acid was shown to be 
neither an agonist or antagonist of the NMDA receptor, or to be neurotoxic.
A number of synthetic routes towards 2-phosphononicotinic acid, an alternative 
quinolinic acid analogue, were attempted though none were successful. These included 
orthometallation strategies and palladium coupling reactions to incorporate the 
phosphonic acid group at the 2- position. Nucleophilic addition routes, methods of 
building up the pyridine ring and including non-selective phosphonic acid addition were 
also examined. However, a related derivative, 2-(phosphonomethyl)nicotinic acid, was 
successfully synthesised.
The non-enzymic decarboxylation of iV-alkyl quinolinic acids was investigated, 
for comparison with the decarboxylation reaction catalysed by QPRTase. Both N- 
methyl and //-ethylquinolinic acid were synthesised, and the pH versus rate profiles 
measured. The rate maximum for both compounds was at pH 1.5, with the rate 
decreasing both above and below the maximum. A-Methylquinolinic acid was 10 times 
faster than quinolinic acid itself, demonstrating the effect of the nitrogen substituent. 
The A-ethyl derivative decarboxylated a further 1.5 times faster, showing the effect of 
increasing the size of the substituent. An Arrhenius plot was also carried out, giving an 
activation energy for the reaction of 153 kJ mol k Attempts to prepare the A-propyl 
derivative were unsuccessful, as decarboxylation occurred very readily to give N- 
propylnicotinic acid.
CHAPTER 1
1. QPRTase - the enzyme
1.1 Background
Q uinolinate phosphoribosyltransferase (QPRTase, B.C. 2.4.2.19) is an 
important enzyme of the de novo NAD biosynthetic pathway in both prokaryotes and 
eukaryotes. QPRTase is unique as it is considered to catalyse two distinct chemical 
reactions. The first of these is the phosphorylation of quinolinic acid (1) with 5- 
phosphoribosyl-1-pyrophosphate (PRPP) (2) as the phosphorylating agent, in the 
presence of Mg^+, to give the intermediate quinolinic acid mononucleotide (3). 
Subsequent decarboxylation of this intermediate at the 2- position of the pyridine ring 
yields nicotinic acid mononucleotide (4) (Scheme 1.1).
a COjH 
C O . » *
(1)
OPPi
QPRTase
Mg2+
CO2H
PiO-
HO OH
(3)
+ PPi
PiO-
OHHO
(4)
+ CO2
Scheme 1.1: QPRTase catalysed reaction
QPRTase is therefore essential for metabolism of quinolinic acid, which is the 
first intermediate in the biosynthesis of NAD common to all organisms. From this 
point in the pathway all biological systems, animals, plants and micro-organisms, 
follow the same route to formation of NAD. The metabolism of quinolinic acid is 
important due to its potency as a neurotoxin. It is an agonist of the NMDA receptor, 
and high levels of the acid have shown to be present in the brain and CSF of patients 
with neurodegenerative diseases such as Huntington's Disease and AIDS (see Section 
1.9).
1.2 Introduction
It was first suggested that quinolinic acid was simply a side product of 3- 
hydroxyanthranilate metabolism, rather than an intermediate in nicotinic acid 
mononucleotide (NAMN) biosynthesis. ^  Nishizuka and Hayaishi showed the presence 
of an enzyme that would convert 3-hydroxyanthranilate to NAMN, via quinolinic acid 
as an intermediate.^ Using I'^C-labelled quinolinic acid, ^^00% was detected in cat and 
rat liver. Later that year the same group demonstrated that nicotinic acid was not an 
intermediate in this pathway, and that quinolinic acid is not inert, but was a vital part.3
Nakamura et al^ first isolated and purified an enzyme from rat liver acetone 
powder and demonstrated that free nicotinic acid is not involved in the PRPP-dependent 
NAMN formation from quinolinic acid. They found that a single enzyme was 
responsible for the reaction to form NAMN, and gained no evidence for the formation 
of quinolinic acid mononucleotide as an intermediate. This group named the enzyme 
"quinolinate transphosphoribosylase". The NAMN formed was isolated, and the 
amount of measured along with the concentration of remaining quinolinic acid. 
The results of this experiment gave the stoichiometry of the reaction. The amount of 
quinolinic acid consumed corresponded directly to the amount of NAMN and 
consumed. Thus one mole of quinolinic acid leads to the formation of one mole of 
NAMN with the additional loss of one mole of ^^ 0 0 2 . When their experiments were
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repeated without PRPP no quinolinic acid was consumed, no NAMN formed and no 
^^C02 detected. The same results were obtained when Mg^+ was the only component 
missing, and when all the components were present, but the enzyme had been boiled 
first, showing that both Mg^+ and PRPP are required for the reaction to take place.
The assay used involved measuring the PRPP-dependent evolution of ^^C0 2  
from [I'^Cl-quinolinic acid.3 The synthesis of [^^CJ^-quinolinic acid is given below 
(Scheme 1.2). Labelled aniline (5) was condensed with glycerol to form quinoline (6), 
which in the presence of divalent copper cations was oxidised to [^^Cj^-quinolinic acid 
with hydrogen peroxide. Acidification, extraction and then treatment with H2S 
produced the required free acid.
CH2OH
CH(OH) +
CH2OH H2N'
* H2SO4, FeS04
 ►
* A, Nitrobenzene
*
(5) (6)
H2O2, Cu 
70 °C
2+
N'
.CO2H
CO2H
H+
Scheme 1.2: Synthesis of [^^C]4-quinolinic acid
Gholson et al confirmed that only one enzyme is required for the transformation 
when they also found no evidence for the presence of quinolinic acid mononucleotide.  ^
From the relatively high rate of reaction, and the low value for quinolinic acid, it 
was proposed that quinolinic acid was an intermediate in the transformation of 
tryptophan to NAD and the biosynthesis of pyridine nucleotides from tryptophan.
A single enzyme thus appeared to be responsible for both the phosphoribosyl 
transfer and decarboxylation, but it was also suggested that the decarboxylation reaction 
could be non-enzymic. Increased electronegativity at position two,^ as the pyridine ring 
nitrogen becomes quaternary on addition of the phosphoribosyl group, could facilitate 
loss of carbon dioxide.
Nakamura et al suggested that the enzyme was found only in the liver and 
kidney of rat and mouse, but not in any other tissues or organs.^ They also found that 
“quinolinate transphosphoribosylase” was widely distributed in micro-organisms, fungi 
and plants, including Pseudomonas fluorescens, E. coUP Neurospora crassaP yeast 
and cucumber. Since this initial discovery, QPRTase has been isolated and purified 
from many sources. Iwai and Taguchi observed high activity for the enzyme in a wide 
range of organisms with persimmon leaf, Shiitake mushroom, Enshitake mushroom, 
bakers' yeast and Pseudomonas riboflavin being revealed as sources of the enzyme for 
the first time.^ Ricinius communis (castor bean) endosperm,^ hog liver^^.ii and 
Alicagenes eutrophusP^ the root and leaves of the tobacco plant 
Nicotiniana tobaccumP^ rat b r a i n a n d  human brain and liver,i'^d8 i^nà Salmonella 
typhimurium^^ have all since been identified as sources of QPRTase.
1.3 Physical properties
1.3.1 Molecular weight
Depending upon the source of the enzyme, QPRTase has been shown to have a 
range of molecular weights. Initial reports of QPRTase from a pseudomonad^O 
revealed a molecular weight (MW) of 178 000. Further work by the same 
researchers^^ modified this to a MW of 165 000, which they could be irreversibly 
dissociated into inactive protein units of MW 54 000. Electrophoresis on the enzyme 
from the castor bean endosperm (Ricinius communis) demonstrated that two subunits 
both of approximately 35 000 were present.^ Hog liver QPRTase^® was found to have 
five subunits of 34 200, giving a total MW of around 172 000. However the X-ray 
diffraction analysis of the enzyme from hog liver^^ indicated that there were actually six 
identical subunits, all of 34 200, and the MW was re-evaluated to between 202 000 - 
210 000. Interestingly, the enzyme from Alicagenes eutrophus nov subsp. 
quinolinicus^^ was shown to have a MW 210 000 - 222 000, but in this case consisted 
of eight identical subunits of 27 500. Rat QPRTase was purified from liver and brain 
sources, and was found to have a MW of 160 000, with five subunits of 32 000, 
whilst purification of human QPRTase^^ revealed a MW of 170 000, again with five 
subunits. The most recent QPRTase to be purified is that from Salmonella typhimurium 
nad C gene,!^ which shows a MW 72 000 with two subunits in this case.
Overall there seems to be a pattern of the enzyme existing either in the form of a 
dimer or a pentamer, depending on the evolutionary history.
1.3.2 Variation of activity with pH
As with the molecular weight the optimum pH for QPRTase varies according to 
the particular source of the enzyme. From beef liver^ maximum activity was seen at pH 
6.2. If the source was a pseudomonad, the optimum pH was 6 .8 , with 50% of 
maximal activity at pH 6.2, and 80% at pH 8.0, whilst another Pseudomonas sp. gave 
optimum activity at pH 7.1. In contrast to these sharp pH optima, QPRTase from 
castor bean endosperm was active over a wide pH range,^ with optimum activity 
between 6.5 and 7.7. Interestingly, Alicagenes eutrophus nov subsp. quinolinicus 
QPRTase had an optimum pH of 8.5 - 9.0, and optimum temperature of 60 °C while 
that of hog liveri4 only pH 6.1, and crystalline hog kidney enzyme pH 5.5. Human 
liver QPRTaseis showed a maximum activity at approximately pH 6.5.
The optimum pH for maximum activity of the enzyme thus appears to differ as 
much according to the location of the enzyme within the organism as it does from 
organism to organism.
1.4 Inhibition studies
Investigation into the inhibition of an enzyme system is an extremely important 
part of understanding the enzyme. The use of inhibitors is vital, not just to prevent the 
enzyme from functioning, but also to examine possible mechanisms for the catalysed 
reaction. QPRTase is no exception and several inhibition studies have been reported.
1.4.1 Cations
The study of Nakamura et al showed that the enzyme from beef liver gave 
maximum activity with a M gCli concentration of 5 x 10"  ^M.^ As the concentration of 
Mg^+ increased, an increase in inhibition was observed, with 90-95% inhibition at 2 x 
lQ-2 M. Inhibition by high concentrations of Mg^+ can be easily reversed by adding a 
boiled crude enzyme extract p reparation ,suggesting  that a substance which is able to 
chelate Mg^+ is present in the crude extract. It was also confirmed that the presence of 
Mg^+ is absolutely required for the activity of the enzyme.
Other divalent cations also inhibited the enzyme. Thus Hg^+, Co^+, Cu^+, Ba^+, 
Mn^+ and Ca^+ all inhibited by almost 100% at 10'^ M, while Zn^+ and Fe^+ inhibited 
by 40-70% at this level. Further studies showed that Cd^+ also inhibited enzyme 
activity by 20-40% at 10-3 m  23
Shibata and Iwai reported that with QPRTase from hog kidney, Mg2+ could 
actually be completely replaced by Mn^+ ions,^^ ^nd that similar results could be 
obtained from the liver e n z y m e . ^ 2  In Alicagenes spM  and Shiitake m u s h r o o m s , 2 4  
Mn2+ was only partially effective in replacing Mg2+.
1,4.2 Nucleotides
It was discovered early on in QPRTase studies that the formation of NAMN 
from quinolinic acid was not reliant on ATP, as is its formation from nicotinic acid 
(NAPRTase).23 In fact ATP actually inhibits QPRTase activity at 10-3-10-4 M. NAD 
also inhibits the reaction, and initially this was thought to be some form of regulatory 
system.3 Such negative feedback control is very well known in the metabolic pathways 
of micro-organisms,25 but rarely occurs in higher organisms.
The reaction, at optimum Mg2+ concentration, is inhibited by other phosphorus 
containing compounds, including AMP, inorganic pyrophosphate, NAD and FAD at 
concentrations between 10-3-10-4 M. Metal chelating agents, such as F also inhibit the 
reaction at 10-3 M. If, however, the Mg2+ is then increased (5 x 10-3 M and higher) 
then the inhibition brought about by these molecules disappears. This implies that 
inhibition by these compounds was not by interaction at the active site of the enzyme 
but rather by chelation of Mg2+ ions.
Okuno et al incubated purified liver QPRTase with [3H ]-NA M N and 
pyrophosphate under normal QPRTase assay conditions and showed that no production 
of [3H]-quinolinic acid was observed by ion exchange c h r o m a to g r a p h y .T h i s  is a 
good indication that NAMN does not inhibit QPRTase. pH]-NAMN was prepared by 
the incubation of 1 irCi pH]-quinolinic acid with 1 mM PRPP, 4 mM MgCl2 in a 
solution of 20 mM sodium acetate-acid buffer (pH 5.5), total volume 0.5 ml, at 37 °C 
for 2 h o u r s . 2 6  Complete reaction of pH]-quinolinic acid was observed by HPLC and 
tic.
10
1.4.3 Nicotinic acid and nicotinamide
In their studies on QPRTase from castor bean endosperm, Mann and Byerrum^ 
examined the effect of pyridine nucleotide precursors nicotinic acid and nicotinamide, 
and showed that neither inhibited the enzyme, and that neither of them were affected by 
the enzyme at all. Studies by Packman and Jakoby on the enzyme from Pseudomonas 
confirmed this observation.27 QPRTase is absolutely specific for quinolinic acid, and 
does not catalyse formation of any other pyridine nucleotides.
1.4.4 5-Phosphoribosyl-l-pyrophosphate analogues
Kunjara et al investigated the stereospecificity of the enzyme-PRPP binding site, 
and especially the m etal-PRPP com plex at this s i t e . 2 8  They synthesised 
phosphorothioate analogues of PRPP and tested them as substrates of QPRTase, using 
either M g 2 + ,  C o 2 +  or C d 2 +  as the cation. These analogues, previously synthesised by 
Smithers and O ’ S u l l i v a n , 29 were phosphoribosyl-l-0-(2-thiodi-phosphate) (PRPPpS) 
and the diastereomers of phosphoribosyl-l-O-(l-thiodiphosphate) (PRPPaS). With 
M g 2 +  PRPP was a better substrate than (PRPPaS), but the velocities were of a similar 
order. The S diastereomer was a better substrate with M g 2 + ,  whereas with C d 2 +  the R 
diastereomer was better. The apparent reversal of enzyme stereospecificity with the 
change of divalent cation suggests that the metal ion remains ligated to the 1-P moiety in 
the rate determining step, as cations such as M g 2 +  (hard) prefer ligation with oxygen, 
and soft Cd2+ prefers complexation with S.
Iwai et al found that potassium phosphate buffer inhibited QPRTase from 
Alicagenes spP"  ^ The two salts constituting a potassium phosphate buffer were 
investigated individually, and as a result, KH2PO 4 was shown to inhibit more than 
K2HPO4, which inhibits to the same extent as both KCl and K3PO4. The inhibition by 
H 2P O 4' was not affected by increased concentrations of phosphoribosyl 
pyrophosphate, and as the ionic strength increased so did the level of inhibition. It was
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suggested from these results that the inhibition by H2PO4- is not only due to an increase 
in the ionic strength, but by some interaction with the protein, in particular the ionic 
binding between the enzyme and its substrate.
In their investigations into the effect of PRPP on hog kidney and liver QPRTase 
Shibata and Iwai demonstrated that increased PRPP concentrations affect the optimum 
pH for QPRTase activity,30 and actually inhibited activity of the enzyme at alkaline pH 
and physiological pH. This inhibition of the enzyme was not recorded at acidic pH, 
although if 30% glycerol was present the same degree of inhibition was seen with a 
lower PRPP concentration than at alkaline pH.
A possible explanation for the inhibition at alkaline pH or physiological pH may 
be that the enzyme conformation is actually native at this pH range, as PRPP inhibits at 
physiological pH. Shibata and Iwai proposed that the enzyme protein may have two 
binding sites, one of which is capable of binding both quinolinic acid and PRPP, the 
other PRPP only.30 This could alter at acidic pH, so that the binding site for quinolinic 
acid and PRPP may only bind quinolinic acid, thus removing PRPP inhibition 
properties.
Glycerol has been shown to affect the binding site of enzymes,3i and has been 
observed to maintain, even at acidic pH, an active conformation of hog kidney and liver 
Q P R T a s e s .2 2 ,3 2  This helps to explain why, in the presence of glycerol, PRPP can still 
inhibit the enzyme.
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1.4.5 Quinolinic acid analogues as inhibitors
This is the area of QPRTase inhibition which has been most studied. The effect 
of these analogues on the rate of the QPRTase reaction should give information on the 
active site of the enzyme and the way in which the enzyme catalyses the reaction.
Mann and Byerrum investigated the effect of several quinolinic acid analogues 
on the rate of the enzymic reaction for the enzyme from castor bean endosperm.^ 
Picolinic acid (7) was by far the most effective inhibitor of those tested, with a Ki of 
10'3 M. The results demonstrated that a free carboxylate at the 2-position was required 
for effective inhibition. The methyl esters tested were not as effective inhibitors as the 
free acids. Interestingly the 2-methyl ester of quinolinic acid (8 ) does inhibit the 
enzyme, and more significantly than the other 2-methyl esters, methyl 3-aminopyridine- 
2-carboxylate (9) and methyl 3-cyanopyridine-2-carboxylate (10). This suggests that 
the 3-carboxylate is also important for substrate binding, but not as significant as the 2- 
caiboxylate.
N CO2H ‘N CO2CH3 N' CO2CH3 N CO2CH3
(7) (8) (9) (10)
The effect of a 2-carboxylate was also demonstrated with inhibition studies on 
the positional isomers of quinolinic acid. The 2,4- (11) and 2,5-dicarboxylic acids 
(12) were mainly ineffective, but pyridine-2,6-carboxylic acid (13) and pyridine-3,4- 
carboxylic acid (cinchomeric acid) (14) did inhibit well. Pyridine-2,6-carboxylic acid 
(dipicolinic acid) acts like picolinic acid, showing the requirement for the 2-carboxylate.
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(11)
HO2C'
(12)
N
(13) (14)
2-Hydroxy nicotinic acid (15) did inhibit QPRTase activity, but not as much as 
analogues with a carboxylic acid group at the 2- position. 4-Hydroxyquinolinic acid 
(16) also inhibited quite well, the steric effect of the C-4 substituent appearing not to 
exclude the molecule from the active site.
OH
N OH
(15) (16)
Shibata and Iwai also showed that dipicolinic acid inhibited the enzyme from 
this source, despite not inhibiting QPRTase from hog liver and Alicagenes sp.^^ 
Dipicolinic acid is known as a metal chelator, but in this case adding extra Mg2+ did not 
decrease inhibition to a significant extent. The same pattern was seen with pyrazine- 
2,3-dicarboxylic acid.
Taguchi and Iwai looked at inhibition of hog liver QPRTase by various 
quinolinic acid analogues.^ Only phthalic acid had any significant inhibitory effect, the 
mode of inhibition for which was shown to be competitive and a Ki value of 1.7 x 10'^ 
M determined.
Shibata and Iwai tested a selection of carboxylic acids as inhibitors of QPRTase 
from Alicagenes sp. and again showed picolinic acid as an inhibitor. Phthalic acid also 
strongly inhibited enzyme activity, which suggests that the nitrogen of quinolinic acid
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may not be required for binding of the substrate at the active site of the enzyme. 
However, as pipecolic acid (piperidine-2-carboxylic acid) does not inhibit, the pyridine 
ring may be essential. The type of inhibition for picolinic acid and phthalic acid was 
shown to be competitive for both with a Ki of 8.22 and 8.87 x lO"  ^ M respectively, 
while the esters of these inhibitors, methyl picolinate and dibutyl phthalate, did not 
inhibit. These results help to confirm the suggestion that C-2 carboxylate group is 
important in binding the substrate to the enzyme, and that having carboxylate groups 
adjacent to each other is also important.
Ki values for phthalic acid from all three sources show how potent an inhibitor 
it is and Km values for quinolinic acid increase significantly when phthalic acid is 
added. The Ki value for phthalic acid as an inhibitor of brain QPRTase is 40-80 times 
lower than the values seen for inhibition in the liver or the enzyme ixom Alicagenes sp., 
so either brain QPRTase is different or is subject to distinct regulatory influences.
Kalikin and Calvo synthesised a group of 2-substituted nicotinic acids and 2- 
substituted 3-nitropyridines to investigate their action as inhibitors (Table 1.1).33 The 
four compounds used in the study were 2-hydroxynicotinic acid, 2-mercaptonicotinic 
acid (17), 2-hydroxy 3-nitropyridine (18) and 2-mercapto-3-nitropyridine (19). The 
mode of inhibition for 2-mercapto-3~nitropyridine was determined and shown to be 
competitive, with a K, of 0.126 mM, which implies that it binds more tightly to the 
enzyme than quinolinic acid (K; of 0.17 mM in this study). All of the compounds 
studied inhibited the enzyme, with varying effectiveness.
H
(15)
H
(17)
H
(18) (19)
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Such compounds, which aie 2-hydroxy or 2-mercaptopyridines, can exist in a 
tautomeric form, where the ring exists as an unsaturated lactam. NMR studies in 
methanol have suggested that only about 4% of 2-hydroxynicotinic acid is present as 
the pyridine, while the amount of 2-mercaptopyridine as the thiol tautomer is slightly 
larger. With 3-nitro substituents, the effect is to even further increase the amount of 
hydroxyl or thiol tautomer relative to the lactam or thiolactam. Obviously both the 
hydroxyl and thiol groups can ionise. Due to the electron withdrawing effect of the 
nitro group, the pKa of these 3-nitropyridines is lower than that of the 3-carboxylate 
substituted compounds.
NO2
SHSH OHOH
pKa
(15)
nd
(17)
nd
(18)
10.3
(19)
6.9
% Inhibition 0.0 8.3 16.0 95.0
Table 1.1: Inhibition of quinolinic acid analogues
It can be seen from the results of Table 1.1 that the actual degree of inhibition 
follows a definite pattern. 2-Mercapto-3-nitropyridine, the compound with the lowest 
pKa of these tested, showed the greatest inhibition, whilst 2-hydroxynicotinic acid 
inhibited the least, and was thought to have the highest pKa. So, as pKa increases, the 
degree of inhibition decreases. These results imply that a negative chai'ge at position 2 
is a big contributor to the tight binding of the inhibitor to the enzyme, as the compound 
with the lowest pKa is also the best inhibitor. Hence there may be some veiy important 
interaction between the negative charge and a positively charged group at the active site 
of the enzyme.
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1.4.6 Amino acid modifications
Reagents that react specifically with sulfhydryl groups, such as p - 
chloromercurobenzoic acid, A^-ethylmaleimide, dithiobis(2-nitrobenzoic acid) and 
monoiodoacetic acid all strongly inhibited the QPRTase catalysed reaction at 37 °C, 
suggesting SH groups have an im portant part to play in the reaction.^4 p . 
Naphthoquinone-4-sulfonic acid and 2,4,6-trinitrobenzenesulfonic acid are known to 
combine with lysine residues, Diethyl pyrocarbonate and p-diazobenzene sulfonic 
acid combine with histidine residues and glyoxal with arginine. These all showed 
inhibitory effects at fairly low concentrations, which implied that lysine, histidine and 
arginine residues may also be involved at the active site of the enzyme. Reaction with 
P-naphthoquinone-4-sulfonic acid and p-diazobenzenesulfonic acid was inhibited by the 
presence of the substrate, although reaction with glyoxal was not.
D iisopropy lfluorophosphate , 2 -hydroxy-5-n itrobenzyl brom ide and 
acetylimidazole are chemical modifying agents for serine, tryptophan and tyrosine 
residues respectively. None of these inhibited QPRTase activity to any degree, 
suggesting that these residues are not present at the active site.
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1.5 Mechanisms
1.5.1 Kinetic mechanism
To date studies on the kinetic mechanism of QPRTase have resulted in no 
conclusive evidence for one particular mechanism. Depending on the source of the 
enzyme, conflicting conclusions have been produced.
For QPRTase from hog kidney double reciprocal plots of initial velocity versus 
a second substrate resulted in parallel, linear plots. From these secondary plots, the 
Km values of quinolinic acid and PRPP were calculated to be 4 x lO'^ M and 1.4 x 10-^ 
M respectively. This made it likely that the reaction mechanism for this source was of 
the "ping-pong" type. Similar results were found for both the hog liver enzyme, and 
QPRTase from Neurospora crassa?-'^'^^
Those enzymes which do operate via a "ping-pong" mechanism require the loss 
of pyrophosphate prior to the binding of quinolinic acid. Alberty developed equations 
for analysis of reactions involving two substrates in which form ation and 
decomposition of binary complexes occur, therefore ruling out ternary c o m p le x e s .I f  
it is assumed that the initial reaction of QPRTase involves PRPP and the enzyme, a 
minimal foimal sequence can be written:
E + PR PP : = ï = i z z = ± i  E'
E' ERP + PP
ERP + QUIN  -  ■■   E"
E" ^  E + NAMN + CO2
In contrast, the enzyme isolated from castor bean endosperm gave double 
reciprocal plots which were linear but non-parallel, representing an ordered reaction 
mechanism.^ This means that both quinolinic acid and PRPP must be bound to the
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enzyme before any product is released. This enzyme, therefore, seems to operate via a 
ternary complex mechanism, facilitated by random binding of the two substrates.
All of this evidence is very much superficial and so no definitive conclusions 
can be drawn from it.
1.5.2 Ylid mechanism for decarboxylation
The significance of the observations by Kilikin and Calvo lies in the chemical 
mechanism for the decarboxylation reaction of QPRTase. An intermediate nitrogen ylid 
m echanism  was proposed by Brown and M oser after their studies on the 
decarboxylation of pyridine-2-carboxylic acids.37 Hammick also postulated a nitrogen 
ylid intermediate in the decarboxylation of picolinic acids,^8 as did Beak and Siegel for 
the decarboxylation of orotic acid,39 while Levine et al explained the inhibition of OMP 
decarboxylase by a barbiturate nucleotide in the same manner.^
If this mechanism is the method of decarboxylation for QPRTase, inhibition by 
the tautomeric forms of 2-hydroxy and 2-mercaptopyridine may also be due to the fact 
that the compounds resemble the intermediate ylid formed im mediately after 
decarboxylation (see Scheme 1.3).
CO2H
PiO
HO OH
Scheme 1.3: Proposed ylid decarboxylation mechanism for QPRTase 
Further work on the ylid mechanism is discussed in Section 3.1.
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1.6 Crystal structure
The first crystallisation of QPRTase was completed by Packman and Jakoby in 
1965.20 Musick^i crystallised the enzyme from hog liver, and investigated the space 
group and the molecular symmetry from this source, by X-ray crystallographic 
methods. In addition to the hexagonal apoenzyme crystals grown, a pseudo-ternary 
complex, containing the enzyme, Mg2+ ions, PRPP and phthalic acid, a known 
competitive inhibitor for the enzyme was obtained. This did not alter the crystal 
morphology, possibly implying that a conformational change does not occur when 
substrate binds to the enzyme. Upon investigation of the space group, the unit cell was 
found to accommodate only two or four molecules in special positions. This implied 
that the enzyme protein was hexameric, which is in direct contradiction to Taguchi and 
Iwai's proposal of a pentamer.^^ These results also lead to a molecular' point symmetry 
of 32.
More recently the detailed crystal structure of QPRTase has been deteimined by 
Eads et al for the enzyme from Salmonella typhimurium^^ The structure has been 
elucidated with bound quinolinic acid to 2.7 Â resolution, and with bound NAMN to 
3.0 Â resolution. Thus the active site of the enzyme, and the amino acid residues 
involved with substrate binding have been identified. Interestingly, the 3-dimensional 
structure of the enzym e shows a com pletely new and novel fold for a 
phosphoribosyltransfer enzyme, one that has a two domain structure, a mixed a /p  N- 
terminal domain and an a /p  barrel like domain which contains seven p strands. The 
active site of QPRTase is present at the C-terminal ends of the P strands of the a /p  
barrel, and is bordered by the N-terminal domain of the second sub-unit of the dimer. 
The site is composed mainly of conserved charged residues, which are obviously 
important both for substrate binding and the actual catalysis.
2 0
1.6.1 cx/p Barrel
The QPRTase ot/p barrel is unlike others previously seen. Seven stranded a /p  
barrels have been previously reported, but the domain of the QPRTase barrel appears to 
be similar to the normal eight stranded oc/p banels. This is the result of a gap between 
the second (B5) and the third (B6) P strands, and this gap gives the appearance of there 
actually being eight strands. No H-bonding exists between B5 and B6 strands and the 
two lie almost orthogonal to each other.
1.6.2 Dimer
The structure of S. typhimurium QPRTase indicates that the dimer is required 
for full activity of the enzyme, as both parts contribute to the active site, and it has been 
shown that the dimer does exist in solution. Both subunits aie very similar.
1.6.3 Active site - quinolinic acid bound
The quinolinic acid molecule is found near the centre of the oc/p barrel close to 
the C-terminal end P strand B4, which is similar to that seen for other a /p  barrel 
enzymes. This also means that the active site is bordered by the N-terminal domain of 
the other subunit in the dimer, which limits the solvent access to quinolinic acid to just 
36 Â2 of a possible 151 van der Waals surface of quinolinic acid normally available.
The resolution of the data is such that it is difficult to orient quinolinic acid 
unambiguously. The 3-carboxylate group of quinolinic acid is within H-bonding 
distance of Ng and N i^ of Arg 175 and Ng of Arg 152, whereas the 2-carboxylate group 
only H-bonds to the mainchain NH of Arg 152. It is also approximately 4 Â from the 
side chain of Lys 153 and Arg 118 from the other dimer. His 174 is near C-5 of 
quinolinic acid and also about 4 Â from the 3-carboxylate group, and these side chains 
form the basic pocket for anionic substrate binding. The active sites of the two
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molecules of the dimers are different. In molecule A, Lys 153 is 3.8 Â from the C-2 
carboxylate group of quinolinic acid, whereas in molecule B it is greater than 4 Â away. 
Lys is only approximately 4 Â away from the C-2 carboxylate in B, but in molecule A 
is much further away (> 6 Â). Both these facts help to explain the reason why 
quinolinic acid has a lower active site occupancy in molecule A.
The fact that there are positively charged residues close to the positions of the C- 
2 and C-3 carboxylate groups of quinolinic acid could certainly stabilise ylid formation, 
both by electron withdrawal of negative charge from the pyridine ring inductively via 
the C-3 carboxylate, or perhaps by direct stabilisation of the negative charge at position 
C-2 by interaction with Lys 185 or Arg 118.
Figure 1.1 below shows the active site of the enzyme with quinolinic acid 
bound, with the close proximity of lysine and arginine residues noted.
Lys 153
Arg 152
Arg
Lys 185
Figure 1.1: Active site structure of QPRTase
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Having a negatively charged C-2 substituent has been shown to be vitally 
important for quinolinic acid binding. Nicotinic acid does not have this negative charge 
and has been shown not to be an inhibitor of QPRTase from E. coli or S. 
typhimurium J Compounds with negative charge at position 2 of the pyridine ring 
have been shown to inhibit e f f e c t i v e l y . 3 3 . 9  From the crystal structure there seems to be 
no particular reason why this is so, as more interactions are seen at C-3 carboxylate 
than C-2. There is a possibility that Arg 118 and Lys 185 could move closer to C-2 
upon binding or the flexibility which can be seen in the region 180 - 206 may bring Lys 
185 to within H-bonding distance of C-2 carboxylate.
Mutant strains of QPRTase from S. typhimurium that are able to grow on 
nicotinic acid rather than quinolinic acid show a mutation at Lys 185, implying that this 
amino acid residue plays an important part in both QPRTase specificity and therefore 
NAD biosynthesis.
1.6.4 Active site - NAMN binding
Both subunits of the dimer bind NAMN equally. The nicotinic acid ring 
occupies a very similar position to that of quinolinic acid, and the bound ribose 
phosphate group extends across the barrel towards B9 and BIO.
When quinolinic acid is bound to the enzyme, Asn 260 occupies a position 
which coincides with the phosphate binding site. When NAMN binds, Asn 260 is 
shifted. The C^ position moves 3 Â away from the phosphate group, the side chain 
atoms further, leading to a 2-3 Â shift of the whole of the 258 - 265 group. One of the 
side effects is a shift of 4 À for € «  from Gly 259 as the backbone NH moves 
completely.
One of the outcomes is that the residues 258 - 265 in the NAMN-QPRTase 
complex is clearer from electron density maps, compared to the poorly defined density 
maps in the quinolinic acid-QPRTase complex.
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Orotate PRTase, HGPRTase and Glutamine-PRPP aminotransferase all have a 
similar type I PRTase, but the thirteen amino acid residue motif is conserved. It is 
found at the centre of the fold and is vital in ribose-phosphate moiety of PRPP.
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1.7 Phosphoribosyl Transfer Reaction
1.7.1 Chemical Mechanism
The chemical mechanism of the reaction catalysed by QPRTase is not fully 
understood. Addition of the phosphoribosyl group can be considered to be similar to 
that catalysed by other members of the PRTase family. However there is still no 
consensus of opinion concerning the mechanism of the PRTases. This group of 
enzymes catalyses the addition of a phosphoribosyl moiety to a nucleophilic nitrogen, 
with a resulting overall stereochemical inversion at the sugar centre implying that a 
direct displacement reaction takes place (Scheme 1.4).
PiO
IFF;
HO OH OHHO
Scheme 1.4: Chemical mechanism
Goitein et al determined primary and secondary kinetic isotope effects 
for a series of phosphoribosyltransferases.44 The common substrate PRPP was 
synthesised with at C-1 or with at the C-1 or C-5 carbon atoms. Pairs of these 
were then used to investigate the kinetic isotope effects for the reaction.
A carbocation like transition state arising from an sp^ ground state generally has 
less total point energy, thus activation for the reaction of a molecule with a heavier 
hydrogen isotope is large, resulting in slower reaction of the substituted molecule.
Kinetic isotope effects in the range 1.11 to 1.30 were obtained for the 
phosphoribosyltransferases. A typical Sn I type reaction with a carbocation like 
transition state should have a kinetic isotope effect of around 1.41, compared to 1.0
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for an S n2 type reaction. However an ambiguity can arise in enzymic reactions, where 
an isotope effect close to 1 does not necessarily indicate an S n 2 mechanism being 
utilised. Some substrates display no significant effect due to steady state suppression 
of the isotope effect.
Determination of the primary kinetic isotope effect for these enzymic 
reactions leads to resolution of this ambiguity. Small primary kinetic isotope 
effects of 1.0 to 1.08 result from a carbocation like transition state, because of the 
asymmetric intermediate state, whereas an S n 2  type reaction, with a symmetric 
transition state, has a primary kinetic isotope effect of 1.09 to l.lS.'^^'^s
The primary kinetic isotope effect for the phosphoribosyltransferases 
studied ranged from 1.01 to 1.05, which supports the theory that on chemical grounds 
a carbocation like Sn I transition state is involved (Scheme 1.5).
aR R
PiO
Q o
PiO
HO OH
OPPi ______ ^
HO OH HO OH   {j
Scheme 1.5: Sn I transition state |
This evidence is consistent with the ternary complex kinetic mechanism, as it 
fits in with the idea of direct attack by the nucleophilic nitrogen. The "ping-pong" 
mechanism is less easy to rationalise as it implies the presence of a ribosyl-enzyme 
intermediate. Orotate and hypoxanthine phosphoribosyltransferases both use the "ping- 
pong" mechanism with the presence of a stable enzyme-bound ribosyl phosphate 
intermediate, but this also implies that stereochemistry is retained. This is obviously 
still a problem that needs to be investigated.
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1.7.2 O ther Phosphoribosyltransferases^^
Phosphoribosyltransferase (PRTase) enzymes are a family of ten enzymes 
which are involved in the biosynthesis of purine, pyridine and pyrimidine nucleotides, 
and the aromatic amino acids histidine and tryptophan. Each of these enzymes is highly 
specific for an aromatic nitrogenous base, a-D -5-phosphoribosyl-l-pyrophosphate 
(PRPP) and a divalent metal ion. The general reaction catalysed by the PRTase family 
is the cleavage of the pyrophosphate group of the PRPP molecule, which by way of an 
anomeric inversion of the ribose ring results in a p-N-ribose monophosphate, e.g. the 
reaction catalysed by APRTase (Scheme 1.6).
NH;
J OPPiN HO OH
Adenine
APRTase
NH
HO OH
Scheme 1.6: APRTase reaction
1.7.3 Structures of other Phosphoribosyltransferase enzymes
The crystal structures of several of the PRTase family of enzymes have been 
resolved, and all have shown a common "PRTase" fold - a type I fold. This consists of 
a central parallel (3 sheet of 5 p strands, surrounded by a  helices. Within the fold, a 
common recognition motif of 13 residues, critical for PRPP binding and catalysis is 
present. These 13 residues usually include four hydrophobic residues which form the 
p strand of the five stranded p sheet, two acidic residues, usually aspartic acid, which 
lie close to the ribose group of the substrate and therefore stabilise the positive charge of 
the transition state, two more hydrophobic residues and four more smaller amino acid
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residues, including at least one glycine, which help to bind the 5-phosphate of PRPP 
and the nucleotide.
However none of QPRTase, NAPRTase and ATP-PRTase contain the thirteen 
residue motif, and so indicate the possibility of at least two PRTase fold types.
1.7.4 PRTase Reactions
PRTase enzymes are vitally important as they act as key control points on their 
respective metabolic pathways. They are allosterically regulated by a variety of 
effectors. In some cases the enzymes consist of sub-units which may occur as bi­
functional complexes and act with an enzyme further down the pathway. Although 
distinct iso-enzymic species of the PRTases do not exist, physical and kinetic var iations 
occur between PRTases in different organisms. Most PRTases in vertebrates are highly 
specific for just one organ, others are found in most tissues, while at the sub-cellular 
level in most organisms the PRTases are confined to the soluble cytoplasmic fractions. 
PRTases are active over a fairly broad pH range, with generally an alkaline pH 
optimum, and inactivation in more acidic conditions.
Although as a family they have similar catalytic and physical properties, these 
common structural features are probably dictated by divergent evolution, where the 
structural information is inherited from a common ancestral protein, rather than 
convergent evolution. There is probably a "core" protein, which is important for 
enzymic activity, as the enzymes have a wide range of subunit molecular weights.
Studies on ATP-PRTase, OPRTase and HGPRTase have shown p-glycoside 
formation occurs through an Sn I carbocation r e a c t io n ,a n d  both APRTase and 
OPRTase stabilise carbonium io n s .W i As this stabilisation can be performed by an 
ionised cysteine residue, it is consistent with the requirements for sulfhydryl reagents 
observed for most of the PRTases. Lysine also appears to be involved with binding at 
the active site, as described before for QPRTase.
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1.7.5 Other Pyridine Nucleotide PRTases
Obviously this is the area of most interest in this study, as QPRTase is a 
member of this group of PRTase enzymes. The biosynthesis of NAD was first 
observed in the liver, and the enzyme thought to be responsible for its production, 
NAPRTase, isolated ^8 Further studies confirmed that quinolinic acid and nicotinamide 
were also precursors to NAD, and while quinolinic acid may be synthesised in the 
organ, nicotinic acid and nicotinamide were obtained exogenously. Therefore 
NAPRTase and NAmPRTase are known as salvage enzymes, and QPRTase a de novo 
pathway enzyme.
As described above, NAPRTase is involved in the salvage pathway of NAD 
biosynthesis. The enzyme has been isolated from many sources, which are split into 
three groups, those which are not affected by ATP, those that are dependent on ATP, 
and those that will use and cleave ATP, but are not reliant on it. In the latter case, the 
role of ATP is to reduce the Michaelis a c t i v i t y  .52.53
Without nicotinic acid or PRPP, ATP phosphorylates the enzyme from bakers 
yeast,49 after which the other substrates are added randomly and sequentially. Even in 
the presence of all substrates this mechanism is followed.
NAPRTase is highly specific for nicotinic acid and shows no activity with 
precursors of other PRTase e n z y m e s . 5 2  ATP can be replaced in some cases by other 
purine nucleotides, and the thermal stability can be replaced by a range of nucleotide 
a n a l o g u e s . 54 .55 This enzyme can be split into two forms, that from sources that require 
ATP absolutely, and that in which a lack of ATP can be overcome by an increase in 
PRPP and Mg2+ l e v e l s . 5 6  Indeed ATP has been shown to have an allosteric effect, and 
the turnover number for the rat liver enzyme has been estimated at less than 1 molecule 
of nicotinamide mononucleotide per hour.
29
1.7.6 Purine Nucleotide PRTases
Glutamine-amido PRTase catalyses the initial and rate determining step of the de 
novo purine nucleotide b i o s y n t h e s i s . 5 7 . 5 8  5-Phosphoribosylamine, the product of this 
reaction can then be transformed to IMP via nine enzymatic steps. Modifications of this 
molecule leads to the production of other purine nucleotides guanine, adenine and 
xanthine. As with the pyridine nucleotides, they are also synthesised by salvage 
pathway enzymes, e.g. HGPRTase and APRTase, or by the degradation of nucleic 
acids. In this case purine nucleotide PRTases are not as specific, and the number of 
bases capable of occupying the enzyme active site is much larger.
1.7.7 Pyrimidine Nucleotide PRTases
The pathway to pyrimidine nucleotide biosynthesis is much simpler than that of 
the purines. Orotic acid, for example, is synthesised simply and then, in a reaction 
catalysed by orotate PRTase, reacts with PRPP to form orotidine-5'-monophosphate 
(OMP), which in turn can lead to the synthesis of other purine nucleotides, uridine, 
cytosine and thymidine. Again the other PRTases in this group are involved in salvage, 
rather than de novo pathways. However in mammals OPRTase catalyses the whole 
pyrimidine reutilization, while plants, bacteria and yeast also have a uracil specific 
enzyme.
1.7.8 Histidine and Tryptophan PRTases
Mammals are incapable of the de novo synthesis of histidine and tryptophan, 
relying on diet for their supply, but bacteria and other lower organisms can 
biosynthesise these compounds. Histidine and tryptophan PRTases utilise ATP and 
anthranilate respectively, and the products of these reactions undergo an interesting 
reaiTangement which includes the opening of the phosphoribosyl ring. Modifications
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of the ribose group occur such that two carbon atoms from the original ring are present 
in tryptophan, whereas in histidine all five are.
1.8 Biological Importance of Quinolinic acid
Quinolinic acid, which has been recognised as a naturally occurring compound 
for many years, is an intermediate in the formation of NAD from tryptophan. Lapin 
first reported its effect on the mammalian Central Nervous System (CNS) when he 
observed that quinolinic acid (and other metabolites on the tryptophan pathway) caused 
stimulant and convulsive effects in r o d e n t s . 5 9  The presence of quinolinic acid in human 
and rat brain has been shown,^®’^ ! but the actual source of quinolinic acid is still open 
to some discussion. The enzymes of the kynurenine pathway are mainly located in 
systemic tissues, in particular the liver. One of the features of quinolinic acid is that, 
because of its polar nature and a lack of a carrier mechanism, it is unable to penetrate the 
blood-brain barrier under physiological c o n d i t i o n s . ^ ^
However, as quinolinic acid is present in both the cellular and extra-cellular 
components of the brain, cerebral mechanisms for the metabolism of quinolinic acid are 
likely to exist. Both 3-hydroxyanthranilic acid, and the enzyme 3-hydroxyanthranilic 
acid oxygenase (3-HAO) are present in the human and rat brain, and provide the most 
likely source of quinolinic acid. As described elsewhere, QPRTase is also present in 
the human brain.
3-HAO is 100 fold more active than QPRTase, implying that activity of the latter 
enzyme is rate limiting, although these relative activities may not be important factors of 
quinolinic acid concentration. 3^ 3-HAO is not normally saturated, as administration of 
3 -hydroxyanthranilic acid results in an increase in quinolinic acid concentration.
In 1981, Stone and Perkins demonstrated that the introduction of quinolinic acid 
excited rat cerebral cortex neurones, and that this occurred through activation of 
receptors for excitatory amino acids (EAA).^4 These EAA are now regarded as the
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major excitatory transmitters in mammalian CNS. Some agonists are known as 
"excitotoxins", to describe both their excitatory and neurotoxic e f f e c t s .^5
There are three main subtype of EAA receptor, named after their agonists, N- 
methyl-D-aspartic acid (NMDA), quisqualate and kianate. Quinolinic acid has been 
shown to be a selective agonist of the NMDA receptor.^^ Its action was shown when it 
was injected into rat striatum or hippocampus. Neurones exposed to quinolinic acid 
showed a massive swelling of dendrites, followed by degeneration of post-synaptic 
c o m p o n e n t s .^7 Antagonists of the NMDA receptor reduced quinolinic acid responses 
therefore quinolinic acid acts primarily at the NMDA receptor.^® NMDA receptors are 
located in the cerebral cortex, basal ganglia and hippocampus and are involved in long 
term potentiation, neuronal plasticity, learning and memory. Therefore an increase in 
quinolinic acid concentration could induce neuronal dysfunction in NMDA receptor
activity in these a r e a s  .^9
However, quinolinic acid is much more potent as a neurotoxin than would be 
suggested from its affinity for the NMDA receptor. The human brain has quinolinic 
acid concentrations of 10 nmol l"i to 1 pmol 1"^ and is 10-60 times less potent than 
NMDA, yet it is equipotent as a neurotoxin. One theory is that local quinolinic acid 
concentrations at the synapses are much higher, and that this is not reflected in mean 
levels.
Quinolinic acid therefore does not act as a classic neurotransmitter, as it is not 
released on depolarisation, and no mechanism exists to remove it from the extracellular 
space. Schwarcz therefore considered quinolinic acid to be a potential neuromodulator 
whose role in excitatory neurotransmission must be investigated further.
Two theories were previously suggested for its action. The pre-synaptic 
hypothesis suggested that quinolinic acid activates specific receptors, causing release of 
a neurotransmitter, which in turn interacts with the NMDA receptor, leading to neuronal 
death.70 Although no direct evidence supports this theory, it would explain why 
quinolinic acid induced neurotoxicity is prevented by blockade of the NMDA receptor 
by antagonists.71
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The second, post-synaptic, hypothesis explains neurotoxicity on the basis of 
interaction between the EAA and post-synaptic membrane. The associated ion channels 
normally blocked by physiological Mg^+ concentration can be activated by injection of 
quinolinic acid which leads to degeneration of the neurones.
As quinolinic acid does not penetrate the blood-brain barrier it must be 
synthesised intracerebrally. Neurodegeneration actually occurs because of increased 
activity of the NMDA receptors as quinolinic acid acts at the receptors on the neuronal 
surface to produce the excitatory and neurotoxic effects.72 Stimulation of the EAA 
receptors over a prolonged period of time degenerates the cells .73
A significant elevation in quinolinic acid concentration has been discovered in 
both the CSF and brain tissue of patients with inflammatory neurodegenerative 
diseases. These diseases include Huntington's disease, AIDS, poliovirus infection, 
Lyme disease and septicaemia. Injections of nM quinolinic acid concentration into 
specific areas of rat brain causes distinctive pattern nerve cell damage and seizures 
reminiscent of human neurodegenerative disorders.26 Systemic administration of 
pokeweed mitogen to mice leads to the accumulation of quinolinic acid in the CNS and 
blood, implying that quinolinic acid is involved with neurodegeneration in inflammatory 
neurological diseases.74
Neuronal vulnerability to quinolinic acid actually increases with brain 
development.75 With chronic increases in quinolinic acid concentration the integrity of 
the blood-brain barrier is eventually compromised. There are many reasons for a 
possible increase in quinolinic acid concentration:
i) An increase in the availability of quinolinic acid precursors.
ii) An increase in 3-HAO levels.
iii) A decrease in QPRTase levels.
iv) A dysfunction in the cerebral mechanism for the release of quinolinic
acid.
v) An alteration in the balance of other systems which interact with 
quinolinic acid.
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Quinolinic acid appears to be less effective as a neurotoxin in the cerebellum, 
hypothalamus and substantia nigra where there is high QPRTase activity, compared to 
areas of low QPRTase activity such as the cerebral cortex, striatum and hippocampus 
where it is very potent. Often an increase in astrocytic 3-HAO activity, due to astrocytic 
proliferation, is responsible for the increase in quinolinic acid.76 Interestingly, the 
activity of 3-HAO increases 4 or 5 fold within days of excitotoxic lesion of rat striatum
or hippocampus.77
34
1.8.1 Quinolinic acid and Neurological Diseases
The two main neurological diseases, associated with an elevation of quinolinic 
acid, studied are Huntington's disease (HD), and AIDS.
1.8.1.1 Huntington's disease
Features of the lesions caused by administration of quinolinic acid into 
experimental rats are similar to the neuronal degeneration occurring in HD patients.78 
HD is a neurodegenerative disorder, symptoms of which include dem entia, 
development of choreiform movements, and psychiatric symptoms.79 The disease is 
characterised neuropathologically by severe atrophy of striatal tissues. Quinolinic acid 
is proposed as the aetiological basis of the disease, and is the strongest candidate for the 
immediate cause of the disease. Another indication is that the activity of 3-HAO is 
increased in various brain regions of patients with HD. 80
However, the role of quinolinic acid is fai* from proven. Excretion of quinolinic 
acid in HD patients is unchanged,81 and QPRTase activity is unchanged in blood 
platelets and erythrocytes of patients.82 There is no general increase in bodily levels of 
quinolinic acid in HD patients or any loss in QPRTase activity, so one possible 
explanation is that the levels of quinolinic acid increase transiently around the excitatory 
amino acid receptors. The quinolinic acid elaborating system is preferentially localised 
in astrocytes, therefore there is a possible involvement of proliferated astrocytes in HD 
as part of the disease process.83
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1.8.1.2 HIV and AIDS
To investigate whether immune stimulation in man is associated with an increase 
in quinolinic acid concentration, Heyes studied the HIV-1 virus in some detail.84 
Patients with AIDS were found to have 3.5 times the normal quinolinic acid levels, with 
the increase in quinolinic acid corr elating with the degree of motor impairment. Two 
thirds of all AIDS patients suffer from neurological problems, including dysfunction of 
cognition, movement and sensation. Azidothymidine (AZT) or anti-microbial therapy 
actually reduced the levels of quinolinic acid in the CSF and increased the neurological 
status of the patients, but those with latter stage ADDS dementia had 20 times the normal 
level of quinolinic acid. AZT inhibited HIV virus reproduction, causing the decrease in 
immunological response and therefore quinolinic acid synthesis.
Heyes also investigated the quinolinic acid concentration in SRV-D infected 
macaques and found that to be three times the normal l e v e l . 8 5 . 8 6  An increase in 
indolamine-2,3- dioxygenase level is associated with the increase in quinolinic acid 
concentration in the brain. This enzyme is induced by several factors, therefore the 
accumulation of quinolinic acid occurs across a broad spectrum of neurological 
diseases. Other diseases studied where increased quinolinic acid levels are observed 
were Lyme disease, poliovirus, auto-immune disease, sepsis and head trauma. The 
enzyme catalyses the first step of the kynurenine pathway (see section 1.9), and is 
actually activated by y-interferon released during immune stimulation. One theory is 
that the extra quinolinic acid derives from m a c r o p h a g e s . ^ 3  These cells, which are I
employed by the non-specific immune system to neutralise foreign substances or cells j
can infiltrate the brain upon immune system activation. They have also been shown to |
synthesise quinolinic acid from L-tryptophan and indolamine-2,3-dioxygenase, the !
enzyme which catalyses the first step of the kynurenine pathway, and which has been 
shown to have been synthesised by macrophages. These factors may all be important
!
in these inflammatory neurological diseases. ‘
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1.8.2 Kynurenic acid
Along with quinolinic acid, kynurenic acid is the other important neurologically 
active metabolite of the kynurenine pathway.^^ Kynurenic acid is a broad spectrum 
antagonist of the excitatory amino acid receptors, in particular the NMDA receptor, and 
increased concentrations of the acid lead to effects consistent with NMDA antagonist 
activity. As a natural constituent of the brain, it is a potential endogenous 
neuroprotective agent against excitatory neurotransmitters, including quinolinic acid.
An ongoing widely debated issue is whether kynurenic acid levels and 
quinolinic acid levels are actually finely balanced to maintain optimum NMDA receptor 
activity, implying that over stimulation of the receptor may arise from a decrease in 
kynurenic acid levels as well as an increase in quinolinic acid levels. Indeed recently 
HD patients have been observed to have lower kynurenic acid levels,^? although this 
may arise from impaired biosynthesis rather than any other issue. In a similar way to 
quinolinic acid, kynurenic acid cannot penetrate the blood-brain barrier and therefore 
may be biosynthesised in situ. The main source of the acid is kynurenine, which can 
enter the brain via the enzyme kynurenine aminotransferase (KAT). This enzyme is 
localised in astrocytes in a system complicated by the fact that there are two distinct 
KAT enzymes, each with different properties.88 Termination of the action of the acid 
appears to be by diffusion from the brain as no catabolic enzyme has been detected.
1.9 Biosynthetic Origin of Quinolinic acid: The Kynurenine 
Pathway
The source of quinolinic acid is the kynurenine pathway of tryptophan 
metabolism (Scheme 1.7).
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The first step in the tryptophan pathway is the oxidation of tryptophan (20) to 
cleave the indole ring, by one of two enzymes. In the liver and kidney of mammals this 
oxidative cleavage is catalysed by tryptophan dioxygenase, but in most other tissues 
indolamine-2,3-dioxygenase catalyses this reaction.89 Both of these enzymes are haem 
dependent, and the product of the catalysis is AT-formylkynurenine (21).
Tryptophan dioxygenase (B.C. 1.3.11.11) is absolutely specific for L -  
tryptophan, and is actually the rate limiting enzyme for the kynurenine pathway. It has 
a bi-uni mechanism as tryptophan binds to the active holo-enzyme, followed by the 
binding of oxygen and only then does the reaction takes place.
The complementary enzyme indolamine-2,3- dioxygenase (E.C.1.3.11.17) is 
located in a wide range of mammalian tissues, including the distal ileum, stomach, lung 
and brain, but not in the liver or kidney. The enzyme has a broader substrate 
specificity, and will cleave other substrates such as D-tryptophan, D -  and L-5-hydroxy 
tryptophan, melatonin and serotonin. However, the human enzyme does prefer L -  
tryptophan as the substrate. Hirati and Hayaishi demonstrated that the addition of 
superoxide dismutase inhibited the enzyme activity, proving that the enzyme is 
dependent on superoxide rather than oxygen.^® The manner in which the enzyme is 
inhibited by different compounds than tryptophan dioxygenase implies that different 
substrate co-factor binding factors occur.
Kynurenine formamidase (B.C. 3.5.1.9) then catalyses the rapid conversion of 
7/-formyl kynurenine to kynurenine (22) by hydrolysis and loss of the formate 
g r o u p . O n l y  slight variations of the enzyme occur from organism to organism, 
though with these there are differences in substrate specificity and inhibitor sensitivity. 
The enzyme actually has a wide substrate specificity and will hydrolyse a range of aryl 
form yl am ines, includ ing  both  D -  and L -  N -fo rm y lk y n u re n in e  and  
A-formylhydroxykynurenine.
Once kynurenine has been formed, it can undergo three very different reactions. 
Hydrolysis to anthranilic acid (23) is catalysed by kynureninase, transamination to 
kynurenic acid (24) by kynurenine aminotransferase, or hydroxylation by kynurenine
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3-hydroxylase to give 3-hydroxykynurenine (25). This last transfoiTnation is the major 
fate of kynurenine in the tiyptophan pathway, leading to the production of NAD.
Transamination of kynurenine by kynurenine aminotransferase (KAT, B.C. 
2.6.1.7) is followed by cyclisation, dehydration and tautomérisation to lead to the 
production of kynurenic acid, a stable aromatic c o m p o u n d . ^ ^  Kynurenic acid is an 
antagonist of the glycine site of the NMDA receptor, so increased levels of the acid may 
have neuroprotective action in some pathological conditions.
Kynurenine 3-hydroxylase (B.C. 1.14.13.9) competes for kynurenine as 
discussed above. In humans the enzyme is located in the outer mitochondrial 
membrane, and incorporates oxygen into kynurenine via a catalytic cycle mechanism. 
The enzyme is FAD dependent, and NADP or NADPH is used as a co-reductant. The 
purified enzyme is an oligomer, with 4 FAD molecules per sub-unit, and interestingly 
the monomer only has 10% of the catalytic activity of the dimer. In some circumstances 
the enzyme may be rate limiting for NAD production while the enzyme is inhibited by 
xanthurenic acid and the enzymic activity is decreased by hyperthyroidism.
Kynureninase (B.C. 3.7.1.3) catalyses the conversion of both kynurenine and 
3-hydroxykynurenine to produce anthranilic acid and 3-hydroxyanthranilic acid (26) 
respectively. Anthranilic acid can then be metabolised into a variety of aromatic 
compounds such as quinoline, quinazoline or acridine alkaloids in plants. It can also be 
transform ed into 3-hydroxyanthranilic acid, the product of catalysis by 3- 
hydroxykynureninase, and become a vital part of the NAD biosynthesis. In mammals 
and fungi where NAD biosynthesis is vital for production of the co-enzyme, there are 
low Km and high Vmax values for 3-hydroxykynurenine, whereas in micro-organisms 
where the de novo NAD route is not as important, there is a high activity towards 
kynurenine.
The enzyme is dependent upon PLP, and from some sources A -form yl 
kynurenic acid is a substrate and hydrolysed to A-formyl anthranilic acid, itself a 
substrate for formamidase. Synthesis of the enzyme is increased by growth in a
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tryptophan rich m edium  3^ and known PLP inhibitors such as p-chloro-2S~alanine and 
2S-serine-0-sulfate inhibit kynureninase.^^
3-Hydroxyanthranilic acid oxygenase (3-HAO) catalyses the cleavage of the 
benzene ring of 3-hydroxyanthranilic acid to produce a very unstable intermediate a -  
am ino-p-carboxym uconic acid c o -se m ia ld e h y d e .N ish iz u k a  and Hayaishi also 
investigated this conversion and were unable to find an enzyme that was responsible for 
the subsequent ring closure of the intermediate to form quinolinic acid (Scheme 1.8).3 
The rate limiting step for the conversion to quinolinic acid is the isomérisation of the 
double bond to produce the carboxylic acid groups in a cis formation, which allows 
condensation to form the stable pyridine ring.
The enzyme is widely distributed in the peripheral organs, e.g. liver and kidney, 
and like other groups on this pathway requires divalent iron for activity, but in this case 
not in the form of haem groups.
OH
O2
3-HAO
N CO2H
CO2H
HO2C"" 'N H 2
Non-enzymic?
XO2H
N CO2H
Scheme 1.8: 3-HAO reaction
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The other fate of a-amino-P-carboxymuconic acid co-semialdehyde is to be 
attacked by picolinic decarboxylase, where the acid is decarboxylated and then picolinic 
acid obtained by ring cyclisation. Picolinic decarboxylase is found in the liver and 
kidney of many mammals, therefore formation of NAD and other derivatives from 
quinolinic acid may have to compete with picolinic decarboxylase for a-am ino-p- 
carboxymuconic acid co-semialdehyde.
1.9.1 Modulating the Kynurenine Pathway
M odulation of the kynurenine pathway is one strategy to obtain useful 
pharmacological control of the central nervous system (CNS). The activity of the 
NMDA receptor can be controlled by altering the relative quinolinic acid and kynurenic 
acid concentrations. Two approaches to this situation have been employed. One is to 
investigate methods of inhibiting quinolinic acid synthesis as a way to produce drugs, 
whilst the other involves the development of analogues of kynurenic acid, which are 
more potent antagonists of the NMDA receptors. There have been several efforts to 
inhibit quinolinic acid biosynthesis by the synthesis of inhibitors of kynurenine 
pathway enzymes. One of those studied the most was nicotinoylalanine (29) which is 
reported to inhibit two enzymes - kynureninase and kynurenine 3-hydroxylase.
O CO2H
NHo
N
(29)
When it was administered to mice following a tryptophan dose, a large increase 
in kynurenic acid concentration was observed, along with behaviour consistent with 
exposure to NMDA antagonists.^^ The most obvious enzyme to inhibit, in order to
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decrease quinolinic acid levels is 3-hydroxyanthranilate oxygenase (3-HAO), the 
enzym e directly responsible for quinolinic acid biosynthesis. 4-Chloro-3- 
hydroxyanthranilic acid is a very potent inhibitor and its in vivo effects have been 
examined. A dose dependent decrease in production of quinolinic acid in the 
hippocampus of rats was observed. When studied in more detail it was shown that 
quinolinic acid biosynthesis was inhibited following interferon stimulation. Inhibitors 
of indolamine 2,3-dioxygenase had similar effects. It therefore seems that inhibitors of 
the kynurenine pathway enzymes modulate the balance of kynurenic acid and quinolinic 
acid levels giving them potential as anti-convulsant agents and for treatment of various 
neurological diseases.
1.10 Metabolism of quinolinic acid: NAD Biosynthesis and 
the Pyridine Nucleotide pathway
NAD is ubiquitous in its role as an essential co-enzyme, and participates in 
many cellular oxidation and reduction reactions. It is important in cellular metabolism, 
functioning in many anabolic and catabolic reactions in biological systems.96 The 
manner of NAD metabolism varies between eukaryotes and prokaryotes, and there is 
also a great deal of variation between different prokaryotes. However E. coli and S. 
typhimurium have a great deal of similarity in NAD m e t a b o l i s m , and are the two 
bacteria investigated most often.
Gholson was the first to report the existence of the pyridine nucleotide cycle in a 
diversity of s p e c i e s , a n d  multiple forms of the cycle have since been examined 
through studies in E. coli and S. typhimurium .
Quinolinic acid is introduced into the NAD biosynthetic pathway by the 
QPRTase catalysed reaction to form NAMN. The two step pathway to NAD (28) from 
NAMN is known as the Priess-Handler pathway, with the intermediate being nicotinic 
acid adenine dinucleotide (NaADN)(2 7 ).i^040 i The conversion of NAMN to 
NaADN, also known as desamido NAD,^^ is catalysed by NAMN adenyltransferase
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(B.c. 2.7.7.18), The enzyme has a much greater affinity for NAMN than nicotinamide 
mononucleotide (NMN), the rate of synthesis of NAD being 17 times faster than NaAD 
from NMN. 102 The final step to NAD is catalysed by the enzyme desamido-NAD: 
ammonia ligase (B.C. 6.3.5.1), also known as NAD synthetase. The enzyme requires 
both ATP and glucose, and involves the deamination of NaADN to NAD.
The major role of the pyridine nucleotide cycle (Scheme 1.9) is to provide a 
mechanism for regulation of NAD metabolism. 103 it is also a method of introducing 
other pyridine compounds into the cycle and therefore other ways of synthesising 
NAD, and is also a source of precursors for the biosynthesis of co-enzymes, including 
vitamin B 12.
The key enzymes in this cycle are subject to allosteric or feedback control, 
regulating NAD biosynthesis, whilst one of the unique features of the pathway is the 
manner in which the pyridine ring is conserved throughout the various cycles.
NAD may go through one of five distinct pyridine nucleotide cycles, of which 
three are known in E. coli and S. typhimurium. The cycles are 2, 3, 4, 5 and 6 
membered cycles.
In pyridine nucleotide cycle II (PNC II), the two components are NAD and 
NMN. The inter conversion between the two is initiated by hydrolysis of the 
pyrophosphate bond in NAD by either NAD pyrophosphatase or DNA ligase, while an 
increase in DNA ligase obviously lends to an increase in NMN production. NMN does 
not occur in E. coli and S. typhimurium, therefore the two membered cycle is not 
present in these bacteria.
In PNC III, NAD is recycled via nicotinamide and NMN. The conversion of 
NAD to nicotinamide is catalysed by NAD glycohydrolase (B.C. 3.2.2.5) whilst 
nicotinamide phosphoribosyltransferase (NAmPRTase, B.C. 2.4.2.12) is the enzyme 
that catalyses the subsequent formation of NAD. Again this cycle is not observed in E. 
coli and S. typhimurium and if it exists is a veiy minor pathway.
PNC IV is the major intracellular NAD recycling p a t h w a y , ^ 0 4 - i 0 8  ^nd 
represents 80 - 90 % of the total NAD recycling pathway. It also preserves the PRPP
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moiety of NMN (30), the route with the minimum amount of energy. The rate of NAD 
turnover is eight times faster in PNC IV in E. coli than in the next fastest route PNC VI.
NAD is converted to NMN as before in PNC II, but is then converted to 
NAMN with the loss of ammonia, by NMN aminohydrolase (B.C. 3.5.1.00). NAD is 
then resynthesised via the Preiss-Handler pathway.
In PNC V deam ination of nicotinam ide (31) to nicotinic acid (32) by 
nicotinamide aminohydrolase (B.C. 3.5.1.19), and the nicotinic acid can then react with 
PRPP to form NAMN, via the action of NAPRTase (B.C. 2.4.2.11). Again the Preiss- 
Handler pathway allows NAD to be formed again.
PNC VI is very similar to PNC IV and PNC II, while NAPRTase appears to be 
the vital enzyme in PNC V and VI. Scheme 1.9 shows the NAD biosynthetic pathways 
and PNC IV, PNC V and PNC VI.
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2. Synthesis of Quinolinic acid Analogues
As discussed, QPRTase lies on the kynurenine pathway of tryptophan 
metabolism. One of the end products of this pathway is the essential co-enzyme 
nicotinamide adenine dinucleotide (NAD) .99 Although animals acquire their NAD from 
dietary uptake and other sources, in fungi the kynurenine pathway is the sole 
biosynthetic route for production of all their NAD .^^9 Therefore any compounds 
synthesised that can block enzymes along this pathway, including inhibitors of 
QPRTase, may have anti-fungal activity. Compounds that inhibit the enzyme could 
also be useful as biological "tools". These may allow the neurological effect of 
quinolinic acid to be investigated by blocking the active site of the enzyme, inhibiting its 
action and therefore artificially raising quinolinic acid levels. The biological effect of 
this increase can then be examined in model systems. The other use for inhibitors of 
QPRTase is to investigate the actual mechanism of the enzyme and its active site 
structure.
To study QPRTase inhibition it was intended to synthesise analogues of 
quinolinic acid that would allow the first of the two reactions catalysed by the QPRTase 
system, the phosphoribosyl transfer, to be exam ined in isolation from the 
decarboxylation reaction. Compounds were thus designed to mimic quinolinic acid by 
containing acidic groups at both the 2- and 3- position of the pyridine nucleus. 
However if the 2-substituent was not a carboxylic acid, this would mean that no 
decarboxylation could take place. Such analogues would therefore be able to undergo 
the first reaction, the phosphoribosyl transfer (Scheme 2.1), but be unable to 
decarboxylate.
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CO2H
R = acidic, NOT CO2H
\  ■ CO2
Scheme 2.1: Effect of analogues on QPRTase reaction
Initially two analogues were identified as suitable synthetic targets. These were
2-sulfonicotinic acid (33) and 2-phosphononicotinic acid (34). These compounds 
could thus be used to probe the mechanism of QPRTase. It would also be of interest to 
assess their neurological effects. Would they be neurotoxic as a result of QPRTase 
inhibition raising quinolinic acid levels, or neuroprotective by acting as agonists for the 
quinolinic acid binding site on the NMDA receptor?
^SOsH
(33)
PO3H2
(34)
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2.1 Synthesis of 2-sulfonieotinic acid
2.1.1 Literature Methods for Pyridine sulfonic acids
The most obvious route for the synthesis of sulfonic acid group was considered 
to be oxidation of a thiol group. Evans and B ro w n in v e s tig a te d  the synthesis of 2-,
3- and 4-pyridine sulfonic acids. Pyridine-2-sulfonic acid (35) was obtained by the 
oxidation of 2 -mercaptopyridine, ^  11 which was itself prepared from 2 -bromopyridine 
and aqueous alcoholic potassium sulfide in a sealed tube at 160-170 °C (Scheme 2.2).
Sealed tube
"N Br 160-170 °C N SH N  SO3 H
(35)
Scheme 2.2: Route to pyridine-2-sulfonic acid
More direct syntheses where the halogen is replaced by a sulfite group were 
also attempted, but even at high temperatures replacement by aqueous alcoholic sodium 
sulfite, in the cases of 2-chloropyridine and 2-fluoropyridine was only partial, and 
under the same conditions 2-bromopyridine decomposed extensively. If the 
halogenated pyridine was activated by iV-oxide formation, nucleophilic displacement by 
the sulphite group occurred, but was also accompanied by reduction of the iV-oxide 
linkage.
Pyridine-3-sulfonic acid was first synthesised by Fischer and co-workers in the 
late nineteenth century by heating pyridine with concentrated sulfuric acid, either in 
sealed tubes at 300-350 °C for a day, or for longer periods of time (30 hours to 20 
days) at the boiling point of the m i x t u r e .  1 2^-114  the early twentieth century
aluminium vanadyl and mercuric sulfates were used as catalysts for the sulfonation with 
fuming sulfuric acid,^^^ both increasing yields and decreasing reaction times. The
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sulfonation of pyridine and picolines was optimised by McElvain and Goese, by 
varying three factors, the catalyst mercuric sulfate levels, the length of time of the 
reaction and the amount of sulfur trioxide in the fuming sulfuric acid. As with the 2- 
substituted halogenated pyridines, the equivalent 3-substituted halogenated pyridine N- 
oxide was susceptible to attack by sodium sulfite to produce pyridine-3-sulfonic acid 
A-oxide, but 3-chloropyridine was stable under the same conditions.
Pyridine-4-sulfonic acid was first proposed by Koenigs and Kinne, who 
oxidised 4-mercaptopyridine with concentrated nitric acid.^^^ However the melting 
point of the product was considerably less than that of the 4-mercaptopyridine, unlikely 
for a sulfonic acid. Evans and Brown successfully synthesised pyridine-4-sulfonic 
acid by oxidation with hydrogen peroxide in barium hydroxide s o l u t i o n . I t  has also 
been produced on a large scale by a method developed by Tiesler,^i7 where A-(4- 
pyridyl)pyridinium chloride was heated at 100 °C with sodium sulfite.
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2.1.2 Oxidation of Thiols with Iodine
The ability of iodine to oxidise a thiol to a sulfonic acid, especially with the 
presence of a carboxylic acid group on an adjacent carbon is important in our aim to 
synthesise 2-sulfonicotinic acid. Shinohara^i^ used Okuda's method of oxidation, 
with a large excess of iodine, to investigate the total oxidation to cysteic acid. This was 
a modified method of that suggested by Rosenheim and Davidshon^^^ and first 
employed by Klason and C a r l s o n .  120
Danehy and Oesteri^i also showed that a thiol with a free p-carboxylic acid 
group over oxidised without going through a disulfide, which is often the end product 
of oxidation of water soluble thiols without a p-carboxylic acid group. The ratio of this 
higher oxidation group, the sulfonic acid, to the disulfide increased as the initial thiol 
concentration decreased, i.e. increasing dilution. The corresponding sulfonic acids 
were synthesised from 3-mercaptopropionic acid (36), mercaptosuccinic acid (37) and 
o-mercaptobenzoic acid (38).
HS-CH2 CH2 CO2 H HS-CH(C02H)CH2C02H
(3 6 ) (3 7 )
CO2H
(38 )
The mechanism of the oxidation of the thiol to disulfide is not widely reported. 
K h a r a s c h i 2 2  suggested the following possible mechanism (Scheme 2.3).
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R S H  +  I 2  ---------------------------^  R S I  +  H I
R S H
RSI
R S S R  + HI
R S O H  +  H IH2O
Scheme 2.3: Oxidation of thiol
If dilution and iodine levels allowed, the following overall reaction could occur: 
R S H  +  2%2 +  2 H 2 O  ---------------------------- ►  R S O 3 H  +  4 H I
This further oxidation to the sulfonic acid, where more than the stoichiometric 
amount of iodine is consumed, is called overoxidation. Danehy's group proposed the 
following mechanism (Scheme 2 .4 ). 123
I I
A
I I  HjO I I  I2V ? ~ ' r
I I  h I I■ C C  + 2HI  ► —— O ' ' C-----  + 2HI
HO o
I I HoO\  CO2H  ^ HO3S CO2H
Scheme 2.4: Danehy's overoxidation mechanism
Attack on the disulfenyl iodide by the much less nucleophilic water is generally 
favoured as thiol ions become scarcer and the sulfonic acid is formed by further 
oxidation by iodine. It has been proposed that intramolecular attack by the carboxylate 
anion on the sulfenyl sulfur to displace the iodide ion and form a five membered cyclic 
intermediate occurs, followed after hydrolysis by oxidation.
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The oxidation of o-mercaptobenzoic acid is an interesting case. Field et al 
investigated the disproportionation of 2-(phenyldithio)benzoic acid (39) to phenyl 
disulfide (40) and 2,2'-dithiodibenzoic acid (4 1 ),^24 and suggested that the ortho 
carboxylic acid group was involved (Scheme 2.5).
S-S-CgHj
C02H LA
2 \ /  2 
(39) (40) (41)
Scheme 2.5: Disproportionation of 2-(phenyldithio)benzoic acid
The five membered thioester has been isolated, confirming the involvement of 
the ortho carboxylic acid group. Dilution effects were minimal, implying that the 
rearrangement was intramolecular. The mechanism for the rearrangement is shown 
below (Scheme 2.6).
H20
CO2H
H ;0
SOH
OH
COjH
H ,0S02H
Scheme 2.6: Rearrangement mechanism 
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2.1.3 Synthetic Routes towards 2-Sulfonicotinic acid
Using this information, the oxidation of 2-mercaptonicotinic acid (17) to 2- 
sulfonicotinic acid was attempted, using a variety of oxidising agents (Scheme 2.7).
.COjH
N  SH
(17)
-COjH
N  SO3 H
Scheme 2.7: Oxidation of 2-mercaptonicotinic acid
2.1.3.1 Oxidation with Nitric acid
Initially the oxidation of 2-mercaptopyridine (42) to pyridine-2-sulfonic acid 
was attempted, to confirm the work of Evans and B r o w n . This was successful and 
gave the product in good yield (Scheme 2.8).
HNO3
N  SO3 HN SH
(42)
Scheme 2.8: Oxidation of 2-mercaptopyridine
The analogous oxidation of 2-mercaptonicotinic acid to 2-sulfonicotinic acid 
therefore seemed feasible. 2-Mercaptonicotinic acid was dissolved in concentrated 
nitric acid and heated to reflux for two hours. Upon cooling, needle-like crystals 
precipitated, which were recrystallised from  boiling water. However, upon 
examination of the product by mass spectrometry, it became obvious the sulfonic acid 
had not been formed. The mass of the product was shown to be 139, much lower than
expected if the sulfonic acid was formed. A significant fragment was produced at 121
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(M-H2O). Careful examination of these results revealed that the actual product to be 2- 
hydroxynicotinic acid (2-hydroxypyridine-3-carboxylic acid) (IS ), which was 
produced in 45% yield. This unexpected result was confirmed by the melting point of 
the product, 260 °C, identical to the literature v a l u e .  2^5 CHN Microanalysis also 
backed up these results, the actual composition, (C, 51.80; H, 3.62; N, 10.07%) was 
compared to the calculated values (C, 51.56; H, 3.26; N, 10.03%) to prove the product 
to be 2-hydroxynicotinic acid.
CO2H
(15)
The proposed mechanism for the foimation is shown in Scheme 2.9. The very 
acidic conditions promote the protonation of the thiol group. Nucleophilic attack by a 
water molecule at position 2 then leads to loss of the hydrogen sulfide group, and 
introduction of the hydroxyl group. The fact that this does not occur with 2- 
mercaptopyridine implies the significant effect of the 3-carboxylic acid substituent. The 
electron withdrawing effect of this group both makes the thiol more prone to 
protonation and more importantly increases the susceptibility of the 2-position to 
nucleophilic attack. The low pH employed presumably makes the latter effect more 
important.
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,C 02H w .C 02H
N SH
J a - ^ 0 H 2
.C02H
N OH
.CO2H
N OH2
Scheme 2.9: Synthesis of 2-hydroxynicotinic acid
An alternative possibility is that oxidation to the sulfonic acid does actually 
occur, but in acidic conditions loss of sulfuric acid leads to the formation of 2 - 
hydroxynicotinic acid.
2.1.3.2 Oxidation with Oxone
The oxidising agent oxone is a mixture of potassium  sulfate salts 
(2KHSO5.KHSO4.K2SO4). When reacted with 2-mercaptonicotinic acid, examination 
by tic showed that some oxidation had taken place. However, isolation of any product 
proved to be very difficult. The starting material, product and oxone are all barely 
soluble in water, and with ten equivalents of oxone required for complete oxidation, 
any oxidation product was not isolated, although ion exchange was attempted.
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2.1.3.3 Oxidation with Iodine and Potassium permanganate
Following the previous unsuccessful attempts at oxidation, iodine^21 and 
potassium permanganate^^ 5 were both examined as oxidising agents (Scheme 2.10).
Basic m n 0 4  /C O 2H
or Iodine  ^
Scheme 2.10: Synthesis of 2-sulfonicotinic acid
2-Mercaptonicotinic acid was partially dissolved in distilled water and the pH 
adjusted to pH 6 with potassium hydroxide. This solution was added dropwise into a 
solution of iodine in distilled water. When addition was completed the solution was 
reduced to dryness, and then the product recrystallised from boiling water. Both 2- 
mercaptonicotinic acid and iodine are not very soluble in water, and so the reaction was 
not very efficient, giving only a 23% yield of product.
To facilitate oxidation by potassium permanganate, 2-mercaptonicotinic acid 
was dissolved in an aqueous sodium hydroxide solution. To this basic solution, 
potassium permanganate solution was added dropwise, and the resulting solution 
heated under reflux for one hour. Upon cooling manganese dioxide was removed by 
filtration, and the free acid generated by passing the solution through an Amberlite IR 
120 ion exchange resin column to give the product in 25% yield.
^H and NMR spectra were identical for both products, but did not confirm 
that oxidation had taken place. However fragments which corresponded to the loss of a 
sulfonic acid group and a caitoxylic acid group, were detected in the mass spectrum. 
CHN Microanalysis for the compounds gave results suggesting that the synthesis of 2- 
sulfonicotinic acid was successful, (Found: C, 35.44; H, 2.00; N, 6.61%; Calculated 
for C6H5NSO5; C, 35.47; H, 2.48; N, 6.89%) while the melting point of 254 °C was 
different from that of the product of the oxidation by nitric acid (260 °C). The structure
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of the product was then confirmed by X-ray crystallography (see next page and 
Appendix for full data).
From the crystal structure (Figure 2.1) it is interesting to note that in the 
crystalline form, the sulfonic acid appears as a zwitterion, and that H-bonding occurs 
between the sulfonic acid and carboxylic acid groups.
These reactions were more successful as both of the oxidations were carried out 
in basic conditions, ensuring that the thiol group was not protonated. Therefore the 
nucleophilic attack by water, observed under acid conditions, did not take place. The 
oxidation with potassium permanganate appeared to be the better procedure. The 
reaction was considerably quicker and cleaner, and the yield could be much more easily 
optimised than the oxidation by iodine, where the lack of solubility o f 2- 
mercaptonicotinic acid and iodine at the optimum pH is problematic.
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Figure 2.1: X-ray structure of 2-sulfonicotinic acid
2.1.4 Biological testing
A series of experiments were designed to screen quinolinic acid analogues, 
including 2-hydroxynicotinic acid and 2 -sulfonicotinic acid, on primary cultures of 
mouse cerebellar granule cells. They were carried out in collaboration with Dr. Roger 
Griffiths in the Biochemistry department at the University of St. A n d r e w s .  ^^ 6 xhese 
were designed to assess the neurotoxic or neuroprotective effects of these compounds. 
The recognition of NMDA receptor was investigated by measurement of intracellular 
Ca^+ concentration and cell viability.
The NMDA receptor is one of the ionotrophic glutamate receptors, the others 
being the kainate and 3-(5-methylisoxazol-4-yl)propionic acid (AMPA), or quisqualate, 
receptors. The ionotrophic glutamate receptors all contain the agonist binding site and 
ion channel in the same macromolecular complex. The open NMDA channel is 
permeable to Ca^+ at a rate ten times greater than it is to monovalent cations (Na+ and 
K+).
There are two agonist binding sites at the NMDA receptor. The first is for 
glutamate, although it is capable of binding NMDA and other short chain dicarboxylic 
acids, including quinolinic acid and aspartic acid. The second binding site is for 
glycine, which is required to bind simultaneously with glutamate. So that this effect is 
not a factor in laboratory experiments, glycine is added at a high level so that the site is 
saturated. There is also a third recognition site for polyamines, which appears to 
possess a regulatory role.
For these glutamate receptors, a common theme is an increase in intracellular 
Ca^+ levels. Elevated Ca^+ levels play a regulatory role through activation of Ca^+ 
dependent enzymes, but a large increase in intracellular Ca^+ levels leads to neuronal 
damage and death through the nature of the cascade of second messenger systems.
The link between the action of 2-hydroxynicotinic acid and 2-sulfonicotinic acid
at the NMDA receptor and changes in intracellular Ca^+ was therefore examined. Thus,
mouse cerebellar granular cells were tested against a range of concentrations of
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quinolinic acid, 2-hydroxynicotinic acid and 2-sulfonicotinic acid and the intracellular 
Ca^ + levels measured. Quinolinic acid gave an increase in Ca^ + from a basal level of 
129 nM to approximately 550 nM over a range of concentrations from 100 |iM to 3 
mM, after which the curve flattened off (see Graph 2.1). However, no rise in 
intracellular Ca^ + levels was seen for either 2-hydroxynicotinic acid or 2-sulfonicotinic 
acid over the same range of agonist levels. These results imply that although quinolinic 
acid is confirmed as an agonist of the NMDA receptor, 2-hydroxynicotinic acid and 2- 
sulfonicotinic acid appear not to be agonists of the NMDA receptor.
600
500-
I 400-
200-
100 o oo
Q WwKmk Add
^  Hidnaywcoiidc Add
D Qmmdndc Add-
Sd |ihonic Add Amlogue
( Agonist 1 QiM)
Graph 2.1
Quinolinic acid was applied to cells at a concentration of 2 mM, a level
established as a concentration which produces a significant rise in intracellular Ca^+
levels. A range of other compounds were then added to the cells, to assess their ability
to antagonise the effect of quinolinic acid. It was found that neither 2-hydroxynicotinic
acid and 2-sulfonicotinic acid antagonised the 2 mM quinolinic acid mediated
intracellular effects to a measurable extent.
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The neurotoxicity of quinolinic acid and derivatives on mouse granule cells was 
then determined using a MTT assay. The MTT (3-(4,5-dimethylthiazolyl)-2,5- 
diphenyltetrazolium bromide) method for determining cytotoxicity is dependent on 
mitochondrial dehydrogenase activity. A solution of MTT is yellow in colour, but if 
the enzymes in viable cells cleave the tétrazolium ring purple crystals of formazan are 
produced. A quantitative measurement of cell damage is given by a spectrophotometric 
reading of the colour, and conclusions from these results can be drawn on the 
neurotoxicity of test compounds.
Graphs 2.2 and 2.3 show the results of MTT assays for quinolinic acid, 2- 
hydroxynicotinic acid and 2-sulfonicotinic acid. As the quinolinic acid concentration 
was increased then the absorbance as a percentage of the control decreased, 
demonstrating the neurotoxic effects of the increase in quinolinic acid levels. Under 
exactly the same conditions, the sulfonic acid analogue showed no statistical effect, a 
result also demonstrated for the MTT assay for 2-hydroxynicotinic acid. These results 
imply that these quinolinic acid analogues have no neurotoxic properties under these 
conditions.
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Graph 2.2: M l 1 assay for quinolinic acid
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Graph 2.3: MTT assay for 2-sulfonicotinic acid
2-Hydroxynicotinic acid and 2-sulfonicotinic acid are therefore neither agonists 
nor antagonists of the NMDA receptor. It appears that replacement of the 2-carboxylic 
acid group greatly reduces the affinity of the compounds for the NMDA receptor. This 
is not unexpected for 2-hydroxynicotinic acid, as the hydroxyl group will be quite 
different in its binding properties to the carboxylate. Certainly a salt bridge or 
charge/charge interaction at the NMDA binding site will no longer exist. The sulfonic 
acid group, however, will have a negative charge at physiological pH as does the 
carboxylate. The problem in this case may be the increased size of the sulfonate over 
the carboxylate, and therefore unfavourable steric factors preventing binding.
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2.2 Synthetic approaches to 2-Phosphononicotinic acid
This analogue of quinolinic acid, although seeming trivial, proved to be a more 
difficult and interesting synthetic challenge. Several synthetic routes to the compound 
were envisaged, incorporating a wide range of organic reactions.
2.2,1 Organometallic Strategies
During the last fifteen years, orthometallation has evolved into a significant 
position in organic c h e m i s t r y . T h e  basic principle involves deprotonation by a 
strong base at a site adjacent to a heteroatom containing substituent, known as a 
directed metallation group (DMG). Normally an alkyl lithium base is required for 
generation of ortho-lithiated species, treatment of which with an electrophilic reagent 
provides the required 1,2-disubstituted product.
This can be condensed into three steps, the coordination of an alkyl lithium to a 
DMG heteroatom, followed by deprotonation at an adjacent carbon, leading to an ortho- 
lithiated species, and then reaction with a suitable electrophile (Scheme 2.11).
DMG
RLi
DMG
-RH
DMG DMGEX
Scheme 2.11: Orthometallation strategy
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Such a strategy could be used for the synthesis of the desired pyridine 
derivative. If a suitable DMG was incorporated at the 3-position, it could be used to 
direct a phosphorus substituent into the 2 -position.
Firstly, diisopropyl nicotinamide was successfully synthesised by treatment of 
nicotinic acid with thionyl chloride, followed by diisopropylamine. Epsztajn et al had 
previously demonstrated that when orfAo-metallation was attempted on the 3-substituted 
pyridine, substitution was ortho- directed but to position 4 rather than position 2.1^^
To allow for this, a trimethylsilyl group was first added at position 4 as a 
protecting group. Diisopropyl nicotinamide (43) was thus lithiated using LDA and 
trapped out using trimethylsilyl chloride in situ. LDA was generated in dry THF, and 
trimethylsilyl chloride added prior to addition of the amide solution. This gave the 
product (44) in 76% yield, the TMS group easily observed in the NMR spectrum at 
0.35 ppm. The TMS group at position 4 can easily be removed at a later stage by 
treatment with TBAF (Scheme 2.12).
O
(43)
Li—
N»Pr2 +
TMSCl
(44)
Scheme 2.12 
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N iP l2 + LiCI
After protection of the 4-position, a second o-metallation was attempted in order 
to get reaction at the 2-position. Lithium diisopropylamide (LDA) was initially used as 
the base, followed by treatment with diethyl chlorophosphonate, but no reaction took 
place, possibly because of a lack of deprotonation (Scheme 2.13). When the synthesis 
of the 2,4-disilyl derivative was attempted, so that a different electrophile was used to 
trap the anion, again no reaction was seen, which was an interesting result as 
previously when the 4-silylated diisopropyl nicotinamide was synthesised, the di­
substituted product was present, albeit in a very small yield.
N
N"
.CO2H .C0N‘Pr2
i) SOCI2  ^
ii) HN‘Pr2 N
i) LDA/THF  ^
ii) TMSCl
.CO2H
PO3H2
C0N‘Pr2
TBAF/THF ^ ------------
P(0)(0Et)2
SiMeg
CON‘Pr2
N
i) LDA/THF
ii) P(0)(0Et)2CI
SiMe.
C0N'Pr2
N P(0)(0Et)2
Scheme 2.13: Proposed route to 2-phosphononicotinic acid
LTMP (Lithium 2,2,6,6-tetramethylpiperidide), known to be suitable for
efficient aromatic deprotonation, and f-BuLi were then used as bases, but again no
reaction took p l a c e . Similarly, mesityl lithium is known to lithiate the 2-position of
3-methoxypyridine,^ ^  ^  but was not successful in this case. The rationalisation of using
TM EDA {N, N, N', A - te tram eth y l-1,2-ethanediam ine) as a base was that
complexation of lithium with the nitrogen of the pyridine and TMEDA would allow
lithiation to take place. However no reaction was seen,
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The directing group was then changed to a cyclic oxazoline (45), to investigate 
whether the size of the diisopropyl group was too great and preventing reaction. The 
oxazoline protected nicotinic acid was synthesised from nicotinyl chloride (Scheme 
2.14), which itself was obtained in the same manner as for the synthetic route to 4- 
silylated diisopropyl nicotinamide. Synthesis of the oxazoline group required two 
further steps. Nicotinyl chloride was treated with 2-amino 2-methylpropan-1 -ol, and 
this reaction followed by chlorination of the terminal caibon, which upon treatment 
with base led to ring closure. However, attempted substitution of the 4-position in a 
manner analogous to the diisopropyl protecteed nicotinic acid gave similarly negative 
results.
OH SOCI2
OH'
SOCI2
OH
HO
(45)
Scheme 2.14: Synthetic route to 2-(3-pyridyl)-4,4-dimethyl-oxazoline
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2.2.2 Palladium Coupling Reactions
Although the Michaelis-Arbuzov reaction provides a well known route for the 
formation of carbon-phosphorus bonds, this method cannot be carried over to the 
formation of aryl carbon-phosphorus bonds. Indeed only a few methods have been 
reported for the synthesis of arenephosphonates.132-138 Many include radical 
photolysis r e a c t i o n s ,^ 34,135 j^ v s  used nickel catalysts nickel chloride or nickel bromide 
for the r e a c t i o n ,  ^ 36 while Kosalopoff and Roy carried out Michaelis-Arbuzov reactions 
to form pyrimidyl p h o s p h o n a t e s . ^ 3 8  However, Burger et al demonstrated that the 
Arbuzov-Michaelis reaction was not possible with 2-bromo- or 2-chloropyridine. ^  39
Hirao et at discovered a novel synthetic route to dialkyl arene phosphonates 
using a palladium (0) c a t a l y s t .  The dialkyl arene phosphonates were synthesised
in good yields by reaction of an aromatic bromide or iodide with the corresponding 
dialkyl phosphite and triethylamine in the presence of tetrakis(triphenylphosphine) 
palladium (Scheme 2.15).
g o
II Pd(PPh3)4,NEt3 II
Ar-X + ^' ^ O R  ^
OR OR
Scheme 2.15: Palladium coupling reaction
The reaction involving diethyl phosphite was successful for a number of 
substituted benzyl bromides and iodides, although chlorobenzenes did not react. These 
aryl phosphonates could also be synthesised with diisopropyl and dibutyl phosphites, 
and no significant effect on the yield was observed following the addition of 
substituents on the benzene ring. It was thus decided to investigate this methodology 
as a route to 2-phosphononicotinic acid.
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In the literature diethyl pyridine-3-phosphonate was synthesised from 3- 
bromopyridine using this method. It was thus important to assess whether the same 
substitution reaction would occur at position two, where substitution is at the carbon 
adjacent to the pyridine nitrogen. Using the literature method diethyl pyridine-2- 
phosphonate was successfully synthesised from 2-bromopyridine in 41% yield. This 
was confirmed by NMR data showing the presence of the diethyl phosphonate group, 
and mass spectrometiy gave the expected molecular ion at 215.
As this was successful, the synthesis of 2-phosphononicotinic acid was 
attempted. In order to prepare the correct compound, the necessary starting material 
was methyl 2-bromonicotinate (46). This was synthesised in the manner described by 
Bryson et al (Scheme 2 .16). 1^ 2
MeO
OMeMel
ZnCl2.
Acetic achydrideMeO
CN
(47)
CN
HBr, AcOH 
 ►
.COzMe
(46)
Scheme 2.16: Synthesis of methyl 2-bromonicotinate
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The zinc chloride catalysed condensation of methyl cyanoacetate and 1,1,33- 
tetramethoxypropane in acetic anhydride led to the production of the enol ether methyl 
2-cyano-5-methoxypentane-2,4-dienoate (47) in 90% yield (Scheme 2.17)443
CN CN
CO2CH3 2 CH3OH
CN
H3CO' CN
OCH3
Scheme 2.17; Synthesis of methyl 2-cyano-5-methoxypentane-2,4-dienoate
Treatment with hydrobromic acid in acetic acid then resulted in the very facile 
intramolecular cyclisation-elimination reaction, to produce methyl 2-bromonicotinate in 
97% yield. The cyclisation was initiated by addition of hydrobromic acid across the 
nitrile group, forming an iminobromide which, in a Michael type reaction, added to the 
terminus of the conjugated ester system. Methyl 2-bromonicotinate was then formed 
by elimination of methanol (Scheme 2.18).
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CN
BrHN
CH3OH
.CO2CH3
^ N ^ B r
Scheme 2.18: Mechanism for methyl 2-bromonicotinate production
It is fortunate in the preparation of the enol ether that only one of the many 
possible geometric isomers form, as is confirmed by and NMR, leading to an 
explanation of the almost quantitative yield for cyclisation. Hydrobromic acid in acetic 
acid is quite a strong reagent, possibly making the geometry of the enol ether iiTelevant. 
If malononitrile was used for the reaction, 2-bromonicotinonitrile would be f o r m e d .  ^ ^3 
The palladium coupling reaction using methyl 2-bromonicotinate was then 
attempted. Methyl 2-bromonicotinate was heated with diethyl phosphite for three days 
in the presence of the palladium (0) catalyst and triethylamine. Although tic suggested 
that some reaction had taken place, none of the expected product was isolated.
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In order to rule out palladium catalyst contamination as a possible problem, the 
experiment was repeated with a newly opened sample of catalyst weighed out under 
nitrogen, but was not successful. The major hindrance to this reaction could be the size 
and position of the methyl ester group which prevented the palladium catalyst from 
coordinating the bromo-pyridine.
The mechanism for the synthesis of methyl 2-bromonicotinate involved the 
nucleophilic attack of bromide ions to initiate the cyclisation reaction. It was considered 
that a phosphorus nucleophile may have a similar effect, and provide a route that would 
introduce a phosphonate group into the desired 2-position on the pyridine ring. 
However a simple reaction in which hydrobromic acid was replaced by triethyl 
phosphite was not successful (Scheme 2.19).
CO2CH3
P(0CH2CH3)3
CN
H3CO
Scheme 2.19: Attempted nucleophilic addition
2.2.3 Nucleophilic Addition Reactions
Many substituted pyridines have been prepared via attack of nucleophiles on N- 
alkoxypyridine salts, prepared from the appropriate iV-oxide.i44 por example, 
Redmore demonstrated that reaction of A-alkoxypyridinium salts with the alkali metal 
derivatives of dialkyl phosphonates provided a general route to the synthesis of dialkyl 
pyridine-2-phosphonates, which can then be hydrolysed in 18% hydrochloric acid to 
the corresponding phosphonic a c i d s . I n  particular it was found that N- 
methoxypyridinium methylsulfonate reacted with lithium diethyl phosphonates to form 
diethyl pyridine-2-phosphonate (48) in 67% yield (Scheme 2.20).
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Q-
(MeO)2S02
MeOH
N P(0)(OEt)2
(48)
OMe
MeOSOg-
n-BuLimP(0 )(0 Et)2
-H
N P(0)(0Et)2
OMe
Scheme 2.20: Synthesis of diethyl pyridine-2-phosphonate
The temperature of the reaction is very important. The loss of methanol from 
the intermediate is rapid at room temperature, which leads to an increase in the 
concentration of methanol, which then competes with the A-methoxypyridine for the 
lithium diphosphonate salt.
LiP(0)(0Et)2 + MeOH LiOMe + H P(0)(0Et)2
If the reaction temperature is lowered to - 20 to -30 °C then attack of the 
nucleophile on the iV-methoxypyridine is much faster, giving higher yields. Diethyl 
pyridine-2-phosphonate has also been obtained by reaction of triethyl phosphite with 2- 
nitropyridine N-oxidcM^
Redmore also carried out the reaction with 3-substituted pyridines. As expected 
a mixture of products was obtained, where substitution occurred at both the 2- and 6- 
positions. For example, 3-methylpyridine A-oxide (picoline A-oxide) was converted 
into a mixture of diethyl 3-methylpyridine-2-phosphonate (49) and diethyl 5- 
methylpyridine-2-phosphonate (50) in a ratio of 6:1 (Scheme 2.21).
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(M e 0 )2 S 0 2
OMe
n-BuLi/HP(0 )(0 Et)2
IT  ^  P(0)(0Et)2 N '^  ^ P (0 )(0 E t)2
(50) (49)
Scheme 2.21: Redmore reaction
It was decided to investigate a similar reaction using ethyl nicotinate (Scheme 
2.22). The A-oxide of ethyl nicotinate (51) was prepared in 75% yield using hydrogen 
peroxide and trifluoroacetic anhydride, and this was methylated in quantitative yield 
with dimethyl sulfate. Treatment of the ethyl 7/-methoxynicotinium methylsulfonate 
with lithium diethylphosphonate (from w-BuLi and diethyl phosphite) produced triethyl 
pyridine-5-carboxylate-2“phosphonate (52) as expected, shown by NMR. However 
no evidence of triethyl pyridine-3-carboxylate-2-phosphonate (53) was observed. The 
presence of 52 was confirmed by the singlet for the proton at position 2 of the pyridine 
ring, observed in the ^H NMR spectrum at 7.75 ppm. The other pyridine protons were 
present as the expected doublets. If the substitution had been successful at position 2, 
then the triplet seen for the proton at position 5 would have been observed in ^H NMR, 
and no singlets would have been present.
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'COiEt H2 O2 , TFAA ,C02Et
N
O'
(51)
(Et0)2(0)
C02Et (MeO)2S02
C02Et
(53)
'N '
OMe
Scheme 2.22: Reaction using ethyl nicotinate
The size of the carboxylate ester group suggests that the bulky diethyl 
phosphonate group will preferentially attack the less hindered carbon at position 2, 
adjacent to the pyridine nitrogen.
An Arbusov type reaction was also attempted where triethyl phosphite was 
heated with methyl 2-bromonicotinate, prepared as in Section 2.2.2, (Scheme 2.23), 
but no reaction was observed. This implies that either the bromide was not sufficiently 
reactive for attack of the phosphonate group or that steric hindrance due to the ester was 
too great.
p(OEt),
Scheme 2.23: Arbusov reaction
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Burger et al had also shown that 2-bromopyridine was unreactive under these 
conditions, and methyl 2-bromonicotinate proved to be the same.^39 The Michaelis- 
Becker-Nylen reaction was also attempted with methyl 2-bromonicotinate (Scheme 
2.24). The lithium salt of diethyl phosphite was formed in the usual way, but no 
reaction of the salt with methyl 2-bromonicotinate was seen.
BuLi, H P ( 0 ) ( 0 E t ) 2
Scheme 2.24: Michaelis-Becker-Nylen
Both of these reactions were also attempted with 2-chloronicotinonitrile. It was 
thought that this group would provide less steric hindrance to attack by the phosphorus. 
The nitrile group could then be hydrolysed to the required carboxylic acid group at a 
later stage (Scheme 2.25).
n-BuLi, HP(0 )(0 Et)2
or P(0Et)3 
N Cl
H3O+
W  P(0)(0Et)2 P(0)(0H)2
Scheme 2.25: Reaction using 2-chloronicotinonitrile
However under the same conditions as for methyl 2-bromonicotinate, no 
reaction occurred. 2-Chloronicotinonitrile again appears not to be sufficiently reactive.
Tavs and Kaite heated 2-bromopyridine with triethyl phosphite, in the presence 
of a copper catalyst, and only obtained a 1% conversion to diethyl pyridine-2- 
phosphonate, which demonstrates the low reactivity of these c o m p o u n d s .  1^7
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2.2.4 Building up the Pyridine Ring
As discussed, routes to the formation of 2-phosphononicotinic acid involving 
the addition of the phosphorus-containing group to the pyridine ring were 
unsuccessful. Therefore, alternative methods were investigated which involved 
formation of the pyridine ring with the phosphorus-containing group already 
incorporated.
The initial investigation focused on the synthesis of a-aminophosphonic acids. 
It was envisaged that the amino acid could be incorporated into the pyridine ring by 
cyclisation, to give the carboxylic acid and phosphonic acid groups in the required 
positions. It was thought that 1,1,3,3-tetramethoxypropane could be utilised to effect 
the cyclisation, followed by aromatisation and deprotection to produce the product in a 
similar manner to that for methyl 2-bromonicotinate (Scheme 2.26). Therefore our 
initial synthetic target was (54).
,C02Et
H2N POgEt2
(54)
OMe
H-*
N P03Et2
H+/ H2O
N PO3H2
Scheme 2.26: Proposed cyclisation
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2.2.4.1 a-Aminophosphonic acids
Many potent antib io tics, 1^8 enzyme inhibitors, herbicides and in secticides 149 
are a-am inophosphonic acids, Generally a-aminophosphonic acids are toxic in 
high concentrations, and differ from amino acids in that many tissues are unable to 
transform the phosphorus into p h o s p h a te .T h e  biological activity and uses of a -  
aminophosphonic acids have been widely reviewed,
2.2.4.2 Synthetic Routes Towards a-Aminophosphonic acids
A proposed synthetic route to this protected a-am inophosphonic acid is 
described in Scheme 2.27 below.
Br
(55)
,C02Et
H 2N  P 03E t2
P(OEt)3
H2NNH2
(56)
i) Base
ii) BrCH2C02Et
C02Et
P03Et2
Scheme 2.27: Proposed route to protected a-aminophosphonic acid
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A-Bromomethylphthalimide (55) was heated with triethyl phosphite over 3 
days at 160 °C to produce diethyl A-phosphonomethylphthalimide (56) which was 
recrystallised from ethyl acetate and hexane to give a white powder in a good yield. 
The melting point coiTesponded to that from the literature confirming the identity.
It was expected that treatment of A-phosphonomethylphthalimide with a base, 
followed by addition of bromomethyl acetate would be successful. This reaction would 
allow the introduction of the protected carboxylic acid group on the carbon adjacent to 
the phosphonate group. The phthalimide group is a good protecting group for this 
function as there are no amide protons.
Initially «-BuL i and r-BuLi were employed as bases to carry out the 
deprotonation. However, little or no anion formation was observed, the only reaction 
observed being hydrolysis of the phosphonate ester groups. Lithium diisopropylamide 
(LDA), sodium hydride and sodium methoxide in methanol were also employed as 
bases, but again, only deprotection of the esters took place, preventing deprotonation, 
and causing great problems upon isolation. The attempts with these bases were 
repeated in a wide range of dry solvents to try and eliminate any possible solvent 
interference. These solvents included THF, DMF, ethanol, methanol and DME.
The much weaker bases potassium carbonate and KHMDS were also 
considered, but although no deprotection of the phosphonate esters occurred, neither 
did deprotonation. If substantial deprotonation, and subsequent incorporation of the 
ethyl acetate group, had taken place, then re-esterification of the hydrolysed product 
would have been an alternative, but no such reaction occurred.
Treatment of the product with hydrazine would deprotect the nitrogen to give 
the ester of an a-am ino phosphonic acid. Cyclisation to form the pyridine ring with 
1,1,3,3-tetramethoxypropane and hydrolysis of the esters would, as described earlier, 
produce 2-phosphononicotinic acid.
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Due to the severity of the problems discussed, this route to the formation of an 
a-am ino phosphonic acid was abandoned, and attention turned to alternative routes. 
Oleksyszyn et al developed a three component coupling route to produce an a-am ino 
phosphonic acid (57) (Scheme 2.28).^^^
O O oAcOH
R H
+ P(OPh)3 +
R'O NH2I / \R'O NH
H- ■P(0)(0Ph)2
R
(57)
Scheme 2.28: Three component coupling route
A similar reaction, this time to synthesise phosphomethionine and other similar 
compounds as the phosphorus analogues of essential amino acids was developed by 
Tam et al (Scheme 2 .29).^^4
O
RSCH2CH2CH P(OPh)3
AcOH
H2N NHPh PhHN NH
RSH2CH2C- ■P(0)(0Ph)2
H
Scheme 2.29: Tam reaction
(A-Phenyl)thiourea was this time used as a protected source of the amino 
group, in reactions which gave good yields in producing both methionine and ethionine 
analogues. This work was adapted to develop a proposed route to 2- 
phosphononicotinic acid (Scheme 2.30).
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EtO
EtO' +> / Glacial acetic acid
P(OPh)3
+
PhCHzNH------ C—  NH2
S
HQ
O
HN P(0)(0Ph)2
NHCHzPh
HN P(0)(0Ph)2
NHCH2PI1
O3
O
HN P(0)(0Ph)2
NHCH2PI1
.CO2H
H2N PO3H2
Scheme 2.30: Proposed route to 2-phosphononicotinic acid
Thus, benzylthiourea, triphenyl phosphite and 3-butenal diethylacetal were
stirred for 16 hours in glacial acetic acid, heated to reflux for a further 2.5 hours and
then the acetic acid removed. No reaction was detected by tic or NMR. It was not
possible to purchase, or easily synthesise butenal, which may have been a better
component than the diethyl acetal, but it was hoped that the diethyl acetal would have
been a successful alternative. When propanal had previously been used as a starting
component the reaction occuiTed in good yield.
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2.2.5 Alternative Routes to 2-Phosphononicotinic acid
Previously, attempts to introduce the phosphonate ester group into the pyridine 
ring have been highly specific, with introduction directed at the 2-position. However, 
as these were unsuccessful, routes which were potentially less efficient, but still 
produced 2-phosphononicotinic acid as one of a mixture of products, were considered.
Steric hindrance, in that the size of the carboxylate ester prevented the 
introduction of the phosphonate ester at the 2-position, was the main factor in these 
unsuccessful synthetic routes. Thus alternative groups for the 3-position small enough 
to allow substitution at position 2, but capable of conversion to a carboxylic acid group, 
were considered. The main focus of these involved compounds with a methyl group at 
the 3-position. The conversion of the 3-methyl group to a carboxylic acid group by 
oxidative methods would then produce the desired compound (Scheme 2.31).
[O]
N P(0)(0Et)2 N P(0)(0H)2
Scheme 2.31: Oxidation of methyl group
For this purpose, the reaction developed by R e d m o r e , ^45 iq produce diethyl 3- 
methylpyridine-2-phosphonate, was employed to produce the diethyl 3-methylpyridine- 
2-phosphonate and diethyl 5-methylpyridine-2-phosphonate. This gave the two 
products in 89% yield, and in a ratio of 10:1, better ratio than that achieved by 
Redmore.
Firstly, picoline N-oxide (3-methylpyridine N-oxide) was methylated in 
quantitative yield, and the resulting iV-methoxypicolininium salt dissolved in diethyl 
phosphite and added to a solution of n-BuLi and diethyl phosphite at - 20 to - 30 °C.
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After addition was complete, the solution was stirred at - 20 to - 30 °C for a further 30 
minutes and then the reaction allowed to warm to room temperature. The reaction was 
followed by tic (3:2 40-60 pet. ether: ethyl acetate) and on completion excess diethyl 
phosphite removed under reduced pressure. Using Kugelrohr distillation, the two 
isomers were then separated giving a 10:1 ratio of products. Hydrolysis of the diethyl 
phosphonate was achieved by refluxing in concentrated hydrochloric acid for 6 hours to 
produce 3-methylpyridine-2-phosphonic acid (58) in 75% yield (Scheme 2.32).
HCl
N P(0)(OEt)2 P(0)(0H)2
(5 8 )
Scheme 2.32: Hydrolysis of ester
The focus then moved onto oxidation of the 3-methyl group to the carboxylic 
acid. DuPriest et al successfully synthesised 2-phenylpyridine-3-carboxylic acid (59), 
in moderate yields from the respective 3-methylpyridines, by oxidation with potassium 
permanganate (Scheme 2 .33).
CO2H
KMn04
Scheme 2.33: DuPriest oxidation
This method was thus examined. 3-MethyIpyridine-2-phosphonic acid and 
potassium permanganate were dissolved in water and heated to reflux and inspection by 
tic appeared to show that oxidation had taken place (Scheme 2.34). No spot 
corresponding to staiting material was observed.
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When all the permanganate was consumed, the hot mixture was filtered through celite 
to remove manganese dioxide. When the water was removed under reduced pressure, 
a white solid formed. However this solid was insoluble in a wide range of NMR 
solvents, C ^ C lg , 2H2O, d-6 DMSO and d-4 methanol.
KMnO,
N P(0)(0H )2
CO2H
N ^ P (0 ) (0 H )2
Scheme 2.34: Attempted oxidation
The lack of solubility of the oxidation product and the tic result implied that 
perhaps the di-acid was formed, but could not be isolated. Analysis by mass 
spectrometry gave no further information on the identity of the oxidation product, 
whilst attempts at recrystallision from boiling water were unsuccessful.
In order to check the success of the reaction, the oxidation was repeated with 
picoline (3-methylpyridine), and nicotinic acid (pyridine-3-carboxylic acid) (32) was 
formed as expected, in good yield (Scheme 2.35).
KMnO^
CO2H
N 'N
(32)
Scheme 2.35: Oxidation of 3-methylpyridine
An alternative oxidation method was investigated, involving bromination of the 
methyl group and subsequent oxidation of the bromomethyl group to the carboxylic 
acid (Scheme 2.36).
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Br
^P(0)(OEt)2
.COgH
N P(0)(0H)2
^P(0)(OEt)2
(60)
[O]
N P(0)(0Et)2
Scheme 2.36; Bromination route to 2-phosphononicotinic acid
In the synthesis of 2-carboxyquinoline-3-acetic acid by Gray et the first 
step involved the bromination of methyl (3-methyl)quinoline-2-carboxylate (61) using 
A-bromosuccinimide to give methyl (3-bromomethyl)quinoline-2-carboxylate (62) in 
22% yield (Scheme 2 .37) . This presents a milder method for the desired oxidation 
and was therefore employed as an alternative method.
NBS, (C6H5C0)202
CCI4
'CO2CH3 N ^C02CH3N
(61) (62)
Scheme 2.37: Bromination of methyl (3-methyl)quinoline-2-carboxylate
Thus diethyl (3-methyl)pyridine-2-phosphonate was dissolved in carbon 
tetrachloride and added to a solution of A-bromosuccinimide in carbon tetrachloride 
with 0.1 equivalents of catalytic dibenzoyl peroxide. The reaction was heated to reflux 
for two days, with further additions of 0.1 equivalent catalyst every 12 hours. On 
cooling the carbon tetrachloride was removed under reduced pressure and purification
of the crude bromide on a silica gel column provided, on crystallisation, a pale orange86
solid of diethyl (3-bromomethyl)pyridine-2-phosphonate (60) in 30% yield. The 
appearance of a singlet at 4.93 in the NMR spectrum, and the disappearance of one 
at 2.50 indicated that bromination had occurred. A pair of peaks at 307 and 309 in the 
mass spectrum confirmed this as did that at 228 (M-Br). Accurate mass data gave 
further weight to the data (Found: [M] 306.9969. CioHigNOgPBr requires 306.9972).
Matt et al described the transformation of primary alkyl bromides, including 
bromoethyl benzene (63), bromomethylbenzene and iV-bromomethylphthalimide into 
the corresponding carboxylic acids (64) by treatment with sodium nitrite and acetic acid 
in dimethyl sulfoxide in good yields (Scheme 2.38). The researchers claim that this 
method is the only synthetically useful one-pot oxidation of primary bromides to 
carboxylic acids.
NaNOz, AcOH  ^
DMSO, 35 °C
OH
X= Br, NO2
(63) (64)
Scheme 2.38: Matt oxidation
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The following mechanism was proposed for the conversion of the nitroalkane 
formed by initial nucleophilic substitution to the acid (Scheme 2.39).
N
OH
R NO2 R
O-
OH O
(65)
o
R OH
V OH
R
R" IN O-
o / \
Scheme 2.39: Oxidation of nitroalkane
If the reaction was carried out at 18 °C rather than 35 °C, the nitrolic acid (65) 
was isolated. It was proposed that the reaction is not acid catalysed but that an 
equivalent of nitrosonium ion, generated in situ by reaction of sodium nitrite and acetic 
acid propels the reaction, a theory supported by the fact that reaction only occurs if both 
species are present.
T herefo re , fo llow ing  the m ethod o f M att et al, d iethyl (3- 
bromomethyl)pyridine-2-phosphonate was dissolved in a mixture of sodium nitrite, 
acetic acid in dimethyl sulfoxide and stirred at 35 °C overnight, but no reaction was 
observed (Scheme 2.40).
.CHoBr
NaN02, AcOH 
------------------
DMSO, 35 °C
^P(0)(0Et)2
Scheme 2.40: Oxidation of diethyl (3-bromomethyl)pyridine-2-phosphonate
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One obvious and simple explanation to the problem is that the size of the diethyl 
phosphonate group interferes and prevents reaction from taking place.
If time had allowed, other methods of oxidation of the bromide to the carboxylic 
acid would have been considered. For example, the Kornblum oxidation, involving 
heating of the halide in DMSO in the presence of a base, oxidises the bromide to the 
corresponding aldehyde (Scheme 2.41).
R' X + Me2S O*
R
O .Me+
Me
H+
O
R' H Me2S O
k “ -‘
Me
Scheme 2.41: Kornblum oxidation
The aldehyde could then be oxidised to the acid. The Krohnke oxidation of a 
halide to an aldehyde involves three steps. Firstly, quatemization of the halide was 
completed using pyridine as the base. Deprotonation and reaction of the resulting 
pyridinium ylid with 7V,//-dimethyl-4-nitrosoaniline followed, and then finally acid 
hydrolysis led to the production of the carbonyl.
Benzyl halides were oxidised to the carboxylic acid with sodium 
h y p o c h l o r i t e ,  ^59 while Borsotti et al described the electrochemical oxidation of some 
benzyl chlorides to the corresponding acids using a nickel hydroxide electrode.
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Other methods using transition metals included the use of perruthenate^^^ and ruthenate 
a n i o n s a n d  the cobalt (III) ion.^^3
Further methods of oxidation of non-activated alkyl halides to the carbonyl 
derivatives include a variety of reagents, such as 2-nitropropane sodium salt, DMSO, 
A^-phenyltrifluoromethane sulphonamide, soluble and supported chromate reagents, 
and dimethyl selenoxideJ^^
2.2.6 Synthesis of 2-(Phosphonomethyl)mcotmic acid
As the routes to 2-phosphononicotinic acid were all unsuccessful, 2- 
(phosphonomethyl)nicotinic acid (66) was considered as an alternative analogue of 
quinolinic acid. Scheme 2.42 shows the synthetic route to the novel phosphonic acid.
.CO2CH3
N B S , (CgHgCOIzOz
CCI4
N '
(67)
CH2B1
(68)
nBuLi/HP(0)(0Et)2
,C02H
HCl
'N N
(66) (69)
Scheme 2.42: Route to 2-(phosphonomethyl)nicotinic acid
Methyl 2-methylnicotinate (67) was brominated on the 2-methyl position, in an 
identical manner as described for diethyl 3-methylpyridine-2-phosphonate, in 30% 
yield (68). The singlet representing the methyl group shifted downfield to 5.02 ppm
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upon bromination, in the NMR spectrum. When the product of this reaction was 
dissolved in diethyl phosphite and then treated with n-butyl lithium and diethyl 
phosphite at -20 to -30 °C, diethyl (3-methoxycarbonyl-2-pyridyl)methylphosphonate 
(69) was formed as an oil, in 20% yield. The methyl group shifted back upfield to 
3.95 ppm in the NMR spectrum, indicating that nucleophilic substitution had taken 
place. A peak at 25.14 in the NMR spectrum and a peak at 1290 cm-^ in the IR 
spectrum, confirmed the presence of the diethyl phosphonate group. The final step was 
to hydrolyse the esters. Diethyl (3-methoxycarbonyl-2-pyridyl)methylphosphonate 
was dissolved in concentrated hydrochloric acid, and heated to reflux for 24 hours. 
Upon cooling and removal of the excess acid, the acid (66) was produced as a white 
solid in 90% yield from the ester (69). Again and NMR data confirmed the 
success of the reaction, as the peaks representing the ester groups disappeared.
2.3 Conclusions and Future W ork
2-Sulfonicotinic acid and 2-hydroxynicotinic acid proved much easier to 
synthesise than 2-phosphononicotinic acid, though the efficiency of the routes towards 
these compounds could be improved through further work. Neither of these two 
compounds proved to be neuroprotective or to antagonise the effects of quinolinic acid 
during biological testing.
It would be interesting to evaluate the effect of 2-(phosphonomethyl)nicotinic 
acid under the same conditions. If the compound showed significant effects in any of 
the tests, either as an antagonist of quinolinic acid, or if the compound is 
neuroprotective, then a series of 2-phosphonoalkyl substituent compounds could be 
investigated.
2-Phosphononicotinic acid proved to be elusive, despite the large number of 
synthetic routes towards the target which were attempted. The oxidation of the 3- 
methyl group to the acid and methods of isolating the di-acid should be investigated
further, as they may hold the key to the successful synthesis.
91
CHAPTER 3
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3. Decarboxylation Studies on the QPRTase System and the 
Non-enzymic Decarboxylation of N - s u b s t i tu te d  
Quinolinic acids
3.1 Introduction
The decarboxylation reaction for the QPRTase catalysed system has not been 
examined in great detail. It has been assumed to have the same mechanism as proposed 
for the decarboxylation of pyridine carboxylic acids. Dyson and Hammick were the 
first to investigate this reaction when they heated quinalidinic and isoquinaldinic acids 
with an excess of certain high boiling aldehydes and ketones (benzaldehyde, 
anisaldehyde and benzophenone).^* These reactions resulted in evolution of carbon 
dioxide and production of a-pyridyl carbinols (70). This was followed by further 
investigation into the decarboxylation of pyridine carboxylic acids, including picolinic 
acid, by Ashworth, Daffern and H a m m i c k .  1^4 Again the carboxylic acids were heated 
in the presence of high boiling aldehydes and ketones. The connection was made that 
only when the carboxylic acid group was on the carbon adjacent to the nitrogen was the 
loss of carbon dioxide observed. No decarboxylation took place with 3- or 4- 
substituted carboxylic acids.
It was recognised by Hammick that an intermediate involving an ylid (71) was 
produced, and that the rate of decarboxylation varied within the series. A mechanism 
for the decarboxylation and the subsequent reaction with the aldehyde or ketone was 
proposed (Scheme 3.1), where decarboxylation to form an ylid was followed by 
nucleophilic attack on the carbonyl to form the a-pyridyl carbinol.
i193 1
NI IH H
(71)
Scheme 3.1: Hammick reaction
CR2 0 -
(70)
Much of the work after Hammick has involved the evaluation of the timing of 
the proton transfer from the acid group to the nitrogen of the pyridine ring during 
decarboxylation. The two possibilities were sequential proton transfer and 
decarboxylation, (Scheme 3.2, path 1), or a concerted reaction, that is the 
decarboxylation of the neutral acid (Scheme 3.2, path 2). In both reactions there is 
increased positive charge on the nitrogen, thus reducing the electron density on the a -  
carbon and facilitating C-C bond cleavage and release of carbon dioxide.
N " C = 0C  C l Path 2
H
Path 1
N ^ C = 0
H O'
Scheme 3.2: Hammick mechanism
+ CO2
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Cantwell and Brown reported the effect of solvents on the rate of 
decarboxylation of picolinic acid.^^^ Both acidic (e.g. phenol) and basic (e.g. aniline) 
solvents lowered the rate of decarboxylation of picolinic acid. In the case of the acids, 
competition for the pyridine nitrogen from the pyridine carboxylic acid proton and the 
solvent acidic proton reduced the concentration of the initial reactant. Therefore higher 
levels of cation (72) present, reduced the amount of zwitterion leading to a slower 
reaction.
or c = o
H— O
In the presence of base formation of the picolinate anion occurs, which lowers 
the rate of decarboxylation. Both these results support the theory that decarboxylation 
occurs through a zwitterion.
3.1.1 Effect of substituents on the pyridine ring
The effect of methyl substituents in the pyridine ring on the rate of 
decarboxylation of picolinic acid was also i n v e s t i g a t e d .  ^^ 6 3.^ 4 .^  5-, 6-Methyl- and 
4 ,6 -d im ethy l-p ico lin ic  acids (7 3 -7 7 ) were synthesised and their rate of 
decarboxylation studied along with that of picolinic acid itself.
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CH,
N CO2H 
(73) (74) (75)
ÇH
(77)
When the methyl group is ortho or para  to the nitrogen, inductive electron 
donation towards the nitrogen should reduce its pull on the a-carbon. This increases 
the energy required to break the C-C bond and therefore reduces the rate of 
decarboxylation, as was observed. The methyl groups meta to the nitrogen should also 
donate electrons towards the a-carbon although to a lesser extent, and again reducing 
the rate, as was observed for 5-methyl picolinic acid. However, 3-methyl picolinic acid 
produced an anomaly, in that the rate of decarboxylation increased with respect to 
picolinic acid, due to the steric effect of the presence of the methyl group at position 3.
Further studies on the decarboxylation of picolinic acid were carried out in polar 
solvents by C l a r k , a n d  led to the conclusion that the zwitterion was not favoured as 
the intermediate, but that the chelate form was. Previous studies by Clark also 
supported this t h e o r y . T h e  decarboxylation of picolinic acid in the molten state and 
polar solvents showed that the effect of these solvents was slight and that the reaction 
was bimolecular.
Brown and Moser examined the electronic effects in the transition states of the 
decarboxylation of pyridine-2-carboxylic acids.37 The rate of decarboxylation of 
several 6-substituted pyridine-2-carboxylic acids in 3-nitrotoluene was determined. 6- 
Nitro, chloro, bromo, acetamido, methoxy and amino picolinic acids (78-83) were all
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synthesised and their rate of decarboxylation used to deduce the structure of the 
intermediate in the transition state for the reaction.
It was proposed that if either the picolinate anion, or the zwitterion, were the 
transition states which lead to decarboxylation, then electron withdrawing effects would 
stabilise the transition states and lead to larger rate constants.
OoN"
HoN"
(78)
CO2H Cl'
(79)
Br^ N CO2H 
(80)
"N^^^^^^^C02H H 2 N O C < ^ ^ N '^  CO,
(81) (82) (83)
H
With a transition state where two events are occurring, i.e. N-H bond formation 
and C-C bond cleavage, there are three possibilities:
i) C-C bond cleavage leads N-H bond formation;
ii) C-C bond cleavage lags behind N-H bond formation;
iii) Both occur simultaneously.
The argument for the case of ii), where if C-C bond cleavage lags far enough 
behind N-H formation then a zwitterion is formed, was proposed as two-fold:
i) Amino acids exist in a stable form as zwitterions.
ii) If this were the case, an acid-base reaction would have a higher energy of 
activation than C-C bond cleavage.
6-Methoxy- and 6-acetamido- picolinic acids were selected to determine whether 
sterically hindering the lone electron pair on the ring nitrogen would have an effect on 
the rate of decarboxylation. Both compounds had a much lower rate of decarboxylation
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than expected, as rotation of the substituent may be preventing access for the acidic 
proton to the nitrogen.
Brown and Moser reported that as the electron withdrawing ability of the 6- 
substituents increased, then the rate of decarboxylation decreased .37  They also 
demonstrated that a linear relation existed between the cr values of Cl, Br, H and NO2 
and their rate constants, which indicated that a large positive charge develops in the 
transition state. This was proposed to be decarboxylation via the chelate intermediate, 
but with N-H formation slightly ahead of C-C bond cleavage.
Conclusions from Kilikin and Calvo's inhibition studies agree with the nitrogen 
ylid theory for decarboxylation.33 The actual degree of inhibition correlated with the 
degree of ionisation at the 2-position, which implied that the negative charge at this 
position contributes significantly to tight binding to the enzyme. Kilikin and Calvo 
proposed that the inhibitor is mimicking the intermediate ylid formed following 
decarboxylation, but the size of the sulfide anion suggests that it may actually mimic the 
carboxylate group of the substrate.
3.1.2 Effect of N-methyl substituents
Haake and Mantecon investigated the effect of N-methyl substitution on the rate 
of decarboxylation of picolinic a c i d .  1^ 9 in a previous paper on the preparation of N- 
methyl pyridine carboxylic acids it was stated that A/'-methylpicolinic acid (homarine) 
(84) "must not be heated or decomposition takes place" which implied that there was 
rapid d e c a r b o x y l a t i o n .  7^0 From this and the discovery that homarine was found to be 
present in large quantities in i n  v e r t e b r a t e s ,  171,172 Haake and Mantecon examined the 
rate of decarboxylation of picolinic acid derivatives in ethylene glycol at 134 °C.
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N COoHI
CH3
(84)
This work also recognised the studies of Brown and Hammick on the 
decarboxylation of iV-methylquinaldinic acid,^^^ but questioned the conclusions when 
it was shown that A^-methylpicolinic acid decarboxylated 720 times faster than picolinic 
acid under the same conditions. The AH* was almost 20 kJ mok^ greater than that for 
picolinic acid, a combination of the increase in electron density on the ring and the 
electron donating ability of the A^methyl moiety.
Haake and Mantecon suggested a strong interaction between the N-methyl 
group and the carboxylic acid group. Any attempt by the methyl group to rotate leads 
to that interaction being lost. As a result, unlike picolinic acid the decarboxylation of 
A-methylpicolinic acid involves mainly rotational but also some vibrational degrees of 
freedom being gained going from the ground state to the transition state, increasing the 
rate of reaction.
This theory also supports the large difference in the rate of decarboxylation 
found by Brown and Hammick for quinaldinic (85) and isoquinaldinic acid (86). The 
carboxylate group in isoquinaldinic acid lies between two electron acceptors - the N-H 
group and the benzene ring. This raises the energy of the ground state, therefore less 
energy is required to reach the transition state.
(85)
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3.1.3 Other heterocyclic carboxylic acids
The rate of decarboxylation of other nitrogen heterocyclic 2-carboxylic acids 
was studied by Dunn and c o - w o r k e r s J ' 7 4 .1 7 5  The decarboxylation of pyrrole-2- 
carboxylic acid (87) in aqueous solution at 50 °C, ionic strength 1.0, was studied. It 
was found to be first order and as the pH decreased from 3 to 1. The rate of 
decarboxylation increased gradually, but from pH 1 to 10 M hydrochloric acid the rate 
increased dramatically. The mechanism supported the same theory as proposed by 
Dunn for the decarboxylation of anthranilic acid (23), where the species undergoing the 
decarboxylation is protonated at the 2-position. At low acidity the rate of protonation is 
the rate determining step, but at high acidity it is the actual decarboxylation reaction 
(Scheme 3.3).
'N'IH
CO,
CÜ2
IH
(87)
Scheme 3.3: Dunn decarboxylation
COoH
(23)
Pyrimidine 2-carboxylic acid undergoes a pseudo-first order decarboxylation. 
The reaction was studied from pH 2 to Ho - 9.5, and whilst decarboxylation increased 
from pH 2 to Ho - 3, it remained constant thereafter. The examination of pyrimidine-2- 
carboxylic acid allowed the effect of an electron withdrawing group at position 3 to be 
studied without the steric influence of a bulky substituent.
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The main decarboxylating species is HA, but H%A also decarboxylates. A 
Hammick type mechanism may account for this, as the mono-protonated pyrimidine-2- 
carboxylic acid undergoes the loss of carboxylic acid to form the ylid, which in 
aqueous solution is converted rapidly to pyrimidine.
3.1.4 Decarboxylation in aqueous solvents
Dunn, Lee and Thimm recognised that all the decarboxylation studies on 
pyridine 2-carboxylic acids had been carried out in non-aqueous solvents, where ionic 
species, ylids and zwitterions are not favoured. Therefore the possibility of the 
cation or anion decarboxylating had not been considered, along with the possibility of 
electrophilic attack at the carbon, accompanying loss of carbon dioxide. The 
decarboxylating species can also be determined more accurately through pKa data. 
Indeed, the decarboxylation of 6-methylpicolinic acid (77), 5-nitropicolinic acid (88) 
and picolinic acid (7) at 180 °C, ionic strength 1.0, produced interesting results.
H ,C
OoN,
N CO2H N ^ C 0 2 H N ^ C 0 2 H
(77) (88) (7)
All three had a rate of decarboxylation with a maximum at an intermediate pH, 
which decreased at higher and lower acidities. The ylid decarboxylation mechanism 
predicted this result, where the decarboxylating species is isoelectric, although it cannot 
be proved whether this is correct as neither the pH or pKa are known at 150 °C.
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Significantly the rate constant versus pH profile was unsymmetrical. At low 
pH the rate decreased very sharply which implied that the cation did not decarboxylate, 
and that any unionised species did not decarboxylate very well. However, above the 
maximum, the rate decreased only slowly as the pH increased and above pH 5 was 
actually constant, at approximately half of the maximum. This unexpected result 
implied that the anion did decarboxylate. Decarboxylation thus occurred without 
nitrogen protonation, indicating that either protonation was not important or the 
isoelectric species contained little zwitterion.
The effect of the substituents was unusual. The 5-nitro group increased the rate 
of decarboxylation whereas it was decreased by a 6-methyl group, which was the 
expected result if negative charge developed at the site of reaction, but the effect was 
much smaller than that seen in the corresponding benzene species. The rate of 
decarboxylation was also slower than seen in non-aqueous solvents.
3.1.5 Decarboxylation of quinolinic acid
Quinolinic acid is actually the fastest of all the pyridine carboxylic acids so far 
studied, decarboxylating in aqueous hydrochloric acid (pH 1) at 95 °C with a half life of 
around 3 days. Quinolinic acid was shown to decarboxylate 500 times faster than 
picolinic acid or any other pyridine dicarboxylic acid at 95 °C and ionic strength 1.0. 
Although this is the fastest it is still a very slow rate under very harsh chemical 
conditions. The effect of the 3-carboxylic acid group seemed to be to disturb the 
coplanarity of the 2-carboxylic acid group and the aromatic ring, lowering bond order 
and thus facilitating bond breaking.
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3.1.6 Kinetic isotope effect
The kinetic isotope effect on the rate of decarboxylation of quinolinic acid 
and picolinic acid was investigated. Dunn et al postulated that a reaction with rate 
maximum at the isoelectric pH is explained by either a rate-controlling decarboxylation 
of the isoelectric species postulated by Hammick, or by the rate dependent step 
being the protonation of the monoanion. If the former is the case a kinetic isotope 
effect on the rate should be detected. At both the isoelectric pH and above, a significant 
carbon isotope effect was observed, implying that C-C bond breaking was the rate 
determining step for decarboxylation of both the isoelectric species and the anion. At 
both the isoelectric pH and higher values, the ^^C kinetic isotope effect (100(Ki2/ki3- 
1) was quite large. It was 1.0284 at pH 0, 1.0267 at pH 3.95 for quinolinic acid). The 
effect was slightly less for the anion for both quinolinic acid and picolinic acid, 
implying that the zero-point energy difference in the starting material is a smaller 
fraction of the activation energy for the slower reaction. The size of the effect 
suggested that C-C bond breaking was well advanced in both the transition states.
3.1.7 Decarboxylation of homarine
As neither 3- or 4- pyridine carboxylic acids decarboxylate, the nitrogen must 
have a profound effect on decarboxylation. A-Methyl picolinic acid (homarine) was 
studied in aqueous solution to complement the study in ethylene glycol by Haake and 
Mantecon. Again it did not decarboxylate when unionised, but did when ionised. A 
rate constant of 1.3 x 10-4 g-i was observed, and compared to a rate constant for the 
decarboxylation of picolinic acid of 5.0 x 10-  ^S'h Thus, the effect of quaternisation of 
the picolinate nitrogen was to increase the rate of decarboxylation by around 250-fold, a 
considerable effect, although not as large as the effect of the presence of the 3-carboxyl 
group.
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As protonation of picolinic acid only doubled the rate of decarboxylation, i.e. 
the maximum rate compared to the rate of decarboxylation of the anion, it seemed to be 
reasonable to suggest that protonation actually occurred on the acid, not the nitrogen, so 
that the decarboxylating species was actually the neutral acid, not the zwitterion. One 
possibility is that the positive charge on the protonated species was dissipated by 
solvation of the proton.
This work was followed up by Dunn and Thimm with studies on the 
decarboxylation of six 3-substituted picolinic acids in aqueous s o l u t i o n .  ^'77 This was to 
investigate whether the effect of the 3-substituent, which in the case of quinolinic acid 
had increased the rate of decarboxylation by a factor of 500, was due to electronic, 
steric or neighbouring group effects.
The six substituted picolinic acids: amino (89), benzoyl (90), bromo (91), 
hydroxyl (92), methyl (73) and nitro (93) were synthesised and decarboxylated in 
buffered aqueous solution, ionic strength 1, at 150 °C and 95 °C.
NHo
N CO2H
(89)
COPh
N CO2H
(90)
N CO2H
(91)
OH
N CO2H
(92)
N CO2H 
(73)
NO,
N CO2H
(93)
3-Amino and 3-hydroxy picolinic acids produced rate profiles very different to 
the other compounds. They were both thought to decarboxylate by an alternative 
mechanism from the others, which probably involved ring protonation, as was the case 
for the decarboxylation of amino- and hydroxy-benzoic acids.
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3-Methylpicolinic acid produced a symmetrical rate profile. The rate maximum 
occurred at an intermediate pH, but the anion did not decarboxylate at all. The other 
three all decarboxylated very quickly. Interestingly none of the acids decarboxylated 
noticeably at high pH (9.2). The fact that electron withdrawing substituents all 
increased the rate of decarboxylation, despite their varied structures made it unlikely 
that neighbouring group effects were the main reason for the acceleration. The effect 
was thought to be partly steric, as 3-methyl picolinic acid increased the rate of 
decarboxylation, although 5- and 6-methyl picolinic acid retarded the rate.
The main cause however, was determined to be electronic. Although 3-bromo 
and 3-methyIpicolinic acids are of similar size, the 3-bromo analogue showed a much 
larger rate increase. The electronic effect was more electrostatic than due to 
delocalisation effects, which is consistent with the mechanism proposed by Hammick. 
Upon decarboxylation, where negative charge at 2- position of the ylid develops, the 
transition state can be stabilised by a positive charge at 1 or 3, but cannot be delocalised 
by resonance structures on 3- or 5- position without the formation of a  carbene. The 
increased rate of decarboxylation of 3-methylpicolinic acid demonstrated that the even 
more pronounced effect of A-methylpicolinic acid to increase the rate was not solely 
due to the quaternisation of nitrogen, but also due to some steric assistance.
Dunn and Thimm noted that significantly, none of the picolinate anions 
decarboxylate,!'77 and suggested that as all anions, irrespective of the substituent, 
followed this pattern the effect may have been steric, with the substituent preventing 
coplanarity between the carboxylate group and the aromatic ring. In the case of the 
anion, this has a retarding effect, by interfering with the cyclic intramolecular electron 
shift.
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3.1.8 Enzymic Decarboxylation
Understanding the mechanism of other enzyme catalysed decarboxylation 
reactions should enable analogies to the QPRTase system to be made and shed light on 
whether the decarboxylation is actually catalysed by the enzyme, and if so by which 
mechanism.
3.1.8.1 Orotate decarboxylase
The enzyme system which has been researched widely and that gives a very 
useful model for QPRTase is orotate decarboxylase (ODase). ODase (B.C. 4.1.1.23) 
is the catalyst for the conversion of orotidine 5'-monophosphate (OMP) (95) to uridine 
5'-m onophosphate (UMP) (94) in the final step of the de novo biosynthesis of 
pyrimidine nucleotides. The previous step is the conversion of orotic acid (96) to OMP 
by QPRTase (B.C. 2.4.2.10) (Scheme 3.4).178
OI I  PRPP, Mg2+
QPRTase ODase ^
' i  ^  _
Rib-5-P Rib-5-P
(96) (95) (94)
Scheme 3.4; ODase reaction
Therefore the two enzymes (QPRTase and ODase) catalyse the transfer of a 
phosphoribosyl group onto a nitrogen of a heterocycle, followed by decarboxylation, 
the reactions catalysed by the single QPRTase protein.
In their model studies, Beak and S i e g e P ^  investigated the decarboxylation of
1,3-dimethylorotic acid (97) to uracil (98) in sulfolane at 206 °C, and obtained a rate
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constant of 7.6 x 10-^ s"i. It was also shown that as the concentration of base (N,N- 
diethylaniline) increases so does the rate of decarboxylation (Scheme 3.5).
O O
-CO2 H3C 'NA
CH3
(97) (98)
Scheme 3.5: Decarboxylation of 1,3-dimethylorotic acid
The rate of decarboxylation of four other orotic acid analogues was also 
examined.
OCHc
N
H.CO N
(99)
CO2H COoHI ^CH3 
(100)
C0 2 H
(101) (102)
In the base catalysed decarboxylation, compounds (100) and (102) can form 
dipole stabilised carbanions as intermediates, as seen in H-D exchange in pyridones 
and pyrimidones. However, compounds (99) and (101) could not form such 
stabilised species, and therefore did not undergo basic decarboxylation.
In the formally neutral conditions, the decarboxylation of (99) involves initial 
zwitterion formation, followed by a first order decarboxylation reaction to form an 
nitrogen ylid, which is reprotonated to give the final product. This is analogous to the 
decarboxylation mechanism of picolinic acid suggested by Haake and M a n t e c o n .  1^ 9 
Beak and Siegel therefore considered the role of the enzyme was to increase the
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concentration of the zwitterion, through interactions at the active site.39 These two 
pathways to the decarboxylation are shown below in Scheme 3.6.
Base catalysed 
OA
"CO2H
CH3
B
-C O 2
Zwitterion
BH^
H - 0 '
CO2
A ,
X
H -  O N
CH3
OAA .O N O ' 'Ijl'
CH3 CH3
Scheme 3.6: Proposed decarboxylation mechanism
It is interesting to note that 6-aza-UMP (103) binds to ODase 10 times stronger 
than the actual substrate, where electrons in the sp^ orbital at C-6 can mimic the ylid 
intermediate, giving support to the zwitterion/ylid mechanism for decarboxylation.
O
O
HNX ,N
Rib-5-P
(103)
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R i b - 5 - P
(104)
Levine et al demonstrated that barbituric monophosphate (BMP) (104) bound 
to ODase 100000 times more strongly than the actual substrate and that it was one of 
the strongest inhibitors observed.'^® In the rat brain enzyme it gave a Kj of 4.1 xlO'^ M 
at pH 7 .4.180 In fact the inhibitor bound so tightly that the enzyme-inhibitor complex 
was purified by gel filtration with no dissociation. It was proposed that desolvation of 
substrate upon binding to the enzyme implied that the active site was hydrophobic, 
which based on B eak and Siegel's proposed m echanism  w ould facilitate 
decarboxylation, or that the desolvation could result from electrostatic bonding of the 
phosphate to a cationic site on the enzyme.
It was also assumed that a negative charge at the 2-position on the pyrimidine 
ring was essential for binding, hence the affinity for BMP relative to OMP. This was 
also shown by the reduced inhibition at low pH, which reduces the concentration of 
ionised BMP. Stabilisation of the zwitterion in Beak and Siegel's proposed mechanism 
also required an increase in basicity of the position 4 oxygen, therefore the enzyme 
must have an acidic residue to "push protons" onto the substrate.
Silverman and Groziak proposed a greatly contrasting mechanism for the 
decarboxylation catalysed by ODase to that of Beak and S i e g e l .   ^81 They suggested 
that, because of the high temperature required in the model studies, a covalent catalytic 
mechanism was responsible for the decarboxylation reaction. This involved 
protonation of the acid followed by Michael attack by an active site nucleophile and 
acid-base catalysed elimination of carbon dioxide, and is shown in Scheme 3.7.
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HN
OH
O H
X
H
Scheme 3.7: Silverman and Groziak proposed mechanism
This mechanism was appealing to Silverman and Groziak for two main reasons. 
Firstly, the six acid-base catalytic steps could be controlled by the enzyme to influence 
the rate of decarboxylation, and also that this type of reaction has precedent in other 
enzymic reactions.
The two main parts of the reaction were considered independently. The results 
of Beak and Siegel actually supported the covalent mechanism, in that protonation of 
the nitrogen activates the substrate for M ichael addition and decarboxylative 
elimination, and that enzyme catalysed protonation of N-6 of 6-azaUMP activated the 
C-5 position for nucleophilic addition.
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To determine which of the suggested mechanisms was most reasonable for the 
decarboxylation reaction catalysed by ODase, Acheson et al reasoned that the NMR 
resonance at C-5 was im p o r ta n t .^ I f  nucleophilic attack at C-5 took place, i.e. the 
Silverman and G roziak theory, then the NMR resonance would shift upfield 
significantly, as sp^ to sp^ geometry change occurred at C-5. With the nitrogen ylid 
mechanism proposed by Beak and Siegel only a small shift in resonance would be 
expected as sp"^  hybridisation would be retained at C-5.
In fact only a 0.6 ppm resonance shift downfield was observed, suggesting no 
change in geometry. This supports Beak and Siegel's theory. Further confirmation 
came from the replacement of a hydrogen with deuterium at the 5-position. No 
significant change in rate, i.e. no secondary deuterium isotope effect, was observed, 
again suggesting no change in geometry.
Decarboxylation of 5-aza UMP, as studied by Shostak and Jones, also supports 
this t h e o r y . ^83 As the aza moiety is not electrophilic, nucleophilic attack, proposed by 
the covalent mechanism, cannot take place, but because 5-azaUMP is a substrate for 
ODase, the result is consistent with the ylid mechanism.
Replacement of the 2-keto group with a thioketone to produce 2-thioOMP gave 
a compound that was neither a substrate nor an inhibitor. 5-FluoroOMP acted as a very 
good substrate, with a Kcat thirty times that of OMP probably due to an electronic 
effect, i.e. stabilisation of the carbanionic transition state by the fluorine.
This work also showed that there was a correlation between the activity of 
OPRTase with orotate analogues as substrates and ODase with the corresponding OMP 
analogues. Similarities between the protein sequences of the two enzymes were shown 
to give 20% homology and 43% similarity, and so a shared evolutionary relationship 
was proposed. This is interesting when it is related to QPRTase, a single enzyme 
which catalyses a combination of two reactions catalysed by OPRTase and ODase.
I l l
A third possible mechanism was proposed by Lee and Honk, based on quantum 
mechanics calculations on the energies of the ground states and possible intermediates 
in the decarboxylation. This showed that in addition to protonation of the 2-oxygen 
accelerating the rate of decarboxylation, protonation at the oxygen at position 4 gave a 
very stable intermediate with both zwitterion and neutral carbene resonance structures. 
It is also predicted that positive charge on N-1 of OMP is not important, leading to 
studies by Wu et al on the role of N-l.^®^
The rate of decarboxylation of 1,3-dimethylorotic acid (97) and citrazinic acid
(105) were compared to evaluate rate enhancement.
O
O "  N  CO2H 
CH3
(97)
CO2H
(105)
As expected, with the proposed ylid mechanism, 1,3-dimethylorotic acid 
decarboxylated faster than citrazinic acid, because of the zwitterion betaine formation at 
N-1. However, the increase in the rate was only a factor of 2 or 3, suggesting that the 
zwitterion formation was not as important as first thought. Both compounds can 
transfer protons onto C-4, an important discovery, confirmed as such when the higher 
basicity of 4-pyridone to 2-pyridone is shown.A
N" "CO2H 
CH3
1(P
CO2H
CH3
1
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In a recent com munication, Nakanishi and Wu isolated 6-benzyl-1,3- 
dimethyluracil (106) by trapping the reaction intermediate from the decarboxylation of
1,3-dimethylorotic acid with benzyl bromide. The existence of the intermediate had 
never been shown, thus this reaction sought to gain insight into the model reaction. 
The decarboxylation of the acid was carried out in refluxing benzyl bromide, and after 3 
hours 6-benzyl-1,3-dimethyluracil was isolated, by column chromatography in 10% 
yield.
No 6-benzyl-1,3-dimethyluracil was produced when uracil was heated with 
benzyl bromide, confirming that the product does not come from this reaction. This 
demonstrated for the first time that the intermediate is a carbon-6 centred nucleophile, 
and although this supports the carbanion nature of the intermediate, it still does not 
distinguish between ylid and carbene structures
CHzPh
(1 0 6 )  (97 )
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3.2 The QPRTase system
It can be seen that there is a good body of work on the decarboxylation of 
pyridine-2-carboxylic acids. However, this still falls short of providing information on 
the QPRTase catalysed decarboxylation of quinolinic acid mononucleotide, the 
intermediate in the QPRTase catalysed reaction. Also, even though there is mechanistic 
work on the related ODase, there is no clearly defined mechanism.
The aim of this study is to further investigate the uncatalysed decarboxylation of 
A^-substituted quinolinic acids. The eventual aim is to examine the decarboxylation of 
quinolinic acid mononucleotide, the real intermediate in the QPRTase reaction. Kinetic 
studies of this reaction would provide very useful data, enabling a direct comparison to 
the enzymic reaction to be made. Any mechanistic differences would be obseiwed and 
it may be possible to decide whether the reaction is actually enzyme catalysed, or 
spontaneous.
3.2.1 Decarboxylation studies on -Alkyl quinolinic acids
Investigation of the pH versus rate profile for the decarboxylation of //-alkyl 
quinolinic acids was the obvious place to stai't in the investigation of substituents on the 
nitrogen of quinolinic acid. In particular the first two to be investigated were N- 
methylquinolinic acid (107) and iV-ethylquinolinic acid (108).
CH3 CH2CH3
(107) (108)
114
3.2.2 Synthesis
Both A^-methylquinolinic acid and A^-ethylquinolinic acid were synthesised in an 
identical manner (Scheme 3.8). Initially, the diethyl ester of quinolinic acid (109) was 
prepared by refluxing the acid in ethanol and hydrochloric acid for 24 hours. A crude 
oil was then distilled under Kugelrohr conditions to produce a colourless oil in 83% 
yield. Alkylation was achieved by heating diethyl quinolinate and a slight excess of the 
corresponding alkyl sulfate gently under a nitrogen atmosphere. The reactions were 
followed by tic (Silica; 3:2 40/60 petroleum ether: ethyl acetate) and upon completion 
excess dialkyl sulfate was removed.
In the case of diethyl A-methylquinolinate methyl sulfonate, a white solid was 
formed upon cooling, in 83% yield. This was recrystallised from boiling methanol, 
and the structure of the white crystals produced confirmed by and NMR. The 
diethyl A-ethylquinolinate ethylsulfate was obtained as an oil.
The esters were then hydrolysed by refluxing with concentrated hydrochloric 
acid. The free acids were obtained as white solids on the removal of excess acid. 
When recrystallised from boiling water, white crystals of A-methylquinolinic acid and 
A-ethylquinolinic acid were produced in good yields of 81% and 76% respectively.
R
EtOH,
HCl, A
C02Et
( 1 0 9 )
(R0)2S02
COgEt
COiEt
R
R = CH2 , CH2CH3
Scheme 3.8: Synthesis of A-alkylquinolinic acids 
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Interestingly, microanalysis data indicated that A^-methylpyridinium-2,3~ 
dicarboxylic acid and A^-ethylpyridinium-2,3-dicarboxylic acid were actually present in 
the zwitterionic monohydrate form shown below.
CO2H
N CO2 .H2O
CH3
CO2H
N C02* H2O 
CH2CH3
The decarboxylation products of A^methylpyridinium-2,3-dicarboxylic acid and 
N -ethylpyridinium -2,3-dicarboxylic acid, A/^-methylnicotinic acid (110) and N~ 
ethylnicotinic acid (111), were synthesised in a similar manner (Scheme 3.9). These 
compounds were important reference compounds for the kinetic studies.
.C02Et (R0>2S02
N
ii) HCl, A 
R = CH3,CH2CH3
CO2H
(110,111)
Scheme 3.9: Synthesis of N-alkylnicotinic acids
In addition, N-methylpicolinic acid (84) and Æ-ethylpicolinic acid (112) were 
also synthesised in a similar manner (Scheme 3.10).
i) (R0)2S02
C02Et ^ CO2H
R = CH3, CH2CH3 
Scheme 3.10: Synthesis of A^-alkylpicolinic acids
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Microanalysis data showed that N-methylpicolinic acid and A^-methylnicotinic 
acid both crystallised as the hydrogensulfate salts (N -m e th y lp ic o l in iu m  
hydrogensulfate, N-ethylnicotininm hydrogensulfate). Confirmation came from the 
titration of known concentrations of the acids against aqueous base.
(84) (110)
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3.2.3 Kinetics studies on A^-methylquinolinic acid and iV- 
ethylquinolinic acid
The kinetics of the decarboxylation of A r-methylpyridinium-2,3-dicarboxylic 
acid monohydrate and A^-ethylpyridinium-2,3-dicarboxylic acid monohydrate were then 
investigated. An effective rate constant versus pH profile for both compounds was 
measured. This enabled determination of the effect of changes in hydrogen ion 
concentration on the rate of decarboxylation, and to compare the profile with that seen 
in previous studies on the rate of decarboxylation of other pyridine carboxylic acids. 
This included the work on the decarboxylation of A-methylpyridine carboxylic acids, in 
particular A-methylpicolinic acid, by Haake and Mantecon,!^^ and Dunn and co­
workers on the rate profile of the decarboxylation of other heterocyclic 2-carboxylic 
acids and some substituted A-methylpicolinic acids.
From these rate profiles, the effect of increasing the size of the substituent on 
the nitrogen was exam ined, by com paring the rate of decarboxylation of N- 
methylquinolinic acid and iV-ethylquinolinic acid under the same conditions.
The effect of temperature on the rate of decarboxylation of iV-ethylquinolinic 
acid was also investigated. Rate constant versus pH profiles over a range of 
temperatures were measured. From  these results, the activation energy for the 
decarboxylation reaction of A-ethylquinolinic acid was calculated.
Rate constant versus pH profiles have also been measured over a range of ionic 
strengths, to assess the effect of increasing the cation concentration on the rate of 
decai'boxylation.
In solution many forms of the salt are present, therefore the salts are referred to 
as A-methylquinolinic acid and A-ethylquinolinic acid.
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3.2.3.1 Method
The decarboxylation reactions were followed using methods similar to those of 
Dunn et The crucial element is that the reactions could be followed directly by 
UV spectroscopy. Each of the pyridine carboxylic acids and their decarboxylation 
products absorb at different wavelengths in the ultra violet spectrum. Thus the change 
in absorbance at a particular wavelength can be followed over time. A suitable 
wavelength has to be chosen for each substrate by compaiison of the starting material 
and the authentic decarboxylation product in basic solution. The wavelength chosen for 
both A-methylquinolinic acid and A-ethylquinolinic acid was 280 nm.
The correct choice of buffer for the decarboxylation reactions is also very 
important. The buffer must not absorb significantly in the ultra violet spectrum, and 
must not be affected by changes in temperature, as the reactions were carried out at high 
temperatures (90 ± 0 .1  °C). For this reason the buffers employed were hydrochloric 
acid, 1 M sodium hydroxide solution and 50 mM potassium phosphate solution.
As the reactions were carried out at high temperatures, a problem was envisaged 
with evaporation. To eliminate this, the reactions were carried out in sealed ampoules. 
Thus, the acid to be studied was dissolved in the correct buffer. For measurements 
below pH 2.5, the acid was dissolved in distilled water, and potassium chloride added 
to adjust to constant ionic strength. Concentrated hydrochloric acid was added to adjust 
the pH to the required value and distilled water added to make up to 25 ml. The pH 
was checked again.
For pH 2.5 and 3.0 the same procedure was followed, except that 50 mM 
potassium phosphate solution replaced the distilled water. For pH values above 3.0, 
the acid was dissolved in 50 mM potassium phosphate solution, but the pH adjusted to 
the correct value with 1 M sodium hydroxide solution.
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Aliquots of the solution (1 ml) were then placed into ampoules, these ampoules 
sealed, and then thermostatted at 90 ± 0.1 °C. At various time intervals, two ampoules 
were removed from the thermostatted vessel, chilled, and for each solution, 0.6 ml 
diluted into 10 ml of 1 M sodium hydroxide. The UV absorbance spectra of each was 
then measured at 280 nm at 25 °C and an average value taken.
Figure 3.1 shows the UV absorbance spectra for AT-methylquinolinic acid at pH 
2 (0 hours), and after 48 hours, where decarboxylation was complete and N- 
methylnicotinic acid produced.
.OOiH
CH,
CH,
006
400350250200 300
Figure 3.1: UV absorbance spectra for V-methylquinolinic acid and V-methylnicotinic
acid at pH 2.
As reactions were carried out under pseudo first order conditions, values of 
kobs could be obtained from plots of In (A280 - A ) versus time. A is the absorbance 
at 280 nm when the reaction is completed, and was obtained by measuring the 
absorbance at 280 nm due to the decarboxylation product at the same concentration as 
the compound investigated. As the reactions were carried out under pseudo-first order 
conditions, a straight line is obtained when the graph of time versus In (A28O - A ) is 
drawn. The gradient of this straight line represents the first order rate constant. Table
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3.1 shows the results from a typical kinetic run for V-ethylquinolinic acid at pH 1.0, 
while Graph 3.1 represents the plot of In (A280 - A ) versus time.
0 0.968 0.773 -0.257 -0.261
0.963 0.768 -0.264
3.6 0.852 0.657 -0.420 -0.436
0.831 0.636 -0.453
7.2 0.718 0.523 -0.648 -0.648
12.6 0.694 0.499 -0.695 -0.704
0.685 0.490 -0.713
14.4 0.648 0.453 -0.792 -0.831
0.613 0.418 -0.872
18.0 0.570 0.375 -0.981 -0.973
0.576 0.381 -0.965
21.6 0.557 0.362 -1.016 -1.049
0.534 0.339 -1.082
27.0 0.470 0.275 -1.291 -1.277
0.478 0.283 -1.262
32.4 0.394 0.199 -1.614 -1.612
0.395 0.200 -1.609
37.8 0.370 0.175 -1.743 -1.743
Table 3.1: Typical kinetic run for decarboxylation of A-ethylquinolinic acid pH 1.0
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Graph 3.1: Typical kinetic run for decarboxylation of iV-ethylquinolinic acid pH 1.0
It was necessary to establish that the reaction taking place was indeed the 
proposed decarboxylation reaction. Thus for both A ^-m ethylpyridinium -2,3- 
dicarboxylate and iV-ethylpyridinium-2,3-dicarboxyIate ampoules were incubated at 90 
±0.1  °C for greater than 10 half-lives. The UV spectra were then measured as before 
and compared with those of the authentic products under identical conditions. These 
gave, within experimental error, identical UV spectra showing that the corresponding 
nicotinic acid had been formed in quantitative yield. Other samples from kinetic runs, 
left for greater than 10 half-lives were evaporated at reduced pressure and the residues 
examined by both and NMR spectroscopy. The observed spectra were 
identical to those of authentic products. There was no evidence for any by-products.
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3.2,3.2 Effect of -alkyl substituents on the rate of 
decarboxylation of quinolinic acid
The effect of introducing a methyl group onto the nitrogen of picolinic acid was 
investigated by Haake and Mantecon,i^9 who demonstrated that V-methylpicolinic acid 
decarboxylated 700 times faster than picolinic acid under the same conditions (See 
Section 3.1.2).
Quinolinic acid decarboxylated 500 times faster than picolinic acid under the 
same conditions, the effect o f the 3-carboxylic acid group being to disturb the planarity 
of the 2-carboxylic acid group and the aromatic ring, lowering bond order and thus 
facilitating bond breaking.
However, the effect of V -substitution on the rate of quinolinic acid 
decarboxylation has not been determined.
3.2.3.2.1 A^-Methylquinolinic acid
The rate of decarboxylation at 90 “C of V-methylquinolinic acid was determined 
at several pH values from 0.5 to 5.0 to produce an extensive pH rate profile. Table 3.2 
represents the overall data for the profile, which can be seen in graphical form in Graph 
3.2.
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0.5
2.242 ± 0.076 
2.086 ± 0.078 
2.564 ± 0 .150
2.297 ±0.211
1.0 2.892 ± 0.226 
2.521 ±0.127
2.706 ± 0 .186
1.5
2.681 ± 0 .082  
2.916 ±0 .132  
2.995 ±0.153
2.864 ±0.183
2.0 2.260 ± 0.097 
2.195 ±0.145
2.228 ± 0.033
2.5 0.675 ± 0.017 
0.871 ± 0.034
0.773 ± 0.098
3.0 0.251 ±0 .015 
0.282 ± 0.011
0.267 ±0 .016
4.0 0.121 ±0.007 
0.135 ± 0.011
0.128 ± 0.007
5.0 0.043 ± 0.003 0.043 ± 0.003
Table 3.2: pH versus rate profile for the decarboxylation of A^-methylquinolinic acid at
90 ±0.1 °C
(0no
2 -
0 1 2 3 4 5 6
pH
Graph 3.2: pH versus rate profile for the decarboxylation of //-methylquinolinic acid
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From the Graph it can be seen that the rate of decarboxylation increases to a 
maximum of 2.86 x 10-5 §4 at pH 1.5. This implied that the cation did decarboxylate, 
but at a much slower rate than the species that decarboxylated the fastest, the 
isoelectronic species.
Above pH 1.5, the rate of decarboxylation decreases sharply, down to a rate of 
4.32 X 10-7 s'l at pH 5.0. The shape of the graph is unlike that shown by Dunn et al. 
In that case decarboxylation was constant and independent of pH above 5.0, at a rate of 
about half the maximum. For iV-methylquinolinic acid at pH 5.0, the rate is about 60 
times less than that at the maximum rate. Although the curve appeared to flatten off, the 
rate of decarboxylation still decreased as pH increased. At pH 4.0 the rate of 
decarboxylation was 1.28 x 10-5 s'^ and at pH 5.0 it was 4.32 x 10-7 §-1^  it was only 
because the rates were very slow, compared to the rate at pH 1.5, that the differences 
between these two pH values was not obvious. This made it likely that the anion did 
not decarboxylate as the concentration of the anion increases with increasing pH.
Graph 3.3 shows the rate of decarboxylation of A-methylquinolinic acid, with 
the pH versus rate constant profile of picolinic acid, at 150 °C, ionic strength 1.0, 
overlaid. The maximum rate of decarboxylation of picolinic acid in water is 1x10-5 g-i 
and above pH 5.0 it is constant at approximately half the maximum rate.
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Graph 3.3: pH versus rate profile for the decarboxylation of A^-methylquinolinic acid
and picolinic acid
The pH versus rate profile for quinolinic acid at 95 °C, ionic strength 1.0 from 
pH 0.08 to pH 4.0 is shown in Graph 3.4 and compared to that for jV-methylquinolinic 
acid.
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Graph 3.4: pH versus rate profile for iV-methylquinolinic acid and quinolinic acid
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The maximum value for the rate constant for quinolinic acid is 2.74 x 10"  ^s'^ at 
pH 1.5. Thus the effect of introducing a methyl group onto the nitrogen of quinolinic 
acid was to increase the rate of decarboxylation by a factor of 10. As described before, 
the methyl group presumably interacts with the carboxylic acid group at position 2. If 
the methyl group attempts to rotate out of the plane of the ring, then this interaction is 
lost.
3.Z.3.2.2 A^-Ethylquinolinic acid
The pH versus rate profile was repeated for A^-ethylquinolinic acid. In addition 
the rate constant was measured at pH 0.1 and pH 0.25, to further investigate the 
decarboxylation. Table 3.3 represents the data for the rate constant at the range of pH 
values studied, which can be seen in graphical form in Graph 3.5, where it is compared 
to the rate profile of A-methylquinolinic acid under identical conditions.
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0.1 1.465 ± 0.048 1.465 ± 0.048
0.25 2.562 ± 0.059 
2.490 ± 0.070
2.526 ± 0.036
0.5
3.029 ± 0.060 
3.383 ± 0.192 
3.209 ± 0.078
3.207 ±0 .178
1.0
3.916 ±0.157 
3.958 ±0.143 
4.010 ± 0.248
3.961 ± 0.045
1.5
4.412 ± 0 .180  
4.608 ±0.121 
3.591 ± 0.120
4.204 ±0.613
2.0
3.458 ± 0.079 
3.074 ± 0.056 
3.298 ± 0.085
3.277 ± 0.203
2.5
1.415 ±0.033 
1.661 ±0.039 
1.405 ± 0.036
1.494 ±0 .167
3.0
0.626 ± 0.039 
0.675 ± 0.030 
0.961 ± 0.025 
0.474 ± 0.007
0.684 ± 0.227
4.0 0.082 ± 0.006 
0.086 ± 0.004
0.084 ± 0.002
5.0 0.067 ± 0.004 
0.069 ± 0.003
0.068 ± 0.001
Table 3.3: pH versus rate profile for the decarboxylation of A-ethylquinolinic acid
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Graph 3.5: pH versus rate profile for the decarboxylation of N-methylquinolinic acid
and A^-ethylquinolinic acid
The most obvious point to note is that the effect of increasing the size of the 
alkyl group as substituent on the nitrogen from a methyl to an ethyl group was to 
increase the rate of decarboxylation by a factor of approximately 1.5. Presumably 
rotation of the -CH3 portion of the ethyl group led to greater interaction between it and 
the carboxylic acid group, increasing the rate of decarboxylation.
The same pattern over the whole of the pH range was demonstrated for N- 
ethylquinolinic acid as was seen for A^-methylquinolinic acid. For A^-ethylquinolinic 
acid the maximum rate of decarboxylation was 4.20 x lQ-5 s"i, at pH 1.5. Below the 
rate maximum, the rate of decarboxylation decreased sharply in the range studied, 
which implied that the cation did not decarboxylate significantly. The rate also 
decreased sharply above the rate maximum pH. Again the curve flattened off at pH 
greater than 4,0, and for N-ethylquinolinic acid the rate of decarboxylation at pH 5.0 
was again approximately 60 times slower than that at pH 1.5.
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3.2.3.3 Kinetics
Dunn et al postulated that neither the rate profiles nor isotope effects require 
protonation at the a -C  prior to the decarboxylation r e a c t i o n . T h e  mechanism is 
shown below (Scheme 3.11), where unimolecular decomposition of the isoelectric 
species (HA), as demonstrated by Hammick, and the monoanion (A"), occurs.
N CO2H IH
H2A+
K,
N CO2 
H 
HA
H^A CO2
/ ^ S 5 ^ C 0 2 H
IH
^ ^ ^ C 0 2 H  
^  ^  K,
N CO2
2-
Scheme 3.11: Dunn postulation
Both HA and A" exist in three isoprotonic forms, any of which can 
decarboxylate without affecting the pH profile. At the pH levels where the rate was 
measured, the concentration of dianion was very low, therefore A^" can be omitted 
from the rate equation.
Therefore if [C] = [H2A+] + [HA] + [A"] = stoichiometric [pyridine carboxylic 
acid], then:
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=k„*[HA] + kJA -]
[H"]   [C] = k ^ [ C ]
Ki [H+] [1]
As kA is much less than kHA, K% can be neglected at pH < 0.9, simplifying the 
approximate equation to:
1 [H+] 1
-  -  +
^ b s knAKi ^HA [2 ]
From this equation values for knA and Ki can be deduced. If this deduction is 
valid, then for pH > 1, equation [1] will reduce to:
k.,. ([H+] +K„) = kHA[H+] + k Æ  [3]
A similar mechanistic scheme to that postulated by Dunn can be envisaged for 
N-alkylquinolinic acids (Scheme 3.12).
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Scheme 3.12: Mechanistic postulation for A-alkylquinolinic acids
Using the equation [2], and the data obtained for A-ethylquinolinic acid at 90 
°C, ionic strength 1.0, Graph 3.6 can be produced for pH < 0.9. Although there are 
only a few points, a linear relationship is shown. From the graph, it is calculated that 
for N-ethylquinolinic acid Icha = 4.58 10-^± 1.6 x 10-'  ^ s ' \  and Ki = 0.70 ± 0.04 
(pKi = 0.15).
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Graph 3.6: Plot to evaluate for Icha and Ki for A^~ethylquinolinic acid.
Similarly, this was also calculated for iV-methylquinolinic acid (Graph 3.7), 
although only two points are available, making the calculation only an approximation. 
For jV-methylquinolinic acid at 90 °C, ionic strength 1.0, it is calculated that knA = 2.95 
X 10-5 s - l ,  and Ki = 0.90 (pKi = 0.05).
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Graph 3.7: Plot to evaluate for Icha and Ki for 7/-methylquinolinic acid.
This data can be compared to the values of Ic h a  = 3.30 x  10*6 s '^ and K i  = 0.70 
(pKi =0.15) for quinolinic acid at 90 °C, ionic strength 1.0. The differences between 
the knA values for the three compounds correspond to the observations, seen earlier, of 
the relative rate constants. The rate of decarboxylation of 7/-ethylquinolinic acid in 
particular is seen to be much faster.
The values of Ki for N-ethylquinolinic acid and N-methylquinolinic acid are 
quite similar. This might be expected as the increase in size from the methyl group to 
the ethyl group should not have much effect on the dissociation of the 2 -carboxylic 
acid.
As noted earlier the pH versus rate of decarboxylation profile for N- 
methylpicolinic acid flattens off, i.e. once the acid is ionised, decarboxylation is 
independent of pH. However it can be seen that for A-methylquinolinic acid and N- 
ethyl quinolinic acid the rate of decarboxylation decreases significantly as the
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concentration of the carboxylate dianion increases. One possible explanation for this 
observation is that the negative charge is not well stabilised in the intermediate. This is 
analogous to that seen for picolinic acid and quinolinic acid.
Equation [3] can be reananged in order to calculate Ica and K2:
o^bs [4]
Due to the nature of the pH profile of AT-methyl and A^-ethylquinolinic acid, in 
that past the maximum, the rate decreases slowly then sharply, kA and K% were 
evaluated at pH > 2.5. Graphs 3.8 and 3.9 show plots from equation [4] for A^-methyl 
and A^-ethyl quinolinic acid.
8.00e-6
6.00e-6
0)JOo 4.008-6
2 .008-6
O.OOe+0
0.0084-0 2 .008-6 4.008-6 6 .008-6 6 .008-6
(kH A -kobs)[H +]
Graph 3.8: Plot to evaluate for kA and K% for //-methylquinolinic acid.
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Graph 3.9; Plot to evaluate for Ica and K2 for A^-ethylquinolinic acid.
The plot for A^-methylquinolinic acid gave kA = 5 .1 9  ±  3 .6 0  x lO'^ s*i and K2 = 
0 .0 1  ±  0 .0 0 1  (pK2 =  2 .0 0 ) ,  whilst that for 7V-ethylquinolinic acid gave kA = 5 .6 4  ±  
3 .2 6  X 10'^ and K2 = 6 .8  ±  0 .3  x  10-3 (pK2 = 2 .1 7 ) .  The values of kA for N- 
methyl and N-ethylquinolinic acid are much lower than for knA» and are actually slower 
than that observed for quinolinic acid (kA = 5 .6 4  x 10'^ s“i). The rate constants agree 
with the proposals that as the amount of the dicarboxylate anion increases then the rate 
of decarboxylation decreases, because of the lack of stabilisation of the ylid produced.
Again the pK a values are very similar for the two acids, showing that the 
difference between the methyl and ethyl groups has very little effect on the rate of 
dissociation. They also correlate closely to that for quinolinic acid (pK2 = 2.43 at 25
OQ176
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3.2.3.4 Effect of temperature on rate of decarboxylation
The effect of temperature on the rate of decarboxylation of N-ethylquinolinic 
acid was determined. Measurement of the rate of decarboxylation at 60, 70, 75, 80, 85 
and 90 °C for N-ethylquinolinic acid at pH 1.5, ionic strength 1.0, allowed the 
activation energy for the reaction to be calculated. The results of the studies are shown 
below in Table 3.4, and in graphical form in Graph 3.10.
................... I
60 0.042 ± 0.002 
0.044 ± 0.001
0.043 ± 0.002
70 0.233 ± 0.009 
0.232 ± 0.007
0.232 ± 0.009
75 0.490 ± 0.009 
0.502 ± 0.020
0.496 ± 0.020
80 0.993 ± 0.030 
1.030 ± 0.056
1.017 ± 0 .056
85 2.068 ± 0.067 
2.164 ± 0 .064
2.116 ±0 .067
90 4.412 ± 0.180 
4.608 ±0.121 
3.591 ± 0 .120
4.204 ±0 .613
Table 3.4: Effect of temperature on the rate of decarboxylation of A-ethylquinolinic acid
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Graph 3.10; Effect of temperature on the rate of decarboxylation of AT-ethylquinolinic
acid
As expected, the rate of decarboxylation increased as the temperature was 
raised, by a factor of 2 as the temperature was raised by 5 °C.
The temperature dependence of the rate of reaction fits the expression proposed 
by Arrhenius.
k = A e ^ -^ "^  [5]
Ea, the activation energy for the reaction, and A, the pre-exponential factor, 
which is (almost) always independent of temperature, are deteimined from a plot of 1/T 
versus In k.
In k = In A - E^ 
RT
[6]
Thus, from this Arrhenius plot the gradient of the straight line obtained is (-Ea 
/R), and the intercept is In A. Table 3.5 shows the data transformed into a suitable 
form for an Arrhenius plot (Graph 3.11).
138
60 333 0.003003 0.043 ± 0.002 -14.657
70 343 0.002915 0.232 ± 0.009 -12.973
75 348 0.002874 0.496 ± 0.020 -12.215
80 353 0.002833 1.017 ± 0.056 -11.502
85 358 0.002793 2.116 ± 0.067 -10.764
90 363 0.002755 4.204 ±0.613 -10.094
Table 3.5: Table of data for Arrhenius plot
-10
y = 40.494 -1 .8352e+4x R 2^ = 1.000
-12
-14
0.0027 0.0028 0.0029 0.0030 0.0031
Q In k
1/T (K-1)
Graph 3.11 : Arrhenius plot
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From the equation of the graph
“A  = -1.835 X 10-4 (where R = 8.314 x 10  ^kJ mofi K '
RT
Ea = 153 kJ mol-i
In A = 40.494
A = 3.858 X 1017 s-i
The activation energy for the decarboxylation of AT-ethylquinolinic acid is very 
similar to that for other pyridine-2-carboxylic acids. 1^ 9 Picolinic acid has an activation 
energy of 145 kJ mok^, whilst that for homarine is 148 kJ mol k
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3.2.3.S Effect of ionic strength
The decarboxylation of N-ethylquinolinic acid at 90 °C, pH 1.5, was repeated 
over a range of ionic strengths, from 0.5 to 3.0. The ionic strength was adjusted for 
each experiment using potassium chloride. Table 3.6 shows the results from these 
experiments, which are placed in graphical form in Graph 3.12.
0.5 4.970 ±0.187  
5.240 ±0.151
5.105 ±0.187
1.0 4.412 ±0 .180  
4.608 ±0.121 
3.591 ±0 .120
4.204 ± 0.613
2.0 3.660 ±0.101 
3.644 ±0.101
3.652 ±0.101
3.0 3.025 ± 0.150 
2.933 ± 0 .104
2.979 ±0 .150
Table 3.6: Effect of ionic strength on the rate of decarboxylation of N-ethylquinolinic
acid
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Graph 3.12: Effect of ionic strength on the rate of decarboxylation of A^-ethylquinolinic
acid
As ionic strength increases, the rate of decarboxylation decreases. This is the 
opposite effect to that expected. If a more charged intermediate is produced in the 
reaction then increasing the ionic strength should provide extra stabilisation which 
would be expected to increase the rate. The pka may change with a change in ionic 
strength, so affecting the rate of decarboxylation.
In the QPRTase system increasing the concentration of potassium cations leads 
to lower activity of the enzyme. In this case the cation is probably bound to the protein, 
altering the active site. Introduction of a chelating agent, such as EDTA, reverses the 
effect as the potassium cation is chelated. One alternative is that the increase in ionic 
stength actually inhibits the starting material from decarboxylating.
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3.2.3 6 Effect of D%0
The decarboxylation of A-ethylquinolinic acid at 90 °C, ionic strength 1.0, was 
carried out in D2O. This allowed us to investigate the effect of the deuterated solvent. 
A change of solvent often has spectacular effects on the rate of a reaction, with solvent- 
solute interactions often responsible. Reactions with ionic species are particularly 
sensitive, because of the large ion-solvent interactions. Table 3.7 shows the rate of 
decarboxylation in the experiments, compared to the same decarboxylation in water.
Water 4.412 ± 0 .180  
4.608 ±0.121 
3.591 ± 0 .120
4.204 ±0 .613
D2O 5.524 ± 0.239 
4.728 ±0.178
5.127 ±0.398
Table 3.7: Effect of deuterated solvent on the rate of decarboxylation of N-
ethylquinolinic acid
Although the effect of carrying out the reactions in D2O has increased the rate of 
the reaction, it is not by such a significant amount to allow any further conclusions to 
be made.
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3.2.4 iV-Propylquinolinic acid
To approach the size of the quinolinic acid mononucleotide, the bulk of the 
group on the nitrogen must be increased. Following on from the synthesis and kinetic 
studies on A-methylquinolinic acid and iV-ethylquinolinic acid, the next obvious 
synthetic target in the series of increasing the size of the nitrogen substituent, was N- 
propylquinolinic acid (113).
CO2H
I
CH2CH2CH3
(113)
The initial route investigated was that identical to the method in which N- 
methylquinolinic acid and A-ethylquinolinic acid were produced.
N ' 'C O jE t
CH2CH2CH3 CH2CH2CH3
Scheme 3.13: Proposed route to A-propylquinolinic acid
Diethyl quinolinate was heated gently, under a nitrogen atmosphere with a slight 
excess of 1-iodopropane, but tic analysis showed that no reaction had occurred even 
after extended times. It is possible that the size of the ethyl ester prevents nucleophilic 
attack by the nitrogen.
As this approach proved unsuccessful alternative routes for the synthesis were 
considered. There are very few literature references on 2-substituted A-alkylated 
pyridines. The majority of our approaches used quinolinic acid anhydride (pyridine
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2,3-carboxylic acid anhydride) as a starting material (114). This was chosen because 
the two carboxylic acid groups are held in the plane of the ring and would hopefully 
avoid the steric problems. Also, following A-alkylation hydrolysis of the anhydride is 
carried out under very mildly acid aqueous conditions. To confirm the suitability of 
quinolinic acid anhydride to allow A-alkyl substitution, A-methylquinolinic acid was 
successfully synthesised in good yield in the following manner (Scheme 3.14). 
Successful production of A-methylquinolinic acid was confirmed by comparing 
spectral data to authentic A-methylquinolinic acid. Quinolinic acid anhydride was then 
reacted with an excess of 1-iodopropane under identical conditions to attempt to 
synthesise A-propylquinolinic acid (Scheme 3.15).
O
O
(CH30)2S02
o
CH
HCl
CHg
(114)
Scheme 3.14: Synthesis of A-methylquinolinic acid
C H 3C H 2C H 2Io ----------
D M F
Scheme 3.15: Reaction of quinolinic acid anhydride and 1-iodopropane
The NMR data gave interesting results. Alkylation on the nitrogen did 
appeal' to have occurred, but it also seemed that the anhydride had been cleaved and that 
a propyl ester formed on one of the two acids. Two sets of propyl group peaks were 
observed, corresponding to the nitrogen substituent and the propyl ester. Thus, 
hydrolysis was still necessai-y to obtain the free acid.
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However, even under relatively mild conditions (< 40 °C, in 1 M hydrochloric 
acid) decarboxylation also appeared to take place, to give AT-propylnicotinium chloride 
(115) in 62% yield. The structure of the product was confirmed by comparing spectral 
data to that from authentic A^-propylnicotinic acid in the manner described below 
(Scheme 3.16).
CH3CH2CH2I ^
DMF a
COzH or
N CO2CH2CH2CH3 
CH2CH2CH3
CO2CH2CH2CH3
ICH2CH2CH3
r
CO2H
CO2H
cr
CH2CH2CH3
62%
CO2 CO2H
CO2 
CH2CH2CH3
(115)
Scheme 3.16: Synthesis of 7V-propylnicotinium chloride
This result implied that decarboxylation does indeed get much faster with the 
increase in size from the ethyl group to the propyl. Indeed, the reaction seemed to be 
too fast to allow any measurements of the kinetics to be made, or the compound to be 
isolated
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Further attempts to synthesise A^-propylquinolinic acid were made. Altering the 
conditions for the reaction between quinolinic acid anhydride and 1-iodopropane 
proved unsuccessful. Reducing the temperature of the reaction slowed down any 
possible reaction significantly, while at higher temperatures the anhydride was cleaved. 
In one case some evidence of substitution onto the nitrogen was observed, but the 
product was very minor, and isolation was not possible by reverse phase tic or HPLC.
Dimethyl quinolinate (116) was synthesised in an identical manner to diethyl 
quinolinate, with methanol replacing ethanol, to produce a white solid (Scheme 3.17), 
in a further attempt to reduce steric interactions.
COzH
N CO2H
CH3OH, H+
CO2CH0
N CO2CH3
(116)
Scheme 3.17: Synthesis of dimethyl quinolinate
The dimethyl quinolinate was then heated with 1-iodopropane under a nitrogen 
atmosphere (Scheme 3.18). It was hoped that the smaller ester group would not 
sterically hinder addition of the propyl group onto the nitrogen. However, no reaction 
was detected by tic.
CO2CH3
N CO2CH3
CH3CH2CH2I
CO2CH3
N CO2CH3 r
CH2CH2CH3
Scheme 3.18: Proposed synthesis of //-propyl quinolinic acid
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3.2.5 Routes to other A^-substituted quinolinic acids
In an attempt to increase the rate of the reaction, compounds with a better 
leaving group were considered. The synthesis of «-propyl trifluoromethanesulfonate 
(«-propyl triflate) was attempted but the product was too unstable. However, «-octyl 
triflate is a stable compound which would produce a larger N-alkyl substituent and a 
better leaving group.
«-Propyl triflate was synthesised in the manner of Gramstad and H a s z e l d i n e , ^ ^ ?  
and octyl triflate by a method described by Beaid, Baum and Grakauskas.^^^
For the synthesis of «-propyl triflate (117), silver triflate and 1-iodopropane 
were suspended in dry dichloromethane, and immediately a precipitate of silver iodide 
formed (Scheme 3.19). After stirring for a further 30 minutes to allow the reaction to 
complete, the precipitate was filtered off and the solvent removed. However, the «- 
propyl triflate proved to be unstable and was not suitable for use in further reactions.
CFgSOgAg + CH3CH2CH2I ---------------------CH3CH2CH2OSO2CF3 + Agi
(117)
Scheme 3.19: Synthesis of propyl triflate
To synthesise «-octyl triflate (118), a solution of octan-l-ol and pyridine were 
dissolved in dry dichloromethane and added dropwise to a solution of triflic anhydride 
in dry dichloromethane at 0 °C (Scheme 3.20). After 30 minutes the solution was 
washed, dried and the solvent removed.
py, DCM
(CF3S02)20 + CH3(CH2)6CH20H -----------^  CH3(CH2)6CH20S02CF3 + CF3SO3H
(118)
Scheme 3.20: Synthesis of octyl triflate 
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However when n-octyl triflate was heated gently with quinolinic acid anhydride 
(Scheme 3.21), both with dry DMF and without solvent, no reaction occurred.
CH3(CH2)6CH20S02CF3
 »»
D M F
O
Scheme 3.21: Proposed route to A^-octyl quinolinic acid
So far attempts to synthesise //-substituted quinolinic acids with larger groups 
on the nitrogen have also proved unsuccessful. 2 ,3 ,4,6-Tetra-O -acetyl-a-D - 
glucopyranosyl bromide (119) was synthesised from D-glucose, in a two step reaction, 
in 94% yield (Scheme 3.22). Acétylation was carried out by dissolving D-glucose in 
acetic anhydride followed by addition of 45% hydrogen bromide in acetic acid. Upon 
complete acétylation, further treatment with 45% hydrogen bromide in acetic acid 
afforded the brominated product, which on crystallisation from diethyl ether produced a 
white solid. and NMR and melting point confirmed the product to be 2,3,4,6- 
tetra-O-acetyl-a-D-glucopyranosyl bromide.
i) (CH3C0 )2 0 , HBr  ^
ii) HBr, AcOH
Scheme 3.22: Synthesis of 2,3,4,6-tetra-O-acetyl-a-D-gIucopyranosyl bromide
It was envisaged that this sugar group would add on to the nitrogen of 
quinolinic acid, which would produce an excellent analogue of quinolinic acid 
mononucleotide, the intermediate in the QPRTase catalysed system.
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HO
HO OH
AcO
AcO
AcO
AcO Br
(119)
This addition of the sugar group was attempted with both diethyl quinolinate 
(Scheme 3.23) and quinolinic acid anhydride (Scheme 3.24) under a variety of 
conditions, but unfortunately none were successful.
AcO
AcOAcO
AcO Br
Scheme 3.23: Proposed synthetic route
AcO
AcOAcO
AcO
Scheme 3.24: Proposed synthetic route
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3.3 Conclusions and Future Work
The kinetic studies on A-methyl and A-ethylquinolinic acid showed very 
interesting results, primarily that increasing the size of the substituent on quinolinic acid 
translates to an increase in the rate of decarboxylation, and secondly that a distinctive 
rate profile was obtained for both acids. To further investigate the effect of the 
substituent group on the rate of decarboxylation, much work needs to be done to 
successfully synthesise another A-substituted quinolinic acid. This should focus on the 
successful synthesis, and kinetic studies of, A-propylquinolinic acid.
Early results from our attempts to synthesise A-propylquinolinic acid indicate 
that it would indeed decarboxylate much faster than A-methyl and A-ethylquinolinic 
acid. A-Propylnicotinic acid was the only product isolated from the reaction of 
quinolinic acid anhydride and 1-iodopropane. When A-propylquinolinic acid is 
successfully synthesised and characterised, full kinetic studies will give further 
information on the effect of the increase in size of the alkyl group on decarboxylation.
The decarboxylation studies so far show that although there was an increase in 
rate from N-methyl to A-ethyl substituent, the actual rate was still quite slow when 
compared to an enzymic reaction (ti/2 for A-methylquinolinic acid at pH 1.5 at 90 °C = 
6.7 hours, t%/2 for A-ethylquinolinic acid at pH 1.5 at 90 °C = 4.6 hours). However, 
as it was shown when routes to A-propylquinolinic acid were investigated, there seems 
to be a sharp increase in the rate of decarboxylation with this seemingly small increase 
in size. Presumably, the larger groups increase steric congestion around the 2- 
carboxylic acid, which is released upon decarboxylation. This would be even greater in 
the case of the intermediate in the QPRTase reaction (quinolinic acid mononucleotide). 
However it cannot yet be deduced whether there would be sufficient rate increase to 
make this reaction as rapid as an enzymatic reaction under physiological temperature 
and pH.
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Ultimately the aim would be to synthesise quinolinic acid mononucleotide, the 
actual intermediate in the QPRTase system. Careful consideration must go into the 
route to this product. The nitrogen of quinolinic acid is not the strongest nucleophile, 
the acid groups must be protected to avoid steric hindrance, and conditions must be 
such that the decarboxylation reaction is measurable and does not occur spontaneously. 
This is not a trivial task, but if it was successful, it would establish whether or not 
decarboxylation is spontaneous or enzyme catalysed.
With the data so far it is probably more likely that it is enzyme catalysed. The 
rates of decarboxylation with the model compounds investigated are very slow. In 
addition, the X-ray structure also shows groups present at the active site, Lys 152 and 
Arg 175, which could be able to stabilise the y lid intermediate by interacting with the 
negative charge at the 2-position.
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CHAPTER 4
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4. Experimental
Melting points were determined using an electrothermal melting point apparatus and are 
uncorrected. M icroanalyses were carried out by the University of St. Andrews 
microanalytical laboratory. NMR spectra were recorded on a Varian Gemini 200 f.t. 
spectrophotom eter (^H, 200 MHz; 50.31 MHz) or a Bruker AM 300 f.t. 
spectrophotometer p ip , 121.49 MHz). NMR spectra are described in parts per million 
downfield shift from TMS and are described consecutively as position (Ôh or ôc), 
relative integral, multiplicity (s.-singlet, d.-doublet, t.-triplet, dd.-doublet of doublets 
and mult.-multiplet), coupling constant (/x,y Hz if applicable) and assignment. Infra­
red spectra were recorded on a Perkin-Elmer series 1420 IR spectrophotometer. The 
samples were prepared as either Nujol mulls or thin films between sodium chloride 
discs. Absorption maxima are given in wavenumbers relative (cm“0  to a polystyrene 
standard. Flash chromatography was performed according to the procedure of StilE^^ 
using Sorbisil C60 (40-60 mm mesh) silica gel. Analytical thin layer chromatography 
was carried out on 0.25 mm precoated silica gel plated (Whatman PE SIL G/UV254) or 
on 0.11 mm precoated cellulose plates (CEL Macheiy-Nagel 3OO/UV254). Compounds 
were visualised by UV fluorescence, iodine vapour, aqueous potassium permanganate 
or 5% sulfuric acid in aqueous ethanol/charring. UV spectra assays were measured on 
a Kontron UVICON 932 scanning spectrophotometer.
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2-Hydroxypvridine-3-carboxvlic acid 1151
CO2H
N OH
2-Mercaptonicotinic acid (5 g, 0.032 mol) was dissolved in water (69 ml) and 
then concentrated nitric acid (23 ml) was added. The solution was heated for 2 hours at 
120 °C. On cooling, a precipitate of needle-like ciystals appeared, which were filtered 
off and recrystallised from boiling water, to give colourless needle-like crystals (1.96 
g, 45%). m.p. 258-260 °C (lit.i^o 260 °C); (Found: C, 51.56; H, 3.26; N, 10.03. 
Calc, for C6H 5NO3: C, 51.80; H, 3.62; N, 10.07%); Dmax (nujol/ cm-i) 3460 ( OH), 
1680 (C =0); ÔH (200 MHz; ^HgO) 6.57 (IH , t ,  4 ,5  = /5,6 7 Hz, 5-CH), 7.55 (IH , 
dd., 4 ,5  7 Hz, 4 ,6  2 Hz, 4-CH), 7.88 (IH , dd., 4 ,6  7 Hz, 4 ,5  2 Hz, 6-CH); Ôc 
(50.31 MHz; ^HgO) 108.9 (5-C), 116.9 (3-C), 141.7 (4-C), 146.4 (6 -C), 164.8 (2- 
C), 165.3 (carbonyl); m/z (El) 139 (M, 45%), 121 (18, M-H2O), 95 (100, M-CO2).
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2-Sulfonicotinic acid (33)
i) Using Potassium permanganate as oxidant
2-Mercaptonicotinic acid (1.25 g, 0.008 mol) was dissolved in a solution of 
sodium hydroxide (0.66 g) in distilled water (125 ml). A solution of potassium 
permanganate (2.75 g, 0,018 mol) in water (50 ml) was added dropwise, with stirring. 
After addition was complete, the solution was left to stir for 15 minutes at room 
temperature, and then heated for 1 hour at 75 °C.
On cooling, excess potassium permanganate was removed by adding ethanol to 
form MnÜ2, which was removed by filtration, and the solid was washed with boiling 
water (50 ml). The free acid was then generated by passing the solution through an 
Amberlite IR-120 ion exchange column. The fractions with UV active components were 
reduced to dryness under reduced pressure and the solid formed was recrystallised from 
boiling water to give white crystals (0.32 g, 20%). m.p. 254 °C (lit.^^s 254 °C); 
(Found; C, 35.44; H, 2.00; N, 6.61; Calc., for CoHgNSOg: C, 35.47; H, 2.48; N, 
6.89%); Umax (nujol/ cm‘1) 3420 (-OH), 1700 (C=0); Ôh (200 MHz; % 0 )  7.56 (IH , 
dd., 4 ,5  9 Hz, 4 ,6  5 Hz, 5-CH), 7.92 (IH , d., 4 ,5  9 Hz, 4-CH), 8.53 (IH , d., 4 ,6  5 
Hz, 6 -CH); ÔC (50.31 MHz; % 2 0 ) 129.3 (5-C), 137.2 (3-C), 139.2 (4-C), 150.6 (6 - 
C), 155.2 (2-C), 192.7 (carbonyl); m/z (El) 185 (M-H2O, 4%), 139 (23, M-SO2), 105 
(100, M-H2O-SO3), 95 (87, M- SO2-CO2), 78 (61, C5H4N).
ii) Using iodine as oxidant
Iodine (15.18 g, 0.06 mol) was partially dissolved in distilled water (200 ml). 
2-Mercaptonicotinic acid (0.78 g, 0.005 mol) was partially dissolved in water and the 
pH adjusted to pH 6 using KOH. 2-Mercaptonicotinic acid is not very soluble in water
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so parts were added slowly under stirring and then the excess 2-mercaptonicotinic acid 
was dissolved in water and then added. On completion of addition, the solution was 
left to stir for 3 hours, and then reduced to dryness under reduced pressure. The solid 
produced was recrystallised from boiling water to give white crystals (0.19 g, 19%). 
m.p. 254 °C; Spectral data as above.
Diisopropyl nicotinamide (431
O
Nicotinic acid (10.0 g, 0.081 mol) was added to thionyl chloride (30 ml, 
distilled from sulfur) and this mixture stirred for 24 hours at room temperature. The 
excess thionyl chloride was removed under reduced pressure and the white acid 
chloride suspended in THF (200 ml). Diisopropylamine (44.8 ml, 0.32 mol) was 
added in excess at 0 °C and this solution stirred for a further 24 hours. The amine 
hydrochloride salt was filtered off and washed with a little THF. An aqueous work-up 
could not be employed due to the solubility of the amide. Removal of THF under 
reduced pressure produced the crude amide, which was reciystallised from ethyl acetate 
to give colourless crystals (11.8 g, 70%). m.p. 95-96 °C (lit.^^i jqo  °C); 
Vmax(nujol/cm-i) 1645 (C =0); Ôr (200 MHz; C^H Cl]) 1.35 (12H, broad s., 
-CH (CH 3)2), 3.70 (2H, broad s., -CH(CH3)2). 7.32 (IH , m., 4-CH), 7.65 (IH , m., 
2-CH), 8.60 (2H, m., 5-CH and 6-CH); ôc (50.31 MHz; C2HCI3) 21.1 (-CH(CH3)2),
124.0 (5-C), 134.1 (4-C), 135.0 (3-C), 147.1 (6-C), 150.4 (2-C), 169.0 (carbonyl); 
m/z (El) 206 (M+, 10%), 191 (11, M-CH3), 163 (21, M-CH(CH3)2), 149 (10, M- 
NCH(CH3)2), 106 ( 100, M-N(CH(CH3)2)2), 78 (42, C5H4N), 44 (21 , C2H 5N).
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4-(TrimethvlsilvlVAr. AT-diisopropylnicotinamide (44)
Dry diisopropylamine (20 mmol, 2.98 ml) was stirred in dry THF (15 ml) 
under a nitrogen atmosphere. A^ -Butyl lithium (22 mmol, 1.4 ml of 1.6  M solution in 
hexane) was added with stirring at -78 °C. After a further 20 minutes a solution of 
trimethylsilyl chloride (20 mmol, 2.53 ml) in THF (5 ml) was added, followed by the 
dropwise addition of a solution of diisopropylnicotinamide (1 0  mmol, 2 .1  g) in dry 
THF (15 ml). The solution was stirred for a further 2 hours at -78 °C and then the 
reaction allowed to warm gradually to room temperature. The reaction was poured over 
5% aqueous sodium hydrogen carbonate (10 ml), extracted with diethyl ether (3 x 60 
ml), washed with water (15 ml), brine (2 x 20 ml) and dried (MgS0 4 ). Removal of the 
solvent under reduced pressure gave a pale yellow oil which crystallised 
spontaneously. Purification by column chromatography (silica gel, 3:2 ethyl 
acetate/40-60 petroleum ether) produced the white solid 4-trimethylsilyl diisopropyl 
nicotinamide (2.1 g, 76%) and the 2,4-disilyl derivative (0.6 g, 11%). m.p. 68-70 °C; 
(Found: C, 64.74; H, 9.72; N, 10.07; Calc., for CisHzeNzOSi: C, 64.70; H, 9.41; N, 
10.03%); Vmax(nujol/cm-i) 1645 (0=0), 840 (Si-(CH3)3); 6 » (200 MHz; C^HC^) 
0.35 (9H, s., -Si(CH3)3), 1.55 (6H, d., J  7.5 Hz, -CH(CH3)2), 3.50 (IH, broad m., 
-CH(CH3)2), 7.52 (IH, d., Js,6 6  Hz, 5-CH), 8.35 (IH, s., 2-CH), 8.50 (IH, d., 
Js,6 6  Hz, 6 -CH); ôc (50.31 MHz; C2HCI3) 20.9, 21.1 (-CH(CH3)2), 48.0 (- 
CH(CH3)2), 130.0 (5-C), 134.1 (4-C), 145.8 (3-C), 148.9 (6 -C, 2-C), 170.3 
(carbonyl); m/z (El) 278 (M+, 16%), 263 (17, M-CH3), 251 (21, M-CHN), 219 (32, 
M-HSi(CH3)2), 205 (15, M-(CH3)3Si), 178 (1 0 0 , M-N(CH(CH3)2)2), 161 (13, 
C5H4N-CON-), 43 (21, CH(CH3)2+).
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2-( 3-pvridvl V4.4-dimethyl-oxazoline (45)
Nicotinoyl chloride was prepared in an identical manner to the first step 
described for diisopropyl nicotinamide, and then suspended in dichloromethane (200 
ml). To this was added, dropwise at 0 °C, a solution of 2-amino-2-methyl propan-l-ol 
(21.7 g, 0.24 mol) in dichloromethane (50 ml). The mixture was stirred for 24 hours, 
and the amine hydrochloride filtered off and washed with dichloromethane. The 
combined filtrate and washings were concentrated to give the amide. Thionyl chloride 
was then added to the solid amide and the solution stirred until all the amide had 
dissolved. This solution was then added dropwise to an excess of 20% sodium ]
hydroxide solution cooled in an ice bath. The aqueous solution was extracted with 4
diethyl ether (5 x 50 ml), washed with brine and dried (K2CO 3). The solvent was j
evaporated under reduced pressure to give a brown oil, which upon distillation under j
Kugelrohr conditions produced a clear oil (3.2 g, 44%). b.p. 92-95 °C/ 2 mmHg j
(lit.'92 80 °C/ 2 mmHg); v„ax(thin film/cm-l) 1635 (CN), 1070, 1020 (CO); 5h (200 j
I
MHz; C^HCla) 1.40 (6H, s.. -C(CH3)2), 4.10 (2H, s., oxazoline-CHa), 7.30 (IH , j
m., 5-CH), 8.18 (IH , m., 6-CH), 9.10 (IH , s., 2-CH); 5c (50.31 MHz; C ^H C b) |
28.8 (-C (£H 3)2), 68.3 (-CH(CH3)2), 79.7 (oxazoline-CHz), 123.6 (5-C), 124.6 (3- j
C), 136.1 (4-C), 149.9 (6-C), 152.3 (2-C), 160.6 (oxazoline-0-C=N); m/z (El) 176 Î
(M+, 7%), 161 (64, M-CH3), 146 (16, M-(CH20), 133 (27, M-CH(CH3)2), 105 (57,
C(H;N), 78 (27, M-oxazoline), 56 (100, isobutene). ’
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Methyl 2-cyano-5-methoxypentane-2.4-dienoate (47)
COoCH
CN
A mixture of tetramethoxypropane (12.3 g, 0.075 mol), acetic anhydride (25 
ml), and dry zinc chloride (68 mg) was heated under reflux, and methyl cyanoacetate 
(4.5 g, 0.05 mol) was added dropwise. The reaction was maintained at reflux for 18 
hours, after which time the volatiles were distilled off until the distillation temperature 
reached 122 °C. The residue was then cooled, and a crude brown solid apppeared. 
This crude product was used for the next step. m.p. 115 - 135 °C (lit .^ "^ 2 n o  - 140 
°C); ÔH (200 MHz; C^HClg) 3.82 and 3.84 (6H, 2 x s., -OCH3), 6.08 ( IH, t., J  12 
Hz, 4-CH), 7.32 ( IH, d., J 12 Hz, 5-CH), 7.86 (IH , d., J  12 Hz, 3-CH); ôc (50.31 
MHz; C2HCI3) 53.2 (CO2ÇH3), 58.9 (OCH3), 98.7 (2-C), 103.6 (4-C), 115.6 (CN),
156.0 (3-C), 163.9 (1-C), 166.8 (1-C).
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Methyl 2-hromonicotinate (46)
.COiMe
Br
M ethyl-2-cyano-5-m ethoxypentane-2,4-dienoate (4 g, 0.024 mol) was 
dissolved in acetic acid (20 ml) and warmed to 40 °C. HBr in acetic acid (40%, 40 ml) 
was added dropwise whilst the temperature of the reaction mixture was maintained at 
40 - 45 °C. After addition was complete the temperature was raised to 55 °C and the 
solution heated for 30 minutes. Upon cooling, this solution was poured into water and 
neutralised by careful addition of sodium carbonate. The aqueous solution was 
extracted with dichloromethane (3 x 300 ml). The organic layers were combined, 
washed with water, dried (NaSO^.) and the solvent evaporated under reduced pressure. 
The residue was distilled in a Kugelrohr apparatus, producing a clear oil (2.2 g, 41%). 
Dmax (cm-1) 2940 (-0 CH3), 1700 (C =0); Ôh (200 MHz; C ^H C b) 3.91 (3H, s., 
O CH3), 7.29 (IH , dd., / 4,5 8 Hz, 75,6 6 Hz, 5-CH), 8.01 (IH , dd., 74.5 8 Hz, 74.6 2 
Hz, 4-CH), 8.40 (IH , dd., 75,6 6 Hz, 74,5 2 Hz, 6-CH); ôc (50.31 MHz; C^H Cb) 
53.4 (OCH3), 122.8 (5-CH), 130.1 (3-CH), 140.1 (6-CH), 141.1 (2-CH), 152.5 (4- 
CH), 165.9 (carbonyl).
Reactions with methvl 2-bromonicotinate
N Br
i) Methyl 2-bromonicotinate (2.16 g, 0.01 mol) and triethyl phosphite (2.04 g, 0.015 
mol) were heated, under a nitrogen atmosphere, to 70 °C for 24 hours. The reaction
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was followed by tic (silica; 3:2 40-60 petroleum ether:ethyl acetate), but no reaction 
was detected.
ii) n-Butyl lithium (2.5 M in hexanes, 4.0 ml, 0.01 mol) was added dropwise to diethyl 
phosphite (2.0 g) at - 20 to - 30 °C under a nitrogen atmosphere over 2 hours. Methyl 
2-bromonicotinate (2.16 g, 0.01 mol) was added, the reaction stirred and warmed to 
room temperature. The reaction was followed by tic (silica; 3:2 40-60 petroleum 
ether:ethyl acetate), but no reaction was detected after 24 hours. The reaction was then 
warmed to 50 °C for 6 hours, but still no reaction was detected.
Reactions with 2-chloronicotinonitrile
.CN
n-BuLi, HP(0)(0Et)2
k  or P(0Et)3
N Cl
i) Sodium (0.06 g, 2.6 mmol) was dissolved in diethyl phosphite (5 ml) at 0 °C, the 
solution stirred and warmed to room temperature. 2-Chloronicotinonitrile (0.33 g,
2.38 mmol) was added, the solution stirred at room temperature for 6 hours, and the 
reaction followed by tic (silica; 3:2 40-60 petroleum ether:ethyl acetate). No reaction 
was detected.
ii) The above reaction was repeated, with M-butyl lithium (2.5 M in hexanes, 0.95 ml,
2.6 mmol) replacing sodium. Again no reaction was detected.
iii) 2-Chloronicotinonitrile (1.33 g, 0.01 mol) and triethyl phosphite (1.68 g, 0.01 mol) 
were heated to 70 °C, under a nitrogen atmosphere, for 24 hours. The reaction 
followed by tic (silica; 3:2 40-60 petroleum ether:ethyl acetate), but no reaction was 
detected.
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Diethvl pvridine-2-phosphonate f48)
5
6
4
2 
1
Tetrakis(triphenylphosphine)palladium (231 mg, 0.2 mmol) was added under a 
nitrogen atmosphere to a solution of diethyl phosphonate (0.61 ml, 4.4 mmol), toluene 
(2 ml) and dry triethylamine (0.61 ml, 4.4 mmol). 2-Bromopyridine (0.70 g, 4.4 
mmol) was then added dropwise. This mixture was stirred under nitrogen at 90 °C for 
5 days, and the reaction followed by t.l.c. (silica; 24:1 CH2CI2: CH3OH). On cooling 
diethyl ether (50 ml) was added, and the triethylamine hydrobromide removed by 
filtration. Evaporation of the solvent at reduced pressure, followed by column 
chromatography on silica gel, eluting with CH2CI2: CH3OH (24:1), gave a yellow oil 
as a product (2.20 g, 41%), which was analysed by and NMR. b.p. 120 1
mm Hg; (Found: C, 49.77; H, 6.98; N, 6.51; Calc., for C9H 14N PO 3: C, 50.23; H, 
6.56; N, 6.51%); 0» (200 MHz; C2HCI3) 1.23 (6H, t., /  8 Hz, -OCH2C H 3), 4.13 
(4H, q., J  8 Hz, -OCH2CH 3), 7.34 (IH , m., 5-CH), 7.70 (IH , dd., ^3,4 7 Hz, 73.5 4 
Hz, 3-CH), 7.86 (IH , t., J 1 Hz, 4-CH), 8.70 (IH , d., 7s,6 4 Hz, 6-CH); 6c (50.31 
MHz; C % C l3) 16.8 (-OCH2CH3), 63.4.(-OCH2CH3), 126.4 (5-CH), 128.6 (3-CH),
136.5 (4-CH), 151.0 (6-CH), 152.4 (2-CH); m/z (El) 215 (M, 6%), 186 (20, M- 
CH3CH2), 171 (42, M-CH3CHO), 142 (51, M-CH3CH2-CH3CHO), 79 (C5H5N+).
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Diethvl A^-phosphonomethvIphthalimide (55)
3
POqEt.
A^-Bromomethylphthalimide (0.9 g, 3.8 mmol) and triethyl phosphite (0.6 g, 3.8 
mmol) were heated to reflux for three days at 160 °C under nitrogen. On cooling, 
excess triethyl phosphite was removed by distillation using Kugelrohr apparatus. The 
remaining solid was crystallised from ethyl acetate/hexane to produce a white powder 
(0.40 g, 37%). m.p. 64 °C (lit.,193 64 °C). (Found: C, 52.53; H, 5.43; N, 4.71; Calc., 
for C 13H 16N PO 5: C, 52.53; H, 5.25; N, 4.90%); n^ax (nujol/ cm-i) 1720 (C=0); Ôh 
(200 MHz; ^Hg-DMSG) 1.29 (6H, t., CH3CH 2), 4.08 (2H, d., N-CH2-P), 4.16 (4H, 
q., CH3CH 2). 7.69 (2H, m., 3-CH), 7.83 (2H, m., 2-CH); 6c (50.31 MHz; DMSG)
13.1 and 13.2 (ÇH 3C H 2), 28.8 and 31.9 (CH3Ç H 2), 62.1 (N-CH2), 121.2 ( 1-C),
132.3 (3-C), 132.6 (2-C), 164.0 (carbonyl); m/z (El) 297 (M, 19%), 160 (100, M- 
PG3Et2).
Reactions with diethyl iV-phosphonomethvlphthalimide
Diethyl AT-phosphonomethylphthalimide (0.40 g, 1.3 mmol) was dissolved in 
dry THE (20 ml) and the solution stirred at -78 °C, under a nitrogen atmosphere. 1.1 
eq. N-Butyl lithium (2.5 M in hexanes, 0.095 g, 0.59 ml) was added dropwise and the 
reaction solution stiiTcd at -78 °C for 30 minutes, after which ethyl bromoacetate (0.29 
g, 1.3 mmol) was added, the reaction warmed to room temperature and left to stir for 24 
hours. The reaction was followed by tic (silica; ethyl acetate). The solution was 
reduced to dryness under reduced pressure, and diethyl ether (20 ml) and water (20 ml) 
added to the solid that remained. The two layers were separated, the solvents
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evaporated to dryness under reduced pressure and the residues examined by NMR. 
No reaction, except hydrolysis of the ethyl ester, was detected.
The reaction was repeated using the same method, with a wide range of bases {t- 
Butyl lithium, LDA, sodium hydride, sodium methoxide/methanol, potassium carbonate 
and KHMDS) in a range of solvents (DMF, ethanol, methanol and DME). No reaction 
was detected in any of the reactions.
Ethvl nicotinate iV-oxide T5T)
O
Hydrogen peroxide (100 volume, 24 ml) was dissolved in dichloromethane (56 
ml) and the solution stirred at 0 °C. Trifluoroacetic anhydride (48 ml) was added slowly 
over 30 minutes, whilst maintaining the temperature at 0 °C. Ethyl nicotinate (2.00 g, 
0.013 mol) was added dropwise, the solution allowed to warm to room temperature, 
and then refluxed for 5 hours. On cooling, the solution was evaporated to dryness 
under reduced pressure, and the residue redissolved in dichloromethane (20 ml). This 
was washed with distilled water (20 ml), the organic layer dried (MgSO^.), and 
evaporated under reduced pressure to leave a yellow solid (1.56 g, 72%). Dmax (nujol/ 
cm-i) 1670 (C=0); §h (200 MHz; C^HClg) 1.40 (3H, t., 7 7 Hz, OCH2CH 3), 4.41 
(2H, q., 7 7 Hz, OCH2C H 3), 7.39 (IH , t., 74,5 =7s,6 5 Hz, 5-CH), 8.31 (IH , d., 74,5 
5 Hz, 4-CH), 8.77 (IH , d., 75,6 5 Hz, 6-CH), 9.23 (IH , s., 2-CH); 8c (50.31 MHz; 
c m c h )  14.5 (OCH2Ç H 3), 62.6 (OCH2), 125.3 (5-C), 131.0 (3-C), 140.8 (4-C),
148.0 (6-C), 150.2 (2-CH).
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Diethyl 3-methvlpvridine-2-phosphonate (491
P(0)(0CH2CH3)2
«-Butyl lithium (2.5 M in hexanes) (16.8 ml, 0.042 mol) was added dropwise 
to diethyl phosphite (7.0 g, 0.042 mol) at - 20 to - 30 °C under a nitrogen atmosphere 
over 2 hours. Meanwhile 3-methylpyridine iV-oxide (5.33 g, 0.042 mol) and dimethyl 
sulfate (4.61 g, 0.042 mol) were heated together to 60 °C for 2 hours, under a nitrogen 
atmosphere. The resulting A-methoxy 3-methylpyridine methylsulfate was dissolved 
in diethyl phosphite (15 ml) and added dropwise to the diethyl lithium phosphonate at - 
20 to - 30 °C under a nitrogen atmosphere over 2 hours. The reaction was allowed to 
warm to room temperature and stirred overnight. Water (50 ml) was added to the 
reaction mixture, which was then extracted with dichloromethane (3 x 50 ml). 
Extraction by acidification (4 M hydrochloric acid, 50 ml) was followed by basification 
and re-extraction with dichloromethane (3 x 30 ml). The solvent was removed under 
reduced pressure, and fractional distillation of the yellow oil using the Kugelrohr 
apparatus to produce a clear oil (8.53 g, 89%). (Found: C, 51.99; H, 7.56; N, 6.63; 
Calc, for C 10H 16N O 3P: C, 52.40; H, 7.04; N, 6.11%); t)max (nujol/ cm"l) 2960 (- 
O CH 2), 1480 (P-py), 1240 (P=0), 1020 (P-OCH2); 6h (200 MHz; C%Cl3) 1.22 
(6H, t., J  7 Hz, CH3C H 2), 2.50 (4H, s., CH3), 4.11 (4H, q., J 1  Hz, OCH2), 7.19 
(IH , dd., 74,5 6 Hz, 75,6 5 Hz, 5-CH), 7.44 (IH , t., 74,5 6 Hz, 4-CH), 8.46 (IH , d.,
75,6 5 Hz, 6-H); 6 c (50.31 MHz; C 2H C I3) 16.8 (Ç H 3C H 2), 19.8 (CH3), 63.2 
(OCH2), 1 2 6 . 1 ( 5 - 0 ,  128.3 (3-C), 139.2 (4-C), 147.8 (6-C), 151.8 (2-C); 6p (121.5 
MHz; C % C l3) 12.20; m/z (Cl) 229 (M, 25%), 200 (30, [M - CH2CH 3]), 185 (37, 
[M - C3H8]), 93 (100, C6H7N).
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3-Methylpvridine-2-phosphonic acid (58)
CH3
N PO3H 2
Diethyl 3-methylpyridine-2-phosphonate (0.80 g, 3.5 mmol) was dissolved in 6 
M hydrochloric acid (15 ml) and heated to reflux for 6 hours. Upon cooling, the acid 
was evaporated under reduced pressure, and trituration of this resulting oil produced a 
white solid which was recrystallised from boiling water to produce white crystals (0.45 
g, 75%). m.p. 284 (lit.,145 282 °C). (Found: C, 41.38; H, 4.67; N, 7.87; Calc., for 
CeHgNOsP: C, 41.63; H, 4.68; N, 8.09%); Ôh (200 MHz; m ^O ) 2.60 (3H, s., CH3), 
7.87 (IH , t., 75,6 4 Hz, 5-CH), 8.34 (IH , dd., 74.5 4 Hz, 74,5 2 Hz, 4-CH), 8.46 (IH , 
d., 75,6 4 Hz, 6-CH); ôc (50.31 MHz; ^HzO) 21.3 (CH3), 130.5 (5-C), 141.3 (4-C),
144.1 (3-C), 149.8 (2-C), 151.3 (6-CH); 0? (121.5 MHz; % 2 0 ) 2.52; m/z (El) 173 
(M, 60%), 155 (18, M  - H2O), 108 (64, M - C5H3NP), 93 (100, C6H7N).
Attempted oxidation of 3-methvlpvridine-2-phosphonic acid
3-Methylpyridine-2-phosphonic acid (0.2 g, 1.16 mmol) was dissolved in water 
(10 ml) and 3 eq. potassium permanganate (0.55 g, 3.48 mmol) added. This reaction 
mixture was heated to reflux over 1.5 hours, and kept at reflux for a further 2 hours. 
On cooling, manganese dioxide was removed by filtering through celite and the residue 
washed with boiling water. The combined filtrates were evaporated to dryness under 
reduced pressure to produce a white solid. This solid could not be dissolved in any 
NMR solvent.
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Diethvl (3-bromQmethynpvridine-2-phosphonate (601
CHiBr
P(0)(0CH2CH3)2
Diethyl 3-methylpyridine-2-phosphonate (1.00 g, 4.4 mmol) was dissolved in 
carbon tetrachloride (15 ml). This was added to a solution of dibenzoyl peroxide (0.11 
g, 0.44 mmol) and A-bromosuccinimide (0.80 g, 4.4 mmol) in carbon tetrachloride (15 
ml). This mixture was heated to reflux for two days, with benzoyl peroxide added at 
regular intervals, and the reaction followed by tic (ethyl acetate). When no further 
reaction was detected, the reaction mixture was filtered and the carbon tetrachloride 
removed under reduced pressure. The dark oil remaining was purified by silica gel 
column chromatography, with ethyl acetate as elutant, to give a pale orange solid of 
diethyl (3-bromomethyl)pyridine-2-phosphonate as the product (0.35 g, 30%). m/z 
(EI+) (Found: [M] 306.9969. CioHisNOsPBr requires 306.9972); t)max (nujol/ cm-^) 
1300 (P=0); ÔH (200 MHz; C^HCls) 1.27 (6H, t., J  8 Hz, CH3CH2), 4.17 (4H, q., J  
8 Hz, OCH2), 4.93 (2H, s., CH2), 7.36 (IH , dd., ^4,5 7 Hz, 75,6 6 Hz, 4-CH), 7.79 
(IH , t., 74,5 7 Hz, 5-CH), 8.62 (IH , d., 7s,6 6 Hz, 6 -H); ôc (50.31 MHz; C^HCh) 
16.7, 16.8 (ÇH3CH 2), 29.8 (CHzBr), 63.7, 63.8 (OCH2), 126.6(5-C), 138.8 (3-C),
139.8 (4-C), 149.6 (6-C), 152.0 (2-C); ôp (121.5 MHz; C2HCI3) 10.1 m/z (BI+) 307, 
309 (M, 17%), 228 (79, [M - Br]), 154 (100, [M - C4HioOBr]), 93 (47, CgH^N).
Attempted oxidation of diethvl G-bromomethvDpvridine-2-phosphonate
Diethyl (3-bromomethyl)pyridine-2-phosphonate (0.13 g, 0.42 mmol), sodium 
nitrite (0.21 g, 3 mmol) and acetic acid (0.60 g, 10 mmol) were dissolved in dimethyl 
sulfoxide (2 ml), the solution stirred at 35 °C for 48 hours, and the reaction followed by 
tic (cellulose; H2O). The reaction was acidified (2 M hydrochloric acid) and the
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solvents rem oved under reduced pressure. Prep, tic (cellu lose; 6:6:1 
isopropanol:H2 0 :NH3) was attempted but no product isolated.
Methyl ('2-bromomethvDnicotinate (681
.CO2CH3
N CH2Br
Methyl 2-methylnicotinate (3.02 g, 0.01 mol) was dissolved in carbon 
tetrachloride (25 ml). This was added to a solution of dibenzoyl peroxide (0.40 g) and 
A-bromosuccinimide (4.84 g, 0.01 mol) in carbon tetrachloride (25 ml). This mixture 
was heated to reflux for two days, with dibenzoyl peroxide added at regular intervals, 
and the reaction followed by tic (3:2 40/60 petroleum ether:ethyl acetate). When no 
further reaction was detected, the reaction mixture was cooled and filtered. The carbon 
tetrachloride was removed under reduced pressure to leave a dark brown oil. 
Purification by silica gel column chromatography, using 3:2 40/60 petroleum 
ether:ethyl acetate as elutant, produced a reddish-brown solid as the product (1.32 g, 
29%). m/z (EI+) (Found: [M] 228.9731. C8HgN02 Br requires 228.9738); (cm- 
Î) 2850 (-OCH3), 1745 (C=0); Ôh (200 MHz; C^HC^) 3.93 (3H, s., OCH3), 5.02 
(2H, s., CH2Br), 7.29 (IH , mult., 5-CH), 8.24 (IH , d., 74,5 8 Hz, 4-CH), 8.67 (IH, 
d., 75,6 7 Hz, 6-H); Ôc (50.31 MHz; C2HCI3) 32.9 (OCH3), 53.2 (CH2Br), 125.5 (5- 
C), 125.5 (3-C), 139.7 (4-C), 152.8 (6-C), 158.3 (2-C), 166.2 (carbonyl); m/z (EI+) 
228, 230 (M, 12, 11%), 150 (100, [M - Br]), 122 (26, [M - Br-C2H 4]), 93 (32, 
CgH^N).
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Diethvl G-methoxvcarbonyl-2-pyridyDmethvlphosphonate (69)
L P(0)(0CH2CH3)2
«-Butyl lithium (2.5 M in hexanes) (2.4 ml, 6 mmol) was added dropwise to 
diethyl phosphite (1.0 g, 6 mmol) at - 20 to - 30 °C under a nitrogen atmosphere over 2 
hours. Methyl (2-bromomethyl)nicotinate (0.69 g, 3 mmol) was dissolved in diethyl 
phosphite (10 ml) and added dropwise to the diethyl lithium phosphonate at - 20 to - 30 
°C under a nitrogen atmosphere over 2 hours. The reaction was allowed to warm to 
room temperature and stined overnight, as the reaction was followed by tic (silica; 9:1 
ethyl acetate: methanol). Upon completion, water (10 ml) was added to the reaction 
mixture, which was then extracted with dichloromethane (2 x 20 ml). The organic 
layer was dried (MgSO^) and the solvent removed under reduced pressure, and the 
yellow oil purified by silica gel column chromatography, elutant 9:1 ethyl acetate: 
methanol, to produce a clear oil (0.14 g, 14%). m/z (EI+) (Found: [M] 288.1036. 
C 12H 19N O 5P requires 288.2615); n^ax (cm-i) 3500 (-OCH3), 1730 (C =0), 1290 
(P=0); ÔH (200 MHz; C2H C I3) 1.14 (6H, t., J  6 Hz, OCH2C H 3), 3.83 (3H, s., 
CO2CH 3), 3.95 (6H, mult., 2x OCH2CH 3 + CH2P), 7.18 (IH , mult., 5-CH), 8.34 
(IH, d., 74,5 8 Hz, 4-CH), 8.57 (IH , d., 7s,6 8 Hz, 6-CH); ôc (50.31 MHz; C^HC^)
16.8 (OCH2CH 3), 35.2 (d., 7 130 Hz, CH2P), 52.2 (CO2CH 3), 62.5 (d., 7 7 Hz, 
POCH2CH3), 122.2 (5-C), 126.8 (3-CH), 138.2 (6-CH), 139.2 (4-C), 154.2 (2-CH); 
ôp (121.5 MHz; C^HCb) 25.14; m/z (El) 288 (M, 7%), 183 (18, M - 0 3 (CH2CH3)2), 
136 (100, M  - 0 3 (CH2CH3)2 - CH2P).
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2-rPhosphonomethyBnicotinic acid (661
N
CO2 H
Diethyl (3-methoxycarbonyl-2-pyridyl)methylphosphonate (0.14 g, 0.49 mmol) 
was dissolved in concentrated hydrochloric acid (2 ml) and heated to 60 °C for 24 
hours, as the reaction was followed by tic (ethyl acetate). The excess acid was 
removed under reduced pressure, and the white solid produced recrystallised from 
boiling methanol to produce a white solid (0.10 g, 95%). m.p. 256-258 °C; \>max 
(nujol/ cm-i) 2700 ( OH), 1720 (C=0), 1280 (P=0); Ôh (200 MHz; ^H^O/NaO^H)
3.30 (2H, d., J  20 Hz, CHgP), 7.12 (IH , t., 74,5 = Js,6 8 Hz, 5-CH), 7.68 (IH , d.,
74.5 8 Hz, 4-CH), 8.67 (IH , d., 7g,6 8 Hz, 6-H); ôc (50.31 MHz; % 2 0 ) 40.1 (d., 7 
115 Hz, CH2P), 123.4 (5-C), 137.5 (d.,7c-P 5 Hz, 3-C), 139.2 (4-C), 150.9 (6-C),
157.5 (d.,7c-p 9Hz, 2-C), 166.2 (carbonyl); Ôp (121.5 MHz; 2H2O) 16.30. m/z (EI+) 
219 (M, 15%), 200 (18, [M - H2O]), 119 (100, C5H5NP).
Diethvl quinolinate (1091
CO2CH2CH3
CO2CH2CH3
A m ixture of quinolinic acid (3.0 g, 0.018 mol), ethanol (14 ml), and 
concentrated sulphuric acid (3 ml) was heated to reflux overnight. The solution was 
then cooled and poured onto crushed ice (10.0 g). Concentrated ammonia solution was 
added until the solution was strongly alkaline. Some of the ester separated as an oil but 
most remained dissolved in the solution. The mixture was extracted with ether (3x 40
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ml), the ethereal layers were dried (MgSO^), and then the sovent removed under 
reduced pressure. The oil produced was distilled using the Kugelrohr apparatus at 
water pump pressure to give a colourless oil, (2.53 g, 63%). 'Umax (cm"0 2920 
(O C H 3), 1700 (C =0); ÔH (200 MHz; C^HClg) 1.35 and 1.39 (6H, 2x t., J  8 Hz, 
CH3CH 2-), 4.39 and 4.42 (4H, 2x q., J  8 Hz, CH3CH 2-), 7.45 (IH , dd., 74,5 8 Hz,
75,6 6 Hz, 5-CH), 8.17 (IH , dd., 74.5 8 Hz, 74,6 2 Hz, 4-CH), 8.71 (IH , dd., 75.6 6 
Hz, 74,6 2 Hz, 6 -CH); Ôc (50.31 MHz; C^HCb) 14.05 (ÇH 3CH 2-), 62.0 and 62.1 
(CH3CH2-), 125.0 (5-C), 126.0 (3-C), 137.8 (4-C), 151.5 (2-C), 151.9 (6-C), 165.0 
and 166.4 (carbonyl).
Diethyl iV-methylquinolinium methvlsulfonate
CO2CH2CH3
c n .o s o o
N*^ ^C02CH2CH3 
CHa
Dimethyl sulfate (1.13 g, 9 mmol) was added slowly, with stirring, to diethyl 
quinolinate (2.0 g, 9 mmol) and the reaction stirred overnight at 60-70 °C. The solution 
was then cooled and placed in an acetone/ C0 2 (s) bath where a glass formed, which on 
removal from the acetone/ C0 2 (s) bath crystallised out to a white solid. This was then 
recrystallised from ethanol to give the product as white crystals (2.50 g, 83%). Ôh 
(200 MHz; C^H C h) 1.34 and 1.38 (6H, 2 x t., 7 7 Hz, CH3 S), 3.53 (3H, s., S- 
O CH 3), 4.40 (2H, q., 7 7 Hz, 3-CO2CH 2), 4.50 (3H, s., NCH3), 4.54 (2H, q., 7 7 
Hz, 2 -CO2C H 2), 8.21 (IH , t., 7 4,5=^5,6 8 Hz, 5-CH), 9.07 (IH , d., 7 4,5 8 Hz, 4- 
CH), 9.12 (IH , d., 7 5 , 6 8  Hz, 6 -CH); ôc (50.31 MHz; C ^H C ^) 16.1 and 16.4 
(CH3's), 50.2 (SOCH3), 58.0 (NCH3) 67.5 and 68.8 (OCH2 S), 131.8 (3-C), 132.2 
(5-C), 149.3 (2-C), 150.6 (6-C), 153.1 (4-C), 163.6 and 165.1 (carbonyl).
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A-Methylquinoliniium-2.3-dicarboxvlic acid (1071
CO2H
N CO2- .H2O
ICH3
Diethyl A/-methylquinolinium methyIsulfonate (2.5 g, 0.01 mol) was dissolved 
in concentrated hydrochloric acid (27.5 ml) and heated to reflux for 2 hours at 100 °C. 
Upon cooling, excess acid was removed under reduced pressure to produce a white 
solid. This was recrystallised from methanol, to give the product as white crystals 
(1.86 g, 81%). m.p. 156-8 °C; (Found: C, 48.55; H, 4.60; N, 7.02. Calc, for 
C 8H 9N O 5: C, 48.25; H, 4.55; N, 7.02%); u^ax (nujol/ cm-i) 3420 (O-H), 1650 
(C=0); §H (200 MHz; % 2 0 ) 4.35 (3H, s., NCH3), 7.93 (IH , t ,  74,5=75,6 6 Hz, 5- 
CH), 8.78 (IH , d., 74.5 6 Hz, 4-CH), 8.91 (IH , d., 75.66  Hz, 6 -CH); ôc (50.31 
MHz; % 0 )  49.6 (NCH3), 128.9 (3-C), 131.6 (5-C), 150.1 (2-C), 150.3 (4-C and 6- 
C), 151.1 and 151.9 (carbonyl).
Ethyl jV-methylpicolinium methylsulfonate
CH3OSO2'
N CO2CH2CH3 
CH3
Dimethyl sulfate (6.3 g, 0.05 mol) was added slowly, with stirring, to ethyl 
picolinate (7.6 g, 0.05 mol) and the reaction stirred overnight at 60-70 °C. The solution 
was then cooled and placed in an acetone/ C0 2 (s) bath where a glass formed, which on 
removal from the acetone/ C0 2 (s) bath crystallised out to a white solid. This was then
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recrystallised from ethanol to give the product as white crystals (12.3 g, 8 8  %). Umax ( 
nujol/ cm-i) 1710 (C=0); 5h (200 MHz; C^HCia) 1.33 (3H, t., J  8  Hz, -OCH2CH3), 
3.49 ( 3H, s., SOCH3), 4.46 (2H, q., J  9 Hz, -OCE2CH3), 4.60 (3H, s., N-CH3),
7.38 (IH, t., 7 4 ,5 =^5 ,6 6  Hz, 5-CH), 7.73 (IH, d., 7 8  Hz, 3-CH), 8.04 (IH, t., 7
4,5 6  Hz, 4-CH), 8.65 (IH, d., 7 5,6 6  Hz, 6 -CH); 8 c (50.31 MHz; C^HCU) 13.9 
(ÇH3CH2O), 49.1 (CH3OS), 54.0 (NCH3), 64.4 (CH3CH2O), 130.3 (3-C), 130.8 
(5-C), 142.5 (2-C), 147.2 (6 -C), 150.0 (4-C), 159.6 (carbonyl).
A/-Methvipicoiinium hvdrogensuifate 1841
HSO4- 
N CO2HICH3
Ethyl iV-methylpicolinium methylsulfonate (12.3 g, 0.045 mol) was dissolved 
in concentrated hydrochloric acid (27.5 ml) and heated to reflux for 2 hours at 100 °C. 
This was then crystallised in the same way as 7/-methylpyridinium-2,3-dicarboxylic 
acid, and reciystallised from methanol, to give the product as a white solid (7.96 g, 
95%). m.p. 169-171 °C (lit.i94 170-173 °C); (Found: C, 35.64; H, 3.74; N, 5.91. 
Calc for C7H9NSO6: C, 35.74; H, 3.85; N, 5.95%); D^ ax (nujol/ cm- )^ 3050 (-OH), 
1760 (C=0); ÔH (200 MHz; ^HiO) 4.39 (3H, s., N-CH3), 7.90 (IH, t., 7 3 ,4 =74,5 8 
Hz, 4-CH), 8.08 (IH, d., 73,4 8 Hz, 3-CH), 8.43 (IH, t., 74,5 =75,6 8 Hz, 5-CH), 
8 .6 6  (IH, d., 75,6 8 Hz, 6 -CH); ôc (50.31 MHz; ^HjO) 50.7 (N-CH3), 131.6 (3-C),
132.0 (5-C), 147.5 (2-C), 149.1 (6 -C), 150.5 (4-C), 164.9 (carbonyl).
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Ethvl N-methvlnicotinium hvdrogensuifate
CH.
CO2CH2CH3
CH3OSO2-
This was synthesised in the identical manner as for ethyl A-methylpicolinium 
methyl sulfate, except using ethyl nicotinate, to give the product as white crystals (12.5 
g, 90%). Umax ( nujol/ cm-i) 1710 (C=0); 5h (200 MHz; C^HClg) 1.19 (3H, t., J  8  
Hz, -OCH2CH3), 3.29 (3H, s., SOCH3), 4.24 (2H, q., J  1 Hz, -OCH2CH3), 4.38 
(3H, s., N-CH3), 8.08 (IH, t., J  6  Hz, 5-CH), 8.73 (IH, d., J  1 Hz, 4-CH), 8.97 
(IH, d., J  6  Hz, 6 -CH), 9.19 (IH, s., 2-CH); Ôc (50.31 MHz; C2HCI3) 14.3 
(CH3CH2O), 49.5 (CH3OS), 54.6 (NCH3), 63.5 (CH3ÇH2O), 128.9 (5-C), 130.7 
(3-C), 145.1 (2-C), 147.0 (6 -C), 149.5 (4-C), 162.1 (carbonyl C).
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AT-Methylnicotinium hvdrogensuifate (1101
N
CH.
.CO2 H
HSO4
This was synthesised in the identical manner as for A -m ethylp icolin ium  
hydrogensulfate, except using ethyl A/-methylnicotinium methylsulfonate (12.3 g, 
0.045 mol) in concentrated hydrochloric acid to give the product as white crystals 
(7.80, 90%). m.p. 167 °C; (Found: C, 36.14; H, 3.90; N, 6.00. Calc for CyHgNSOg: 
C, 35.74; H, 3.85; N, 5.95%); Umax (nujol/ cm-i) 3050 (-OH), 1760 (C=0); Ôh (200 
MHz; 2H 2O) 4.44 (3H, s., N-CH3), 8.13 (IH , t., 7 4,5=75,6 5 Hz, 5-CH), 8.94 (2H, 
t., 7 4,5, 4-CH), 8.97 (IH , t ,  7s,6 5 Hz, 6-CH), 9.35 (IH , s., 2-CH); ôc (50.31 MHz; 
2H2O) 51.3 (N-CH3), 130.9 (5-C), 147.7 (3-C), 148.3 (2-C), 149.5 (6 -C), 150.8 (4- 
C), 164.2 (carbonyl).
i7-Ethylpyridinium-2.3-dicarboxvlic acid monohvdrate (108^
N CO2HICH2CH3
.HoO
Diethyl sulfate (1.38 g, 8.96 mmol), was added slowly to diethyl quinolinate 
(1.00 g, 4.48 mmol) and this mixture stirred for 24 hours at 40-45 °C, under a nitrogen 
atmosphere. The reaction was followed by tic (3:2 40/60 petroleum ether/ ethyl 
acetate), and upon completion excess diethyl sulphate was removed under reduced 
pressure. The structure of N-ethylquinolinium ethylsulfonate was confirmed by IH
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and "C n.m.r but not isolated. 8 h (200 MHz; C^HCis) 1.26 (3H, t., J 1 Hz, 
COCH2CH3 ), i.42 (6 H, 2x t., J  7 Hz, SOCH2CH.3), 1.71 (3H, t., J  8 Hz, 
NCH2CH3), 4.10 (2H, q., 7  7 Hz, SOCH2CH3), 4.46 and 4.60 (4H, 2x q„ 7  7 Hz, 
COCE2CH3), 4.78 (2H, q., 7  8  Hz, NCH2CH3), 8.55 (IH, t., 7 4 ,5 =  7s,6 6  Hz, 5- 
CH), 9.10 (IH, d., 7 4 , 5  6  Hz, 4-CH), 9.63 (IH, d., 7s,6 6  Hz, 6 -CH); 8 c  (50.31 
MHz; C^HCis) 14.1 and 14.4 (COCH2CÏÏ3), 15.6 (SOCH2CH3), 17.6 (NCH2CJi3),
53.4 (SOCH2CH3), 63.9 and 64.4 (COCE2CH3), 65.6 (NCE2CH3), 129.0 (5-C),
131.1 (3-C), 146.9 (4-C), 147.7 (6 -C), 151.0 (2-C), 160.1 and 161.1 (carbonyl).
Diethyl Al-ethylquinolinium ethylsulfonate (1.5 g, 3.8 mmol) was dissolved in 
concentrated HCl (12.5 ml) and refluxed for 12 hours at 100 °C. Upon cooling, excess 
acid was removed under reduced pressure to produce a white solid. This was 
recrystallised from methanol, to give the product as white crystals (1 .8 6  g, 81%). m.p. 
146 °C; (Found: C, 50.89; H, 5.03; N, 6.47. Calc, for C9H11NO5; C, 50.71; H, 5.20; 
N, 6.57%); Umax (nujol/ cm->) 3020 (O-H), 1720 (C=0); 8 h  (200 MHz; % 2 0 ) 1.54 
(3H, t., 7  7 Hz, NCH2CH3 ), 4.06 (2H, q., 7 7 Hz, NCH2 CH3), 8.01 (IH, t., 
74,5=75,6 7 Hz, 5-CH), 8.89 (IH, d., 74,5 7 Hz, 4-CH), 8.94 (IH, d., 7s,6 7 Hz, 6- 
CH); 8 c (50.31 MHz; ^HjO) 18.8 (NCH2CH3), 58.6 (NCE2CH3), 129.2 (3-C),
129.4 (5-C), 148.5 (4-C), 150.2 (2-C and 6 -C), 176.7 and 178,6 (carbonyls).
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jV-Ethvlpicolinium hvdrogensuifate (112)
N COgH .HSO4 
CH2CH3
//-Ethyl picolinic acid was synthesised in an identical manner to N-ethyl 
quinolinic acid, except that ethyl picolinate (3.02 g, 0.02 mol) was heated with diethyl 
sulfate (3.08 g, 0.02 mol). The intermediate ethyl A-ethylpicolinium ethylsulfonate 
was confirmed by and nmr, but not isolated. Ôh (200 MHz; C^HCls) 1.26 
(3H, t., J  1 Hz, COCH2CH3), 1.47 (3H, t., J  8 Hz, SOCH2CH3), 1.68 (3H, t., J  8  
Hz, NCH2CH3), 4.05 (2H, q., J 1 Hz, COCH2CH3), 4.54 (2H, q., J  8 Hz, 
COCH2CH3), 5.06 (2H, q., J  8 Hz, NCH2CH3), 8.38 (IH, mult, 5-CH), 8.47 (IH, 
d., 73,4 9 Hz, 3-CH), 8.76 (IH, t , 73.4 = 4^,5 9 Hz, 4-CH), 9.50 (IH, d., 75.6 8 Hz, 
6 -CH); ÔC (50.31 MHz; C2HCI3) 14.3 (COCH2CH3), 15.4 (SOCH2CH3), 17.4 
(NCH2CH3), 58.5 (CSOCH2CH3), 65.0 (SOCH2CH3), 65.1 (NCH2CH3), 131.1 (5- 
C), 132.0 (3-C), 142.5 (2-C), 147.8 (4-C), 149.3 (6 -C), 159.9 (carbonyl).
This was then treated with hydrochloric acid (25 ml) and the solid produced 
upon removal of excess hydrochloric acid recrystallised from boiling methanol to form 
//-ethyl picolinic acid (2.11 g, 62%). Umax (nujol/cm" )^ 3000 (O-H), 1720 (C=0); §h 
(200 MHz; 2H2O) 1.29 (3H, t , 7 8 Hz, NCH2CH3), 4.53 (2H, q., 7 8 Hz, 
NCH2CH3), 7.78 (IH, t , 74,5 = 75.6 6  Hz, 5-CH), 7.94 (IH, d., 73,4 9 Hz, 3-CH),
8.30 (IH, t , 7 3 ,4= 74,5 9 Hz, 4-CH), 8.58 (IH, d., 7 5 ,5 6  Hz, 6 -CH); ôc (50.31 
MHz; 2H2O) 18.6 (NCH2CH3), 58.6 (NCH2CH3), 130.8 (5-C), 131.5 (3-C), 148.3 
(4-C), 149.0 (6 -C), 150.9 (2-C), 166.6 (carbonyl).
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A-Ethvlnicotiniumhvdrogensuifate ('IIP
CO2 H
N .HSO4
CH2CH3
//-Ethylnicotinium hydrogensulfate was synthesised in an identical manner to 
Atethyl quinolinic acid, except that ethyl nicotinate (3.02 g, 0.02 mol) was heated with 
diethyl sulfate (3.08 g, 0.02 mol). The intermediate ethyl //-ethylnicotinium  
ethylsulfonate was confirmed by and nmr, but not isolated. Ôh (200 MHz; 
c m c h )  1.21 (3H, t , J  8 Hz, SOCH2CH3), 1.50 (3H, t., /  8 Hz, COCH2CH3), 1.70 
(3H, t., J 1 Hz, NCH2CH3), 4.03 (2H, q., J  8 Hz, SOCH2CH3), 4.45 (2H, q., J  8  
Hz, COCH2CH3), 4.88 (2 H, q., J 1 Hz, NCH2CH3), 8.27 (IH, t., 7 4 ,5= 75.6 6  Hz, 
5-CH), 8.90 (IH, d., 74,5 6  Hz, 4-CH), 9.33 (IH, s., 2-CH), 9.36 (IH, d., 75.6 6  
Hz, 6 -CH); ÔC (50.31 MHz; C^HClg) 14.5 (COCH2CH3), 15.7 (SOCH2CH3), 17.4 
(NCH2CH3), 58.8 (SOCH2CH3), 63.5 (COCH2CH3), 63.8 (NCH2CH3), 129.6 (5- 
C), 131.5 (3-C), 145.4 (4-C), 145.9 (6 -C), 149.2 (2-C), 161.7 (carbonyl).
This was then dissolved in hydrochloric acid (25 ml) and the solution heated to 
50 °C for 12 hours. The solid produced upon removal of excess hydrochloric acid was 
recrystallised from boiling methanol to form iV-ethylnicotinium hydrogensulfate (2.43 
g, 72%). m.p. 234-236 °C; Umax (nujol/ cm-i) 3000 (O-H), 1730 (C=0); Ôh (200 
MHz; 2H2O) 1.54 (3H, t., 7 7 Hz, NCH2CH3), 4.52 (2H, t., 7 7 Hz, NCH2CH3),
8.08 (IH, t., 7 4 ,5=7 5 ,5 7  Hz, 5-CH), 8 .8 8  (IH, d., 7 4 ,5  7 Hz, 4-CH), 8.95 (IH, d., 
7 5,6 7 Hz, 6 -CH), 9.34 (IH, s., 2-CH); ôc (50.31 MHz; 2H2O) 18.3 (NCH2CH3),
60.6 (NCH2CH3), 131.2 (5-C), 134.0 (3-C), 148.0 (4-C), 148.4 (6 -C), 149.8 (2-C),
167.1 (carbonyl).
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Dimethyl quinolinate (116)
CO2CH3
N " CO2CH3
A mixture of quinolinic acid (6.0 g, 0.0368 mol), methanol (30 ml), and 
concentrated sulfuric acid (6  ml) was refluxed overnight. The solution was then cooled 
and poured onto crushed ice (20 g). Concentrated ammonia solution was added until 
the solution was strongly alkaline.This solution was extracted with ether (3x 40 ml), 
the ethereal layers dried (MgSO^), and then the solvent removed under reduced 
pressure to preduce a white solid, (5.43 g, 78%). Reciystallisation from diethyl ether 
produced white crystals upon filtration, m.p. 55 °C; (Found: C, 55.55; H, 4.72; N, 
7.13; Calc., for C9H9NO4 : C, 55.39; H, 4.65; N, 7.18%); Umax (nujol/cm-^) 1760 
(C=0); ÔH (200 MHz; C^HClg) 3.88 (3H, s., CH3) 3.95 (3H, s., CH3), 7.46 (IH, 
dd., 74,5 8 Hz, 75,6 3 Hz, 5-CH), 8.12 (IH, d., 74,5 8 Hz, 4-CH), 8.71 (IH, d., 75.5  
3 Hz, 6 -CH); ôc (50.31 MHz; C2HCI3) 53.48 and 53.62 (CH3), 125.5 (5-C), 126.9 
(3-C), 138.1 (4-C), 151.0 (2-C), 152.2 (6 -C), 166.2 and 167.0 (carbonyl); m/z (Cl) 
195 (M, 1 1 %), 164 ( 1 0 0 , M-OCH3), 136 (8 6 , M-CO2CH3), 107 (67, M-CO2CH3- 
CHO), 79 (83, C5H5N).
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//-Propvlnicotinium chloride (1151
CO2 H
cr
CH2CH2CH3
i) 1-Iodopropane with ethyl nicotinate
1-Iodopropane (3.40 g, 0.02 mol) was added slowly to ethyl nicotinate (1.51 g,
0.01 mol) and the mixture heated for 24 hours under a nitrogen atmosphere. The 
reaction was followed by tic (3:2 40/60 petroleum ether: ethyl acetate) and upon 
completion excess 1-iodopropane was removed under reduced pressure. A yellow 
solid was obtained (2.61 g, 81%). m.p. 68-70 °C; Umax (nujol/ cm- )^ 1730 (C=0); Ôh 
(200 MHz; C^HClg) 0.92 (3H, t., J  8 Hz, COCH2CH3), 1.33 (3H, t., J  7 Hz, 
NCH2CH2CH3), 2.04 (2H, sextet, J  1 Hz, NCH2CH2CH3), 4.36 (2H, q., J  8 Hz, 
COCH2CH3), 4.97 (2 H, t., J 1 Hz, NCH2CH2CH3), 8.31 (IH, t., 74 ,5= 75.6 7 Hz, 5- 
CH), 8.89 (IH, dd., 74,5 7 Hz, 74,6 2Hz, 4-CH), 9.58 (IH, s., 2-CH), 9.72 (IH, d.,
75,6 7 Hz,74,6 2Hz, 6 -CH); Ôc (50.31 MHz; C^HCU) 11.0 (COCH2CH3), 14.8 
( N C H 2 C H 2 C H 3 ), 25.7 (NCH2 C H 2 C H 3 ), 64.1 (COCH2 C H 3 ), 64.3 
(NCH2CH2CH3), 129.6 (5-C), 131.3 (3-C), 145.8 (4-C), 148.9 (6 -C), 1619.2 (2-C),
170.2 (carbonyl).
The propyl A-propylnicotiniumiodide (2.00 g, 6.3 mmol) was dissolved in 
concentrated hydrochloric acid (10 ml) and this solution heated for 24 hours. Upon 
completion, excess acid was reoved under reduced pressure to produce an off-white 
solid, which upon recrystallisation gave white crystals (1.05 g, 90% from ester), m.p. 
81 °C; Umax (nujol/ cm-i) 3000 (O-H), 1710 (C=0); Ôh (200 MHz; 2H2O) 0.87 (3H, t.,
7 8 Hz, NCH2CH2CH3), 1.97 (3H, sextet., 7 8 Hz, NCH2CH2CH3), 4.58 (2H, t., 7
8 Hz, NCH2CH2CH3), 8.12 (IH, t., 7 4 ,5=75.6 7 Hz, 5-CH), 8.94 (IH, m., 6 -CH, 4- 
CH), 9.33 (IH, s., 2-CH); ôc (50.31 MHz; 2H2O) 6.3 (NCH2CH2CH3), 20.8
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(N C H 2CH 2C H 3), 60.5 (NCH2C H 2C H 3), 125.3 (5-C), 128.7 (3-C), 142.6 (4-C),
144.0 (6-C), 144.1 (2-C), 161.6 (carbonyl).
ii) 1-Iodopropane with quinolinic acid anhydride
Quinolinic acid anhydride (0.5 g, 3.3 mmol) was dissolved in dry DMF (10 
ml), excess 1-iodopropane added, and this solution heated gently (35 - 40 °C) for 2 
days under a nitrogen atmosphere. The reaction was followed by tic (silica; ethyl 
acetate) and upon completion excess 1 -iodopropane and DMF were removed under 
reduced pressure to produce propyl //-propyl quinolinate as a brown oil (0.67 g, 67%). 
ÔH (200 MHz; C^HC^) 0.88 (3H, t., J  8 Hz, COCH2CH2CH3), 1.28 (3H, t., J 1 Hz, 
N CH 2CH2C H 3), 1.84 (2H, sextet, J  1 Hz, COCH2CH2CH 3), 2.00 (2H, sextet, 1 1  
Hz, NCH2CH 2CH 3), 4.36 (2H, q., J  8 Hz, COCH2CH2CH 3), 4.97 (2H, t., J 1 Hz, 
N CH2CH2CH 3), 8.27 (IH , t., 74,5= 75.6 8 Hz, 5-CH), 8.80 (IH , dd., 74.5 8 Hz, 74,6 
3 Hz, 4-CH), 9.67 (IH , d., 7s,6 8 Hz, 74,6 3 Hz, 6-CH).
The ester was dissolved in concentrated hydrochloric acid and heated gently (< 
40 °C) for 24 hours. Excess acid was removed under reduced pressure, again with 
gentle heat, to produce a white solid (0.40 g, 62% from anhydride). Spectral data as 
above.
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«-Propyl trifluoromethanesulfate («-propvl triflatelül?]
CH3CH2CH2OSO2CF3
1-Iodopropane (1.99 g, 0.012 mol) was added to a suspension of silver 
trifluoromethanesulfate (3.0 g, 0.012 mol) in dry dichloromethane (15 ml). A 
precipitate of iodide was observed, and the reaction left to stir for 30 minutes until the 
reaction was completed. The precipitate was filtered through celite, and 
dichloromethane removed under reduced pressure, to produce an unstable brown oil 
(1.52 g, 6 6 %). 5h (200 MHz; C^HClg) 1.02 (3H, t., J 1 Hz, SOCH2CH2CH3), 1.85 
(2H, sextet, J 1 Hz, SOCH2CH2CH3), 4.51 (2H, t., J 1 Hz, SOCH2CH2CH3).
«-Octyl trifluoromethanesulfate («-octyl triflate¥l 181
CH3(CH2)6CH20S02CF3
A solution of «-octanol (1.30 g, 0.01 mol) and pyridine (0.79 g, 0.01 mol) in 
dichloromethane (5 ml) was added, dropwise over 45 minutes, to a solution of 
trifluoromethanesulfonic anhydride (2.82 g, 0 .0 1  mol) in dichloromethane (2 0  ml) at 0  
°C. The insoluble pyridiniura salt was removed by filtration, and the dichloromethane 
removed by distillation to produce an oil (1.90 g, 71%). Ôh (200 MHz; C2HCI3) 0.90 
(3H, t., J 6  Hz, S0 CH2(CH2)6CH3), 1.29 (lOH, m., SOCH2CH2(CH2)5CH3), 1.83 
(2H, quintet, 7 7 Hz, SOCH2 CH.2 (C H 2 ) 5 C H 3 ), 4.42 (2H, t., 7 7 Hz, 
S0 CH2CH2(CH2)5CH3); ôc (50.31 MHz; C2HCI3) 14.2 (SOCH2(CH2)6CH3), 21.0 
(SOCH2(CH2)5CH2CH3),  25.8 (SOCH2(CH2)4CH2CH2CH3),  29.9 
(S0CH2CH2(CH2)3CH2CH2CH3),  32.1 (SOCH2CH 2 (CH 2 )5CH 3 ), 53.8 
(S0CÏÏ2(CH2)6CH3).
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2.3.4.6-Tetra-O-acetyl-q-D-glucopyranosyl bromide (119')
AcO
AcO
AcO
AcO Br
D-GIucose (19.5 g, 0.11 mol) was dissolved in acteic anhydride (75 ml), and 
45% hydrogen bromide in acetic acid (30 ml) added dropwise. This solution was 
stirred under a nitrogen atmosphere at room temperature, and the reaction followed by 
tic (3:2 40-60 petroleum ether: ethyl acetate, developed using 5% sulfuric acid in 
ethanol). When acétylation was complete further 45% hydrogen bromide in acetic acid 
(90 ml) was added, the solution stirred for 16 hours and the reaction followed by tic as 
above. On completion dichloromethane (150 ml) was added to the solution and this 
solution poured onto ice/water, with stirring. The two layers were separated, and the 
organic layer washed twice with an ice/saturated sodium hydrogen carbonatate solution. 
The organic layer was separated, the organic layer dried (MgSÛ4), and the solvent 
removed under reduced pressure to produce a white solid, which was recrystallised 
from diethyl ether to give a white powder (41.6 g, 94%). m.p. 87 “C (lit.^95 gg “Q ; 
[q]D +195.9“ (c 2.42 in CHCI3) (lit.i96 +197.84“ (c 2.42 in CHCI3)); Vmax(nujol/cm- 
1 )  1730 (CO); 6 h ( 2 0 0  MHz, C2HCI3) 2.04 (12 H, 4 x s., COOCH3), 4.09 (1 H, m., 
5-CH), 4.29 (2 H, m., 6A6b-CH), 4.81 (1 H, dd., / i ,2 4 Hz, 72,3 10 Hz, 2-CH), 5.14 
(1 H, t., 73,4 = 74.5 10, 4-CH), 5.53 (1 H, t., 72,3 = 7b,4 10 Hz, 3-CH), 6.59 (1 H, d.,
7i,2 4 Hz, 1-CH); 6c(50.31 MHz, C^HClg) 21.06, 21.16 (CH3), 61.37 (6-C), 67.55 
(4-C), 70.57 (2-C), 71.01 (5-C), 72.56 (3-C), 87.04 (1-C), 169.96, 170.28, 170.35,
171.00 (CO); m/z (Cl) 428, 430 ([M+NH4]+, 18%), 331 (8, [M-Br]+) and 213 (29, 
[M-Br-2 OAc]+).
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Kinetics
Spectra
U ltraviolet absorption spectra were obtained using a U vikon 932 
spectrophotometer. Spectra were measured from 580 - 190 nm, and the change in 
absorption at 280 nm measured.
General Procedure
For measurements at pH 0.1, 0.25, 0.5, 1.0, 1.5, and 2.0, the acid to be 
studied {ca. 0.015 g) was dissolved in distilled water (23 ml), and potassium chloride 
added to adjust to constant ionic strength (1.0). Concentrated hydrochloric acid was 
then added to adjust the pH to the required value, and distilled water added to make up 
to 25 ml. The pH was then re-checked.
For pH 2.5 and 3.0, the acid {ca, 0.015 g) was dissolved in 50 mM potassium 
phosphate (24 ml), and potassium chloride added to adjust to constant ionic strength 
(1.0). Concentrated hydrochloric acid added to adjust the pH to the required value, and 
50 mM potassium phosphate added to make up to 25 ml. The pH was then re-checked.
For pH values of 4.0, 5.0 and 6.0, the acid {ca. 0.015 g) was dissolved in 50 
mM potassium phosphate (24 ml), and potassium chloride added to adjust to constant 
ionic strength (1.0). 1 M Sodium hydroxide solution added to adjust the pH to the 
required value, and 50 mM potassium phosphate added to make up to 25 ml. The pH 
was then re-checked.
Approximately 0.8 ml of the required solution was added to each 1 ml ampoule 
which was then sealed. The ampoules (except two, used to measure the absorbance at t 
= 0) were placed in a water bath at 90 °C to initiate reaction.
Pairs of ampoules were removed at regular intervals. After cooling, an ampoule 
was opened, 0.6 ml of the solution diluted to 10 ml with 1 M sodium hydroxide 
solution, and the UV absorbance spectra at 25 °C measured at the required wavelength. 
This was repeated for each ampoule.
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For each result, A was removed from the figure obtained for the absorbance at 
280 nm, the natural log of this figure calculated, and the average of the pair of results 
noted. A was the absorbance at 280 nm of the decarboxylation product of the acid, at 
the same concentration. A pseudo-first order plot of In (A280“ A ) versus time was 
drawn for each run. The best straight line was fitted by regression Each run was 
repeated at least once for the whole pH range, and on completion of these a pH versus 
observed rate constant plot was calculated.
This method was repeated at pH 1.5 for A^-ethyl quinolinic acid over a range of 
temperatures from 60 - 90 °C. It was also repeated at pH 1.5 for N-ethyl quinolinic 
acid over a range of ionic strengths from 0.5 to 3.0, and at pH 1.5 for A -ethyl 
quinolinic acid replacing distilled water with deuterated water (D2O).
The identity of the decarboxylation products of the kinetic experiments was 
determined by UV absorbance and NMR. A sample kinetic run of each of the acids 
studied was carried out until completion. The solvent was removed under reduced 
pressure, and the absorbance at 280 nm of the product measured, along with the ^H 
and 13c NMR spectra. These were then compared to the authentic spectra of the 
decarboxylation products to confirm that it was decarboxylation that had taken place.
186
CHAPTER 5
187
5. References
1. D. M. Bonner and C. Yanofsky, Proc. N atl Acad. ScL U.S., 1949, 3 5 , 576-
581.
2. Y. Nishizuka and O. Hayaishi, J. Biol Chem., 1963, 238 , 483-485.
3. Y. Nishizuka and O. Hayaishi, J. Biol Chem., 1963, 238, 3369-3375.
4. S. Nakamura, M. Ikeda, H. Tsuji, Y. Nishizuka and O. Hayaishi, Biochem.
Biophys. Res. Commun., 1963, 13, 285-290.
5. R. K. Gholson, I. Ueda, N. Ogasawara and L. M. Henderson, J. B iol Chem.,
1964, 239 , 1208-1214.
6 . E. M. Kosower and J. A. Skorcz, J. Am. Chem. Soc., 1960, 82, 2195-2203.
7. A. J. Andreoli, M. Ikeda, H. Tsuji, Y. Nishizuka and O. Hayaishi, Biochem. 
Biophys. Res. Commun., 1963, 12, 87-92.
8 . K. Iwai and H. Taguchi, J. Nutrl Scl Vitaminol, 1973,19, 491-499.
9. D. F. Mann and R. U. Byerrum, J. B iol Chem., 1974, 249 , 6817-6823.
10. H. Taguchi and K. Iwai, Biochim. Biophys. Acta, 1976, 422 , 29-37.
11. K. Iwai and H. Taguchi, Biochem. Biophys. Res. Commun., 1974, 56, 884-891.
12. K. Shibata and K. Iwai, Biochim. Biophys. Acta, 1980, 611, 280-288.
13. K. Shibata and K. Iwai, Agric. B iol Chem., 1980, 44, 301-308.
14. K. Iwai, K. Shibata, H. Taguchi and T. Ikatura, Agric. B io l Chem., 1979, 4 3 ,
345-350.
15. R. Wagner and K. G. Wagner, Phytochemistry, 1984, 23, 1881-1883.
16. B. Okuno and R. Schwarcz, Biochim. Biophys. Acta, 1985, 841, 112-119.
17. A. C. Foster, W. O. Whetsell, B. D. Bird and R. Schwarcz, Brain Res., 1985, 
336, 207-214.
18. E.Okuno, R. J. White and R. Schwarcz, J. Biochem., 1988, 103, 1054-1059.
19. K. Hughes, A. Dessen, P. Gray and C. Grubmeyer, J. Bacteriol, 1993, 175 , 
479-486.
188
20. P. M. Packman and W. B. Jakoby, J. Biol Chem., 1965, 240 , 4107-4108.
21. P. M. Packman and W. B. Jakoby, J. Biol Chem., 1967, 242 , 2075-2079.
22. K. Iwai, K. Shibata, H. Taguchi and T. Ikatura, Agric. B iol Chem., 1979, 43 , 
351-355.
23. Y. Nishizuka and S. Nakamura, Methods in Enzymology, 1970, 17, 491-500.
24. H. Taguchi and K. Iwai, J. Nutrl Scl Vitaminol, 1974, 20, 269-281.
25. S. H. Moyed and H. E. Umbarger, Physiol Rees., 1962, 4 2 , 444-466.
26. A. C. Foster, W. C. Zinkland and R. Schwarcz, J. Neurochem., 1985, 4 4 , 446-
454.
27. P. M. Packman and W. B. Jakoby, Methods in Enzymology, 1970,17, 501-505.
28. S. Kunjara, C. S. Lee, G. W. Smithers, K. Shibata, K. Iwai and W. J. 
O’Sullivan, Int. J. Biochem., 1986. 18, 489-491.
29. G. W. Smithers and W. J. O'Sullivan, Biochemistry, 1984, 23, 4767-4773.
30. K. Shibata and K. Iwai, Agric. Biol Chem., 1980, 44, 2785-2791.
31. J. S. Myers and W. B. Jakoby, J. B iol Chem., 1975, 2 5 0 , 3875-3879.
32. K. Shibata and K. Iwai, Agric. Biol Chem., 1980, 44, 293-300.
33. L. Kilikin and K. C. Calvo, Biochem. Biophys. Res. Commun., 1988, 152, 
559-564 .
34. H. Taguchi and K. Iwai, Agric. Biol Chem., 1976, 40 , 385-389.
35. P. M. Packman and W. B. Jakoby, Biochem. Biophys. Res. Commun., 1965, 
18, 710-715.
36. R. A. Alberty, Adv. Enzymology, 1956, 17, 1-34.
37. E. V. Brown and R. J. Moser, J. Org. Chem., 1971, 36, 454-457.
38. P. Dyson and D. L. Hammick, J. Chem. Soc., 1937, 1724-1725.
39. P. Beak and B. Siegel, J. Am. Chem. Soc., 1976, 98, 3601-3606.
40. H. L. Levine, R. S. Brady and F. H. Westheimer, Biochemistry, 1980, 19, 4993- 
4999.
41. W. D. L. Musick, J. M ol B iol, 1977, 117, 1101-1107.
189
42. H. Taguchi and K. Iwai, Agric, Biol. Chem., 1975, 39, 1493-1500.
43. J. C. Eads, D. Ozturk, T. B. W exler, C. Grubmeyer and J. C. Sacchettini,
Structure, 1997, 5, 47-58.
44. R. K. Goitein, D. Chelsky and S.M. Parsons, J. Biol. Chem., 1978, 253, 2963- 
2971.
45. S. Scheppele, Chem. Rev., 1972, 72, 511-523.
46. A. Fry in "Isotope Effects in Chemical Reactions", eds. C. J. Collins and N. S.
Bowman, Van Nostrand Reinhold Co., New York, 1970, 364-414.
47. V. F. Raaen, T. Juhlke, F. J. Brwon and C. J. Collins, J. Am. Chem. Soc.,
1974, 96, 5928-5930.
48. A. Maccoll, J. Chem. Soc. A, 1974, 77-101.
49. W. D. L. Musick, CRC Crit. Rev. Biochem., 1981, 11, 1-34.
50. M. Kori and J. F. Henderson, J. Biol. Chem., 1966, 241, 3404-3408.
51. J. Victor, L. B. Greenberg and D. L. Sloan, J. Biol. Chem., 1979, 254, 2647-
2655.
52. T. Honjo, S. Nakamura, Y. Nishizuka and O. Hayaishi, Biochem. Biophys. Res.
Commun., 1966, 25, 199-204.
53. A. Kosaka, H. O. Spivey and R. K. Gholson, J. Biol. Chem., 1971, 246, 3277- 
3283.
54. L. D. Smith and R. K. Gholson, J. Biol. Chem., 1969, 244, 68-71. |
55. J. Preiss and P. Handler, J. Biol. Chem., 1958, 233, 488-492. |
56. M. C. Powanda, O. Muniz and L. S. Dietrich, Biochemistry, 1969, 8 , 1869- !
1873. I
57. S. Singer and E. W. Holmes, J. Biol. Chem., 1977, 252, 7959-7963. |
58. G. L. King, C. G. Bounous and E. W. Holmes, J. Biol. Chem., 1978, 253, |
3933-3938. I
59. I. Lapin, Epilepsia, 1981, 22, 257-265.
60. F. Moroni, G. Lombardi, V. Carla and G. Monetti, Brain Res., 1984, 195, 352- |I355. . !
190 '
61. M. Wolfensberger, U. Amsler, M. Cuenod, A. C. Foster, W. O. Whetsell and R. 
Schwarcz, NeuroscL Lett., 1983, 38, 85-90.
62. R. Schwarcz, Biochem. Soc. Trans., 1993, 21, 77-82.
63. N. P. Dotting, Chem. Soc. Rev., 1995, 401-412.
64. T. W. Stone and M. N. Perkins, Eur. Pharmacology, 1981, 72, 411-412.
65. A. C. Foster and R. Schwarcz, in Quinolinic acid and the Kynurenines, ed. T. W.
Stone, CRC Press, Boca Raton, 1989, 173-192.
6 6 . S. R. Birley, J. F. Collins, M. N. Perkins and T. W. Stone, Br. J. Pharmacol, 
1982, 77 , 7-12.
67. R. Schwarcz, W. O. Whetsell and R. M. Mangano, Science, 1983, 2 1 9 , 316- 
318.
6 8 . M. N. Perkins and T. W. Stone, J. Pharmacol Exp. Theor., 1983, 2 2 6 , 551- 
557.
69. M. P. Heyes, M. Gravell, M. April, D. Blackmore, W. T. London, J. A. Yergey 
and S. P. Markey, in "Kynurenine and Serotonin Pathways", eds. R. Schwarcz,
S. N. Young and R. R. Brown, Plenum Press, New York, 1991, 555-561.
70. A. C. Foster, J. F. Collins and R. Schwarcz, Neuropharmacology, 1983, 2 2 ,
1331-1342.
71. V. I. Teichberg, M. Beaujean and O. Goldberg, in Quinolinic acid and the
Kynurenines, ed. T. W. Stone, CRC Press, Boca Raton, 1989, 161-172.
72. A. C. Foster, L. P. Miller, W. H. Oldendorf and R. Schwarcz, Exp. Neurol
1984, 8 4 , 428.
73. R. P. M. Bruyn and J. C. Stoof, J. Neuro. Scl, 1990, 95 , 29-30.
74. M. P. Heyes, P. Kim and S. P. Markey, J. Neurochem., 1988, 51, 1946-1948.
75. R. Schwarcz and F. Du, in "Kynurenine and Serotonin Pathways", eds. R.
Schwarcz, S. N. Young and R. R. Brown, Plerum Press, New York, 1991, 185- 
199.
76. R. Schwarcz, E. Okuno and R. J. White, Brain Res., 1989, 490 , 103-109.
191
77. C. Spéciale and R. Schwarcz, Abs. Soc. NeuroscL, 1986, 12, 243.
78. M. F. Beal, N. W. Kowall, D. W. Ellison, M. F. Mazarek, K. J. Schwartz and J.
B. Martin, Nature, 1986, 231, 168-171.
79. G. P. Reynolds, S. J. Pearson, J. Halket and M. Sandler, J. Neurochem., 1988, 
50 , 1959-1960.
80. R. Schwarcz, E. Okuno, R. J. White, E. D. Bird and W. O. Whetsell, Proc. Natl. 
Acad. Sci. (USA), 1988, 85, 4079-4081.
81. M. P. Heyes, E. J. Garnett and R. R. Brown, Life Sel, 1985, 37, 1811-1816.
82. A. C. Foster and R. Schwarcz, J. Neurochem., 1985, 45 , 199-205.
83. W. O. Whetsell, C. Kohler, E. Okuno and R. Schwarcz, Clin. Neuropath., 1988,
7, 222.
84. M. P. Heyes, Biochem. Soc. Trans., 1993, 21, 82-89.
85. M. P. Heyes, Ann. N.Y. Acad.Scl, 1993, 679, 211-216.
86 . M. P. Heyes, D. Rubinow, C. Lane and S. P. Markey, Ann. Neurol, 1989, 26,
275-277.
87. D. Jauch, E. H. Urbanska, P. Guidetti, E. D. Bird, J. P. G. Vonsattel, W. O. 
Whetsell and R. Schwarcz, J. Neurol Scl, 1995,130, 39-47.
8 8 . J. H. Connick, G. C. Heywood, G. J. Sills, G. G. Thompson, M. J. Brodie and 
T. W. Stone, Gen. Pharmacol, 1992, 23, 235-239.
89. D. A. Bender, Quinolinic acid and the Kynurenines, ed. T. W. Stone, CRC Press, 
Boca Raton, 1989, 3-38.
90. F. Hirati and O. Hayaishi, J. Biol Chem., 1971, 246, 7825-7826.
91. N. Eguchi, Y. Watanabe, K. Kawanash, Y. Hashimoto and O. Hayaishi, Arch. 
Biochem. Biophys., 1984, 232 , 602-609.
92. L. D. Buckbery, B. W. Bycroft, P. N. Shaw and I. S. Blagborough, Bioorg. 
Med. Chem. Lett., 1992, 2, 1225-1230.
93. F. C. Ross, Ph.D. Thesis, University of St. Andrews, 1996.
94. G. M. Kishore, J. Biol Chem., 1984, 259 , 10669-10741.
192
95. A. H. Mehler, J. Biol. Chem., 1956, 218 , 241-254.
96. J. G. Foster and A. G. Moat, Microbiological Rev., 1980, 44, 83-105.
97. G. J. Tritz, E. Coli and S, Typhimurium Cellular and Molecular Biology, Vol. 1, 
eds. F. C. Niedhart, J. L. Ingraham, K. Blow, B. Magasanik, M. Schaechter and 
H. C. Umbarger, Am. Soc. for Microbiology, Washington D. C., 1987, 557-563.
98. H. B. White, Pyridine nucleotide coenzymes, eds. J. Everse, B. M. Anderson and 
K. S. You, Academic Press Inc., New York, 1982, 1-17.
99. R. K. Gholson, Nature, 1966, 212, 933-935.
100. J. Preiss and P. Handler, J. Biol. Chem., 1958, 233, 488-492.
101. J. Preiss and P. Handler, J. Biol. Chem., 1958, 233, 493-500.
102. W. Dahmen, B. Webb and J. Preiss, Arch. Biochem. Biophys., 1967, 120, 440-
450.
103. J. W. Foster, D. M. Kinney and A. G. Moat, J. Bacteriol., 1979,138, 957-961.
104. T. Penfound and J. W. Foster, E. Coli and S. Typhimurium Cellular and 
Molecular Biology, Vol. 1, ed. F. C. Niedhart, Am. Soc. for Microbiology, 
Washington D. C., 1995, 721-730.
105. A. J. Andreoli, T. Grover, R. K. Gholson and T. S. Matney, Biochim. Biophys. 
Acta, 1969, 193, 539-541.
106. J. W. Foster and A.M. Baskowsky-Foster, J. Bacteriol, 1980 ,142, 1032-1035.
107. D. Hillyard, M. Rechsteiner, P. Manlapaz-Ramos, J. S. Imperial, L. J. Cruz and 
B. M. Olivera, J. Biol. Chem., 1981, 256, 8491-8497.
108. P. Manlapaz-Ramos and B. M. Olivera, J. Biol Chem., 1973, 248, 5067-5073.
109. L. S. Hanna, S. L. Hess and D. L. Sloan, J. B iol Chem., 1983, 258, 9475-
9454.
110. R. F. Evans and H. C. Brown, J. Org. Chem., 1962, 27, 1329-1332.
111. W. Marckwald, W. Klemm and H. Trabert, Ber., 1900, 33, 1556-1566.
112. O. Fischer et al. Ber., 1882,15, 62-64.
113. O. Fischer et al. Ber., 1883,16, 1183-1185.
193
114. O. Fischer et al, Ber., 1884, 17, 763-764.
115. S. M. McElvain and M. E. Goese, J. Am. Chem. Soc., 1943, 65 , 2233-2236.
116. E. Koenigs and G. Kinne, Ber., 1921, 54, 1357-1362.
117. A. F. Tiesler, U.S. Patent, 2,330 ,641; Chem. Abstr., 1944, 38 , 1249.
118. K. Shinohara, J. Biol. Chem., 1932, 96, 285-297.
119. A. Rosenheim and I. Davidsohn, Z. anorg. Chem., 1904, 41, 231.
120. P. Klason and T. Carlson, Ber., 1906, 39, 738.
121. J. P. Danehy and M. Y. Oetser, J. Org. Chem., 1967, 37, 1491-1495.
122. N. Kharasch, in "Organic Sulfur Compounds", ed. N. Kharasch, Pergamon 
Press, Oxford, 1961, 387.
123. J. P. Danehy, B. T. Doherty and C.P. Egan, J. Org. Chem., 1971, 2 5 , 2525- 
2530.
124. L. Field, P. M. Giles and D. L. Tuleen, J. Org. Chem., 1971, 25 , 623-626.
125. J. Delarge and C. L. Lapiere, Bull. Chem. Soc. Beiges, 1986, 75 , 321-327.
126. A. Stewart, Unpublished results. University of St. Andrews, 1997.
127. V. Snieckus, Chem. Rev., 1990, 90 , 879-883.
128. M. A. M. Easson, and N. P. Bolting, unpublished results.
129. J. Epsztajn, E. Bieniek, J. Z. Brezinski and A Jozwiak, Tetrahedron Lett., 1983, 
24, 4735-4738.
130. S. Sengupta and V. Snieckus, Tetrahedron Lett., 1990, 31, 4267-4270.
131. D. L. Comins and D. H. LaMunyon, Tetrahedron Lett., 1988, 29, 773-776.
132. K. H. Worms and M. Schmidt-Dunker, in "Organic Phosphorus Compounds" 
vol. 7, eds. G. M. Kosolapoff and I. Maier, J. Wiley & Sons, New York, 1976, 
1 .
133. L. D. Freedman and G. O. Doak, Chem. Rev., 1957, 57, 479-523.
134. E. F. Jason and E. K. Fields, J. Org. Chem., 1962, 27 , 1402-1405.
135. A. G. Vargolis, Tetrahedron Lett., 1972, 31-32.
136. P. Tavs, Chem. Ber., 1970, 103 , 2428-2436.
194
137. R. A. Naylor and A. W illiams, J. Chem. Soc., Perkin Trans. II, 1976, 1908- 
1913.
138. G. M. Kosolapoff and C. H. Roy, J. Org. Chem., 1961, 26, 1895-1898.
139. A. Burger, J. B. Clements, N. D. Dawson and R. B. Henderson, J. Org. Chem., 
1955, 20, 1383-1386.
140. T. Hirao, T. Masanaga, Y. Oshiro and T. Agawa, Synthesis, 1981, 56-57.
141. T. Hirao, T. Masanaga, N. Yanada, Y. Oshiro and T. Agawa, Bull. Chem. Soc. 
Japan, 1982, 55, 909-913.
142. T. A. Bryson, J. C. Wisawaty, R. B. Dunlop, R. R. Fisher and P. D. Ellis, J. 
Org. Chem., 1974, 39, 3436-3438.
143. T. B. Windholz, L. H. Peterson and G. J. Kent, J. Org. Chem., 1963, 28, 1443.
144. A. R. Katrizky and E. Lunt, Tetrahedron, 1969, 25, 4291-4305.
145. D. Redmore, J. Org. Chem., 1970, 35, 4114-4117.
146. J. I. G. Cadogan, D. J. Sears and D. M. Smith, J. Chem. Soc. C, 1969, 1314- 
1318.
147. P. Tavs and F. Korte, Tetrahedron, 1967, 23, 4677-4679.
148. D. J. Hunter, J. Bird, F. Cassidy, R. C. DeMello, G. P. Harper, E. H. Karran, 
R. E. Markwell, A. J. M iles-Williams and R. W. Ward, Bioorg. Med. Chem. 
Lett., 1994, 4, 2833-2836.
149. P. A. Bartlett and C. K. Marlowe, Biochemistry, 1983, 22, 4618-4624.
150. S. Hanessian and Y. L. Bennani, Tetrahedron Lett., 1990, 6465-6468.
151. V. L. Ryzhkov, M. I. Kabacknik, L. M. Tarasevich, N. A. Medved, N. K. 
Zeitenok, J. K. M archenko, V. A. Vagzhanova, E. F. Vianova and N. V. 
Cherburkina, Doklady Akad. Nauk U.S.S.R., 1954, 98, 849-852.
152. D. N. Moothoo, M. Sc. Literature Report, University of St. Andrews, 1995.
153. J. Olefsyszyn, L. Subotkowska and P. Mastalerz, Synthesis, 1979, 985-986.
154. C. C. Tam, K. L. Mattocks and M. Tischler, Synthesis, 1982, 188-190.
155. M. T. DuPriest, C. L. Schmidt, D. Kuzmich and S. B. Williams, J. Org. Chem., 
1985, 50, 2021-2023.
195
156. N. M. Gray, M. S. Dappen, B. K. Cheng, A. A. Cordi, J. P. Biesterfeldt, W. F.
Hood and J. B. Monahan, J. Med. Chem., 1991, 34, 1283-1292.
157. S. Danishefsky, T. A. Bryson and J. J. Puthenpurayil, J. Org. Chem., 1975, 40 , 
796-797.
158. C. Matt, A. Wagner and C. Mioskowski, J. Org. Chem., 1997, 62, 234-235.
159. S. Cacchi and F. L. Torre, Chem. Ind., 1986, 286-287.
160. G. P. Borsotti, M. Foa and N. Gatto, Synthesis, 1990, 207-208.
161. A. J. Bailey, W. P. Griffith, S. I. Mostaya and P. A. Sherwood, Inorg. Chem.,
1983, 32 , 268-271.
162. A. Onopchenko, J. G. D. Schulz and R. Seekircher, J. Org. Chem., 1972, 37 , 
1414-1417.
163. L. Garuti, A. Ferranti, M. Roberti, E. Katz, R. Budriesi and A. Chiarni, 
Pharmazie, 1992, 47 , 295-297.
164. M. R. F. Ashworth, R. P. Daffern and D. L. Hammick, J. Chem. Soc., 1939, 
809-812.
165. N. H. Cantwell and E. V. Brown, J. Am. Chem. Soc., 1953, 75 , 4466-4468.
166. N. H. Cantwell and E. V. Brown, J. Am. Chem. Soc., 1952, 74 , 5967-5970.
167. L. W. Clark, J. Phys. Chem., 1965, 69, 2277-2280.
168. L. W. Clark, J. Phys. Chem., 1962, 66 , 125-127.
169. P. C. Haake and J. Mantecon, J. Am. Chem. Soc., 1964, 86 , 5230-5234.
170. E. M. Kosower and J. W. Patten, J. Org. Chem., 1961, 26 , 1318-1319.
171. F. A. Hoppe-Seyler, Z. Physiol. Chem., 1933, 222 , 105-115.
172. E. L. Gasteiger, P. C. Haake and J. A. Gergen, Proc. N.Y. Acad. Sci., 1960,
90 , 622-636.
173. B. R. Brown and D. L. Hammick, J. Chem. Soc., 1949, 649-653.
174. G. E. Dunn and G. J. K. Lee, Can. J. Chem., 1971, 49 , 1032-1035.
175. G. E. Dunn, E. A. Lawler and A. B. Yamashito, Can. J. Chem., 1977, 55, 2478-
2481.
196
176. G. E. Dunn, G. J. K. Lee and H. F. Thimm, Can. J. Chem., 1972, 5 0 , 3017- 
3027.
177. G. E. Dunn and H. F. Thimm, Can. J. Chem., 1977, 55, 1342-1347.
178. G. Scapin, C. Grubmeyer and J. Sacchettini, Biochemistry, 1994, 33, 1287- 
1294.
179. R. E. Handshucmacher, J. Biol. Chem., 1960, 235 , 2917-2929.
180. B. W. Potvin, H. J. Stern, S. R. May, G. R. Lam and R. S. Krooth, Biochem  
Pharmacol, 1978, 27, 655-665.
181. R. B. Silverman and R. P. Groziak, J. Am. Chem. Soc., 1982, 104, 6434-6439.
182. S. A. Acheson, J. B. Bell, M. E. Jones and R. Wolfenden, Biochemistry, 1990, 
29, 3198-3202.
183. K. Shostak and M. E. Jones, Biochemistry, 1992, 31, 12155-12161.
184. J. K. Lee and K. N. Houk, Science, 1997, 276, 942-945.
185. W. Wu, A. Ley-Kam, F. M. Wong, T. J. Austin and S. M. Miller, Bioorg. Med. 
Chem. Lett., 1997, 7, 2623-2628.
186 M. P. Nakanishi and W. Wu, Tetrahedron Lett., 1998, 39, 6271-6272.
187. T Gramstad and R. N. Haszeldine, J. Chem. Soc., 1956, 173-180.
188. C. D. Beard, K. Baum and V. Grakauskas, J. Org. Chem., 1973, 3 8 , 3673- 
3677.
189. W. C. Still, M. Khan and A. M itra, J. Org. Chem., 1978, 43, 2923-2925.
190. J. D. Crum and C. H. Fuchsman, J. Het. Chem., 1966, 3, 252-256.
191. A. P. S wain and S. K. Nagele, J. Am. Chem. Soc., 1957, 79, 5250-5253.
192. A. I. Meyers and R. A. Gabel, J. Org. Chem., 1982, 47, 2633-2637.
193. K. Yanauchi, M. Kinoshita and M. Imoto, Bull Chem. Soc. Japan, 1972, 45, 
2531-2534.
194. H. Neunberg, Ber., 1935, 68 , 1474.
195. S. Karayala and K. P. Link, J. Am. Chem. Soc., 1940, 62, 917-920.
196. D. H. Brauns, J. Am. Chem. Soc., 1925, 47 , 1280-1284.
197
CHAPTER 6
198
6. Appendix
Full experimental data for the crystal structure of 2-sulfonicotinic acid is given in 
this appendix.
199
Experimental
Data Collection
A colourlessblock block crystal of C6 H5 NSO5  having approximate dimensions of 0.20 x 0.20 x 0.10 mm 
was mounted on a glass fiber. All measurements were made on a Eigaku AFC7S diffractometer with graphite 
monochromated Mo-Ka radiation.
Cell constants and an orientation matrix for data collection, obtained from a least-squares refinement 
using the setting angles of 17 carefully centered reflections in the range 7.39 < 26 <  15.34® corresponded to 
a primitive monoclinic cell with dimensions:
a =  5.950(2) A
b =  9.335(3) A 0 =  92.51(3)® 
c =  13.115(3) A 
V =  727.7(4) A3
For Z =  4 and F.W. =  203.17, the calculated density is 1.85 g/cm^. The systematic absences of:
hOl: h+1 2n 
OkO: k ^ 2 n
uni(pjely determine the space group to be:
P 2 i/n  (#14)
The data were collected at a temperature of 20 j ;  1®C using the w-26 scan technique to a maximum 
26 value of 50.0®. Omega scans of several intense reflections, made prior to data collection, had an average 
width at half-height of 0.28® with a take-off angle of 6.0®. Scans of (1.10 +  0.35 tan 0)® were made at a 
speed of 16.0®/min (in omega). The weak reflections (I < 15.0cr(I)) were rescanned (maximum of 4 scans) 
and the counts were accumulated to ensure good counting statistics. Stationary background counts were 
recorded on each side of the reflection. The ratio of peak counting time to background counting time was 
2:1. The diameter of the incident beam collimator was 1.0 mm and the crystal to detector distance was 235 
mm, The computer-controlled slits were set to 9.0 mm (horizontal) and 13.0 mm (vertical).
D ata  R eduction
O f the 1501 reflections which were collected, 1364 were unique (R,n« =  0.020). T he in tensities o f  three 
reprc.sentative reflection were measured after every 150 reflections. No decay correction was applied.
T he linear absorption coefficient, p, for M o-K a radiation is 4.1 cm “ ^. An em pirical absorption correction  
based on azim uthal scans o f several reflections was applied which resulted in transm ission factors ranging  
from 0.93 to 1.00. T he data  were corrected for Lorentz and polarization effects.
Structure Solution and Refinement
The structure was solved by direct methods^ and expanded using Fourier techniques^. The non-hydrogen 
atoms were refined anisotropically. Some hydrogen atoms were refined isotropically, the rest were included in 
fixed positions. The final cycle of full-matrix least-squares refinement^ was based on 1048 observed reflections 
(I > 3.00<r(I)) and 1 2 2  variable parameters and converged (largest parameter shift was 0.08 times its esd) 
with unweighted and weighted agreement factors of:
R  =  E ||fo | -  \F c \ \ /J : \F o \  =  0.031
iC  =  v/(Suj(|Fo| -  |fc |)2 /S w F o2)] =  0.030
The standard deviation of an observation of unit weight"* was 2.13. The weighting scheme was based 
on counting statistics and included a factor (p =  0.003) to downweight the intense reflections. Plots of 
SiwdFoj — |Fc|)3 versus |F o |, reflection order in data collection, sin 6 / \  and various classes of indices showed 
no unusual trends. The maximum and minimum peaks on the final difference Fourier map corresponded to 
0.26 and -0.33 e '/A ^ , respectively.
Neutral atom scattering factors were taken from Cromer and Waber® . Anomalous dispersion effects 
were included in Fcalc®; the values for A f’ and A f’ were those of Creagh and McAuley^. The values for the 
mass attenuation coefficients are those of Creagh and Hubbel®. All calculations were performed using the 
teXsan® crystallographic software package of Molecular Structure Corporation.
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EXPERIMENTAL DETAILS
A. Crystal Data
Empirical Formula 
Formula Weight 
Crystal Color, Habit 
Crystal Dimensions 
Crystal System  
Lattice Type
No. of Reflections Used for Unit 
Cell Determination {26 range)
Omega Scan Peak Width 
at Half-height
CeHsNSOs
203.17
colourlessblock, block 
0.20 X 0.20 X 0.10 mm 
mono clinic 
Primitive
17 ( 7.4 - 15.3® )
0.28®
Lattice Parameters
Space Group 
Z value 
O c a /c  
Pqoo
/i(MoKa)
a =  5.950(2)A 
b =  9.335(3) A 
c =  13.115(3)1  
/? =  92.51(3)®
V =  727.7(4) A® 
P 2 i/n  (#14)
4
1.854 g/cm® 
416.00 
4.12 cm“ *
B. Intensity M easurem ents
Diffractometer
Radiation
Attenuator 
Take-off Angle 
Detector Aperture
Crystal to Detector Distance
Temperature
Scan Type
Scan Rate
Scan Width
No. of Reflections Measured 
Corrections
Rigaku AFC7S
MoKa (A =  0.71069 A) 
graphite monochromated
Zr foil (factors =  1.00, 8.53, 8.53, 8.53)
6 0*
9.0 mm horizontal
13.0 mm vertical
235 mm
20.0*C
u}-2e
16.0*/m in (in w) (up to 4 scans)
(1.10 -f- 0.35 tan #)*
50.0*
Total; 1501
Unique: 1364 (R,„f =  0.020)
Lorentz-polarization
Absorption
(trans. factors: 0.9334 - 1.0000)
C. Structure Solution and Refinem ent
Structure Solution  
Refinem ent 
Function M inim ized  
Least Squares W eights 
p-factor
A nom alous Dispersion
No. O bservations (I>3.00cr(I))
No. Variables
R c'fiection/Param eter R atio
Direct M ethods (SIR 92) 
Full-m atrix least-squares 
Eu,(|Fo| -  |Fc|)2
1 _ 4Fo=»a^(Fo)  ~  a^(Fo^)
0.003
All non-hydrogen atom s 
1048 
122 
8.59
Residuals; R; Rw 0.031 ; 0.030
Goodness of Fit Indicator 2.13
Max Shift/Error in Final Cycle 0.08
Maximum peak in Final Diff. Map 0.26 e~ fAA
Minimum peak in Final Diff. Map -0.33 e~/AA
Table 1. Atomic coordinates and B i,o/B eq
atom X y z Beq
S (l) 1.2456(1) 0.02291(8) 0.70666(5) 1.54(1)
0 ( 1 ) 1.4745(3) 0.0570(2) 0.6809(1) 2.04(5)
0 (2 ) 1.1582(3) -0.1069(2) 0.6610(1) 2.16(5)
0 (3 ) 1.2043(3) 0.0369(2) 0.8144(1) 2.33(5)
0 (4 ) 1.2805(3) 0.0429(2) 0.4675(2) 2.07(5)
0 (5 ) 1.3140(4) 0.2718(2) 0.4192(2) 2.79(5)
N (l) 0.9236(4) 0.2180(2) 0.7144(2) 1.61(5)
C (l) 0.7648(5) 0.3141(3) 0.6870(2) 1.97(7)
C(2 ) 0.7537(5) 0.3668(3) 0.5898(2) 2.14(7)
0(3) 0.9113(5) 0.3215(3) 0.5227(2) 1.96(6)
0(4) 1.0730(4) 0.2191(3) 0.5522(2) 1.45(6)
0 (5 ) 1.0732(4) 0.1649(3) 0.6502(2) 1.33(6)
C(C) 1.2373(5) 0.1801(3) 0.4729(2) 1.81(6)
1 1 ( 1 ) 0.9311 0.1855 0.7831 1.9336
1 1 (2 ) 0.6605 0.3456 0.7350 2.3705
H(3) 0.6401 0.4332 0.5689 2.5612
11(4) 0.9096 0.3601 0.4556 2.3743
H(5) 1.367(6) 0.021(4) 0.415(3) 6 ( 1 )
lirq =  +  Un(bt>’ Ÿ +  U33{cc*f +  2Ui2aa*bb* COS7  +  2 U\3aa*cc* cos (3 +  2 1 / 2 3 6 1
Table 2. Anisotropic Displacement Parameters
atom U ii U2 2 U3 3 U1 2 Ul3 U2 3
S (l) 0.0200(4) 0.0214(4) 0.0172(4) 0.0015(3) 0.0023(3) 0.0010(3)
0 ( 1 ) 0.017(1) 0.031(1) 0.029(1) 0.0007(9) 0.0033(9) -0.0011(9)
0 ( 2 ) 0.032(1) 0 .0 2 1 ( 1 ) 0.029(1) -0.0025(9) 0 .0 0 0 2 ( 1 0 ) -0.0007(9)
0 (3 ) 0.037(1) 0.037(1) 0.015(1) 0.006(1) 0.0043(9) 0.0039(9)
0 (4 ) 0.027(1) 0.027(1) 0.024(1) 0.0056(10) 0.0091(9) - 0 .0 0 1 2 ( 1 0 )
0 (5 ) 0.047(1) 0.033(1) 0.027(1) -0.007(1) 0.019(1) 0.003(1)
N (l) 0 .0 2 2 ( 1 ) 0.023(1) 0.016(1) 0 .0 0 0 ( 1 ) 0.005(1) 0 .0 0 0 ( 1 )
0 ( 1 ) 0 .0 2 1 (2 ) 0.026(2) 0.029(2) 0.003(1) 0.007(1) -0.006(1)
0 (2 ) 0.026(2) 0.026(2) 0.029(2) 0.006(1) -0 .0 0 1 ( 1 ) 0 .0 0 0 ( 1 )
0 (3 ) 0.030(2) 0.024(2) 0 .0 2 0 (2 ) -0 .0 0 1 ( 1 ) 0 .0 0 2 ( 1 ) 0 .0 0 2 ( 1 )
0 (4 ) 0.019(1) 0.019(1) 0.018(1) -0 .0 0 2 ( 1 ) 0.003(1) -0 .0 0 1 ( 1 )
0 (5 ) 0.016(1) 0.018(1) 0.017(1) -0 .0 0 1 ( 1 ) 0.003(1) - 0 .0 0 2 ( 1 )
0 (6 ) 0.023(2) 0.032(2) 0.015(1) 0 .0 0 0 ( 1 ) 0 .0 0 1 ( 1 ) -0.004(1)
Tlv' general temperature factor expression:
exp(-27r^(a*^Fii/%^ +  +  2a*b*Ui2hk +  2a*c*Uizhl +  2b*c*U23kl))
Table 3. Bond Lengths(A)
atom atom distance atom atom distance
S (l) 0 ( 1 ) 1.453(2) S (l) 0 (2 ) 1.439(2)
S (l) 0 (3 ) 1.451(2) S (l) 0(5) 1.814(3)
0 (4 ) 0 (6 ) 1.309(3) 0 (5 ) 0 (6 ) 1.211(3)
N (l) 0 ( 1 ) 1.340(4) N (l) 0 (5) 1.347(3)
C (l) 0 ( 2 ) 1.365(4) 0 (2 ) 0 (3 ) 1.380(4)
C(3) 0 (4 ) 1.398(4) 0 (4) 0 (5 ) 1.381(4)
C(4) 0 (6 ) 1.503(4)
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Table 4. Bond Lengths(A)
atom atom distance atom atom distance
0 (4 ) H(5) 0.90(4) N (l) H (l) 0.95
C (l) H(2) 0.95 C(2) H(3) 0.95
C(3) H(4) 0.95
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Table 5. Bond Angles(*)
atom atom atom angle atom atom atom angle
0 ( 1 ) S (l) 0 (2 ) 114.4(1) 0 ( 1 ) S(l) 0 (3 ) 114.0(1)
0 ( 1 ) S (l) 0 (6 ) 105.3(1) 0 (2 ) S (l) 0 (3 ) 114.1(1)
0 (2 ) S (l) 0 (5) 104.9(1) 0 (3 ) S (l) 0 (5 ) 102.4(1)
0 ( 1 ) N (l) 0 (5 ) 123.8(2) N (l) 0 ( 1 ) 0 (2 ) 119.7(3)
0 ( 1 ) C(2) 0 (3) 118.6(3) 0 (2 ) 0(3) 0 (4 ) 120.8(3)
0 (3) C(4) 0 (5) 118.7(3) 0 (3 ) 0(4) 0 (6 ) 115.8(2)
0 ( 6 ) C(4) 0 (6 ) 125.5(3) S (l) 0(5) N (l) 113.0(2)
S (l) C(5) 0 (4 ) 128.7(2) N (l) 0(5) 0 (4 ) 118.2(2)
0 (4 ) C(6 ) 0 (5 ) 125.5(3) 0 (4 ) 0 (6 ) 0 (4 ) 114.2(3)
0 (5 ) C(6 ) 0 (4) 120.3(3)
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Table 6. Bond Angles(*)
atom atom atom angle atom atom atom angle
0 (6) 0 (4 ) H(5) 112(2) 0 (1) N (l) H (l) 118.1
0 (5) N (l) H (l) 118.1 N (l) 0 (1) H(2) 120.3
0 (2) 0 (1) H(2) 120.0 0 (1) 0 (2) H(3) 120.6
0(3) 0 (2) H(3) 120.8 0 (2) 0 (3) H(4) 119.6
0(4) 0 (3 ) H(4) 119.6
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Table 7. Torsion Angles(*)
atom atom atom atom angle atom atom atom atom angle
S (l) C(5) N (l) C (l) -173.7(2) S (l) 0(5) 0 (4 ) 0 (3 ) 174.7(2)
S (l) C(5) 0(4) 0 (6) -6.7(4) 0 (1) S (l) 0 (5 ) N (l) -133.8(2)
0 (1) S (l) 0(5) 0(4) 48.4(3) 0 (2) S (l) 0 (5 ) N (l) 105.2(2)
0 (2) S (l) 0 (5) 0(4) -72.6(3) 0 (3 ) S(l) 0 (5 ) N (l) -14.2(2)
0 (3 ) S (l) 0 (5) 0 (4 ) 168.0(2) 0 (4 ) 0 (6) 0 (4 ) 0 (3 ) -137.9(3)
0 (4 ) C(6) 0(4) 0 (5 ) 43.5(4) 0 (5 ) 0 (6) 0 (4) 0 (3) 40.6(4)
0 (5 ) C(6) 0(4) 0 (5 ) -138.0(3) N (l) 0 (1) 0 (2) 0 (3) -1.5(5)
N (l) C(5) 0(4) 0 (3 ) -3.0(4) N (l) 0(5) 0 (4) 0 (6) 175.6(3)
0 (1) N (l) 0 (5 ) 0 (4 ) 4.3(4) 0 (1) 0 (2) 0 (3) 0 (4 ) 2.7(5)
0 (2) C (l) N (l) 0 (5) -2.1(4) 0 (2) 0 (3) 0 (4) 0 (5 ) -0.5(4)
0 (2) C(3) 0(4) 0 (6) -179.2(3)
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Table 8. Non-bonded Contacts ont to 3.60 A
atom atom distance ADO atom atom distance ADC
S (l) N (l) 3.588(2) 74602 OU) OU) 2.651(3) 85603
0 ( 1 ) c u ) 2.957(4) 65501 OQJ N (l) 3.080(3) 65501
() ( 1 ) c a ) 3.211(3) 74602 OU) N (l) 3.492(3) 74602
() ( 1 ) (](6 ) 3.493(3) 85603 (]( 1 ) (3(2) 3.567(4) 65501
0 ( 1 ) ()(5) 3.587(3) 85603 (](2 ) (](6 ) 2.954(3) 75603
()( 2 ) ()(4) 3.103(3) 75603 ()( 2 ) (3(3) 3.146(4) 75603
()( 2 ) (3(4) 3,235(3) 75603 ()( 2 ) 0 (5 ) 3.333(3) 75603
()( 2 ) N (l) 3.344(3) 74602 (3(2) (3(1) 3.360(3) 64602
0 ^ 4 0 (3 ) 3.436(3) 74602 (]( 2 ) (3(5) 3.589(3) 74602
0 ^^ 0 (3 ) 3.230(3) 4 (3(3) 0 (6 ) 3.278(3) 45504
0 (2 ) 3.439(4) 64602 (3(3) C (l) 3.480(4) 64602
0(4 ) 0 (4 ) 2.827(4) 85603 0(4 ) (3(5) 3.208(3) 75603
OM) (%4) 3.229(3) 75603 0(4) 0(4) 3.572(4) 75603
OH) N (l) 3.584(3) 75603 0(4) (%3) 3.592(4) 75603
0 ^ 0 N (l) 2.793(3) 55404 0(5) (%1 ) 3.149(4) 55404
0 ^ ) Q[2 ) 3.400(4) 76603 0(5 ) (%2 ) 3.482(4) 65501
0(3) 0 ^ 0 3.555(6) 76603
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The ADC (atom designator code) specifies the position of an atom in a crystal. The 5-digit number 
shown in the table is a composite of three one-digit numbers and one two-digit number: TA (first digit) 
-h TB (second digit) -f TC (third digit) +  SN (last two digits). TA, TB and TC are the crystal lattice 
translation digits along cell edges a, b and c. A translation digit of 5 indicates the origin unit cell. If TA =  4, 
this indicates a translation of one unit cell length along the a-axis in the negative direction. Each translation 
digit can range in value from 1  to 9 and thus ± 4  lattice translations from the origin (TA=5, T B =5, TC =5) 
can be represented.
The SN, or symmetry operator number, refers to the number of the symmetry operator used to generate 
the coordinates of the target atom. A list of symmetry operators relevant to this structure are given below.
For a given intermolecular contact, the first atom (origin atom) is located in the origin unit cell and its 
position can be generated using the identity operator (S N = 1 ). Thus, the ADC for an origin atom is always 
55501. The position of the second atom (target atom) can be generated using the ADC and the coordinates 
of the atom in the parameter table. For example, an ADC of 47502 refers to the target atom moved through 
symmetry operator two, then translated - 1  cell translations-along the a axis, + 2  cell translations along the 
b axis, and 0  cell translations along the c axis.
An ADC of 1 indicates an intermolecular contact between two fragments (eg. cation and anion) that 
reside in the same asymmetric unit.
Symmetry Operators:
(1) X, Y , Z (2) 1 /2-X , 1/2-f-Y, 1/2-Z
(3) -X, -Y , -Z (4) 1 /2 - fX ,  1 /2 -Y , 1/2-t-Z
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aPo f = o
